Mml的个人主页 - 老虎社区

Mml

Mml

暂无个人介绍

IP属地：未知

458关注

119粉丝

0主题

0勋章

2021-12-21

Yup

MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote>

2021-12-21

Hmmm

AMC Stock: There Are 7 Million Reasons AMC Is on Wall Street’s Big Screen Today<blockquote>AMC股票：AMC今天出现在华尔街大银幕上的原因有700万个</blockquote>

2021-12-19

Hmmm

抱歉，原内容已删除

2021-12-18

Hmmm

抱歉，原内容已删除

2021-12-17

Hmmm

5 Stocks To Watch For December 17, 2021<blockquote>2021年12月17日值得关注的5只股票</blockquote>

2021-12-17

Informative

Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>

2021-12-16

Informative

10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote>

2021-12-16

Hmmmm

Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>

2021-12-16

Informative

Shopify rallies after Evercore ISI calls out +25% upside potential<blockquote>Evercore ISI评级上涨潜力+25%后Shopify上涨</blockquote>

2021-12-16

Informative

Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>

2021-12-14

Informative

Tesla Stock Is in a Bear Market Again. What’s Next for Musk’s EV Firm.<blockquote>特斯拉股票再次陷入熊市。马斯克电动汽车公司的下一步是什么。</blockquote>

2021-12-13

Great

Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>

2021-12-11

Hmmm

Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>

2021-12-09

Good

Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>

2021-12-08

Hmmm

Pinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote>

2021-12-07

Good

Intel shares surged more than 7% in after-hours trading<blockquote>英特尔股价在盘后交易中飙升逾7%</blockquote>

2021-12-06

Hmmm

Singapore Bourse Expected To Remain Rangebound On Monday<blockquote>新加坡证券交易所预计周一将保持区间震荡</blockquote>

2021-12-03

Hmmm

抱歉，原内容已删除

2021-12-02

Informative

Glaxo says its vaccine retains activity against key Omicron mutations<blockquote>葛兰素史克表示其疫苗保留了针对关键奥密克戎突变的活性</blockquote>

2021-11-29

Oh

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3584863771682470","uuid":"3584863771682470","gmtCreate":1622209062843,"gmtModify":1706620618674,"name":"Mml","pinyin":"mml","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":119,"headSize":458,"tweetSize":318,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":693793472,"gmtCreate":1640074494388,"gmtModify":1640074495552,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693793472","repostId":"1173202355","repostType":4,"repost":{"id":"1173202355","kind":"news","pubTimestamp":1640053734,"share":"https://www.laohu8.com/m/news/1173202355?lang=zh_CN&edition=full","pubTime":"2021-12-21 10:28","market":"us","language":"en","title":"MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1173202355","media":"InvestorPlace","summary":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omic","content":"<p><div> As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p><p><blockquote><div>随着华尔街又一周的开始，很明显，奥密克戎变种蔓延的不祥报道仍在给市场蒙上阴影。本周以喜忧参半的消息开始...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-21 10:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p><p><blockquote><div>随着华尔街又一周的开始，很明显，奥密克戎变种蔓延的不祥报道仍在给市场蒙上阴影。本周以喜忧参半的消息开始...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","PFE":"辉瑞","OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173202355","content_text":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.\nWhat’s Going on With Vaccine Stocks?\nFor the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.Moderna(NASDAQ:MRNA) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.\nMeanwhile, most of its peers aren’t fairing much better.Novavax(NASDAQ:NVAX) just received authorization from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally, Ocugen(NASDAQ:OCGN) is also falling after an initial early day rise driven by superficial catalysts.\nThe only vaccine stock in the green this morning is Pfizer(NYSE:PFE), which is up more than 2% today despite the recent setback the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based BioNTech(NASDAQ:BNTX) is down 4.19% so far, despite the recent news that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.\nWhy It Matters\nWhile the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.\nHowever, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.\nWhat It Means\nDespite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.\nRegardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9,"MRNA":0.9,"NVAX":0.9,"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693793575,"gmtCreate":1640074461030,"gmtModify":1640074462166,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693793575","repostId":"1158137251","repostType":4,"repost":{"id":"1158137251","kind":"news","pubTimestamp":1640054738,"share":"https://www.laohu8.com/m/news/1158137251?lang=zh_CN&edition=full","pubTime":"2021-12-21 10:45","market":"us","language":"en","title":"AMC Stock: There Are 7 Million Reasons AMC Is on Wall Street’s Big Screen Today<blockquote>AMC股票：AMC今天出现在华尔街大银幕上的原因有700万个</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158137251","media":"InvestorPlace","summary":"Movie theater giant and meme-stock darling AMC Entertainment(NYSE:AMC) has an extra spring in its st","content":"<p><div> Movie theater giant and meme-stock darling AMC Entertainment(NYSE:AMC) has an extra spring in its step today.Spider-Man: No Way Homecrushed box office expectations — and several attendance records. ...</p><p><blockquote><div>电影院巨头和迷因股宠儿AMC院线（纽约证券交易所股票代码：AMC）今天又多了一个春天。蜘蛛侠：英雄无归打破了票房预期——以及多项上座率记录。...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Stock: There Are 7 Million Reasons AMC Is on Wall Street’s Big Screen Today<blockquote>AMC股票：AMC今天出现在华尔街大银幕上的原因有700万个</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Stock: There Are 7 Million Reasons AMC Is on Wall Street’s Big Screen Today<blockquote>AMC股票：AMC今天出现在华尔街大银幕上的原因有700万个</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-21 10:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Movie theater giant and meme-stock darling AMC Entertainment(NYSE:AMC) has an extra spring in its step today.Spider-Man: No Way Homecrushed box office expectations — and several attendance records. ...</p><p><blockquote><div>电影院巨头和迷因股宠儿AMC院线（纽约证券交易所股票代码：AMC）今天又多了一个春天。蜘蛛侠：英雄无归打破了票房预期——以及多项上座率记录。...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://investorplace.com/2021/12/amc-stock-there-are-7-million-reasons-amc-is-on-wall-streets-big-screen-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158137251","content_text":"Movie theater giant and meme-stock darling AMC Entertainment(NYSE:AMC) has an extra spring in its step today.Spider-Man: No Way Homecrushed box office expectations — and several attendance records. Despite mounting omicron variant concerns, AMC stock is up 1.99% today after Friday’s 20% leap.\nWhat else do you need to know about AMC’s web-slinging stock surge?\nSpider-Man closed its opening weekend with a bang. The film claimed the biggest December opening of all time, even breaking post-quarantine domestic attendance numbers three times since Friday. When all was said and done, AMC sold more than 7 million tickets from Thursday’s midnight premiere through Sunday. More than 5 million tickets were from U.S. theaters alone. This marks the first time AMC sold at least 1 million tickets each day through a premiere since October 2019. International numbers also enjoyed new highs, setting a new single-day attendance record on Saturday.\nEven trifling through screening options, AMC enjoyed across-the-board boosts from the friendly neighborhood spider. Premium large format (PLF), Dolby Cinema and IMAX each saw elevated screenings this weekend, as it was the biggest weekend ever for AMC Prime.\nNo Way Homeisn’t just unique in its sales numbers: It’s a hyper-modern crypto experiment that may have succeeded. AMC surprised consumers after announcing the giveaway of non-fungible tokens (NFTs) for early buyers of the Spider-Man midnight-release showings. There were a number of conditions to be met to receive the NFT, but roughly 86,000 early birds ended up with a digital item.\nWill the Spidey Upswing Shift AMC Stock Perspectives?\nIt’s a bit too early to say whether the NFT promotion served as a boost to movie demand —Spider-Man is practically always a box-office success. Additionally, the film received rave reviews from the jump, earning a 94% aggregate score on review site Rotten Tomatoes.CinemaScoreeven gave the Marvel film a rare A-plus. As such, the NFT offering clearly didn’t stifle interest in Tom Holland’s latest endeavor, despite it being difficult to definitively attach any causation to the giveaway.\nHowever, will Spider-Man sling the recently stumbling theater industry back into the spotlight? AMC CEO Adam Aron had some uplifting words for the movie business in lieu of the promising numbers.\n\n “Historically, December is one of the biggest months of the year for major blockbuster releases, so to see SPIDER-MAN: NO WAY HOME set a new all-time opening weekend box office record this month is significant not just for AMC, but for the entire theatrical industry. … We commend our friends at Sony Pictures and Marvel on their wonderfully successful movie, which millions of people have already watched at a U.S. AMC theatre in just 4 days.”\n\nThe news brings with it a sigh of relief for the recently struggling movie industry. Only time will tell if Spider-Man marks a resurgence for the star-studded business, but prospects are better than ever.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":2555,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693093016,"gmtCreate":1639921042860,"gmtModify":1639921044084,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693093016","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":2770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699244211,"gmtCreate":1639824079138,"gmtModify":1639824080377,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699244211","repostId":"2192754259","repostType":4,"isVote":1,"tweetType":1,"viewCount":2577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699311815,"gmtCreate":1639748452488,"gmtModify":1639748453638,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699311815","repostId":"1154435289","repostType":4,"repost":{"id":"1154435289","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639733312,"share":"https://www.laohu8.com/m/news/1154435289?lang=zh_CN&edition=full","pubTime":"2021-12-17 17:28","market":"us","language":"en","title":"5 Stocks To Watch For December 17, 2021<blockquote>2021年12月17日值得关注的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1154435289","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Darden Restaurants, ","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能引起投资者关注的一些股票包括：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Darden Restaurants, Inc.</b>&nbsp;to report quarterly earnings at $1.44 per share on revenue of $2.23 billion before the opening bell. Darden Restaurants shares slipped 0.8% to $145.99 in after-hours trading.</li>  <li><b>FedEx Corporation</b>&nbsp;reported better-than-expected results for its second quarter and boosted its FY22 earnings guidance. The company also reported a $5 billion buyback, including $1.5 billion accelerated buyback program. FedEx shares climbed 4.9% to $250.30 in the after-hours trading session.</li>  <li>Analysts are expecting&nbsp;<b>Winnebago Industries, Inc.</b>&nbsp;to have earned $2.25 per share on revenue of $1.01 billion for the latest quarter. The company will release earnings before the market open. On Thursday, Winnebago’s board approved a quarterly cash dividend of $0.18 per share. Winnebago shares gained 4.6% to $71.00 in after-hours trading.</li> </ul> <ul>  <li><b>Steelcase Inc.</b>&nbsp;reported downbeat results for its third quarter and issued weak sales forecast for the current quarter. Steelcase shares dropped 3.7% to $11.09 in the after-hours trading session.</li>  <li><b>United States Steel Corporation</b>&nbsp;said it projects adjusted earnings before interest, taxes, depreciation and amortization of around $1.65 billion for the fourth quarter, versus analysts’ estimates of $2.13 billion amid a slowdown in orders. United States Steel shares dropped 5.1% to $22.26 in after-hours trading.</li> </ul></p><p><blockquote><ul><li>华尔街预计<b>达顿餐饮公司。</b>开盘前公布季度收益为每股1.44美元，营收为22.3亿美元。达顿餐厅股价在盘后交易中下跌0.8%，至145.99美元。</li><li><b>联邦快递公司</b>公布的第二季度业绩好于预期，并上调了2022财年盈利指引。该公司还报告了50亿美元的回购，其中包括15亿美元的加速回购计划。联邦快递股价在盘后交易时段上涨4.9%至250.30美元。</li><li>分析师预计<b>温尼贝戈工业公司。</b>最近一个季度的营收为10.1亿美元，每股收益为2.25美元。该公司将在开盘前发布财报。周四，温尼贝戈董事会批准了每股0.18美元的季度现金股息。温尼贝戈股价在盘后交易中上涨4.6%，至71.00美元。</li></ul><ul><li><b>斯蒂尔凯斯公司。</b>报告了悲观的第三季度业绩，并发布了疲软的本季度销售预测。Steelcase股价在盘后交易时段下跌3.7%，至11.09美元。</li><li><b>美国钢铁公司</b>该公司表示，由于订单放缓，预计第四季度调整后息税折旧摊销前利润约为16.5亿美元，而分析师预期为21.3亿美元。美国钢铁公司股价在盘后交易中下跌5.1%，至22.26美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 17, 2021<blockquote>2021年12月17日值得关注的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 17, 2021<blockquote>2021年12月17日值得关注的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-12-17 17:28</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能引起投资者关注的一些股票包括：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Darden Restaurants, Inc.</b>&nbsp;to report quarterly earnings at $1.44 per share on revenue of $2.23 billion before the opening bell. Darden Restaurants shares slipped 0.8% to $145.99 in after-hours trading.</li>  <li><b>FedEx Corporation</b>&nbsp;reported better-than-expected results for its second quarter and boosted its FY22 earnings guidance. The company also reported a $5 billion buyback, including $1.5 billion accelerated buyback program. FedEx shares climbed 4.9% to $250.30 in the after-hours trading session.</li>  <li>Analysts are expecting&nbsp;<b>Winnebago Industries, Inc.</b>&nbsp;to have earned $2.25 per share on revenue of $1.01 billion for the latest quarter. The company will release earnings before the market open. On Thursday, Winnebago’s board approved a quarterly cash dividend of $0.18 per share. Winnebago shares gained 4.6% to $71.00 in after-hours trading.</li> </ul> <ul>  <li><b>Steelcase Inc.</b>&nbsp;reported downbeat results for its third quarter and issued weak sales forecast for the current quarter. Steelcase shares dropped 3.7% to $11.09 in the after-hours trading session.</li>  <li><b>United States Steel Corporation</b>&nbsp;said it projects adjusted earnings before interest, taxes, depreciation and amortization of around $1.65 billion for the fourth quarter, versus analysts’ estimates of $2.13 billion amid a slowdown in orders. United States Steel shares dropped 5.1% to $22.26 in after-hours trading.</li> </ul></p><p><blockquote><ul><li>华尔街预计<b>达顿餐饮公司。</b>开盘前公布季度收益为每股1.44美元，营收为22.3亿美元。达顿餐厅股价在盘后交易中下跌0.8%，至145.99美元。</li><li><b>联邦快递公司</b>公布的第二季度业绩好于预期，并上调了2022财年盈利指引。该公司还报告了50亿美元的回购，其中包括15亿美元的加速回购计划。联邦快递股价在盘后交易时段上涨4.9%至250.30美元。</li><li>分析师预计<b>温尼贝戈工业公司。</b>最近一个季度的营收为10.1亿美元，每股收益为2.25美元。该公司将在开盘前发布财报。周四，温尼贝戈董事会批准了每股0.18美元的季度现金股息。温尼贝戈股价在盘后交易中上涨4.6%，至71.00美元。</li></ul><ul><li><b>斯蒂尔凯斯公司。</b>报告了悲观的第三季度业绩，并发布了疲软的本季度销售预测。Steelcase股价在盘后交易时段下跌3.7%，至11.09美元。</li><li><b>美国钢铁公司</b>该公司表示，由于订单放缓，预计第四季度调整后息税折旧摊销前利润约为16.5亿美元，而分析师预期为21.3亿美元。美国钢铁公司股价在盘后交易中下跌5.1%，至22.26美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","SCS":"Steelcase Inc.","DRI":"达登饭店","FDX":"联邦快递","WGO":"温尼巴格实业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154435289","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Darden Restaurants, Inc. to report quarterly earnings at $1.44 per share on revenue of $2.23 billion before the opening bell. Darden Restaurants shares slipped 0.8% to $145.99 in after-hours trading.\nFedEx Corporation reported better-than-expected results for its second quarter and boosted its FY22 earnings guidance. The company also reported a $5 billion buyback, including $1.5 billion accelerated buyback program. FedEx shares climbed 4.9% to $250.30 in the after-hours trading session.\nAnalysts are expecting Winnebago Industries, Inc. to have earned $2.25 per share on revenue of $1.01 billion for the latest quarter. The company will release earnings before the market open. On Thursday, Winnebago’s board approved a quarterly cash dividend of $0.18 per share. Winnebago shares gained 4.6% to $71.00 in after-hours trading.\n\n\nSteelcase Inc. reported downbeat results for its third quarter and issued weak sales forecast for the current quarter. Steelcase shares dropped 3.7% to $11.09 in the after-hours trading session.\nUnited States Steel Corporation said it projects adjusted earnings before interest, taxes, depreciation and amortization of around $1.65 billion for the fourth quarter, versus analysts’ estimates of $2.13 billion amid a slowdown in orders. United States Steel shares dropped 5.1% to $22.26 in after-hours trading.","news_type":1,"symbols_score_info":{"FDX":0.9,"DRI":0.9,"WGO":0.9,"SCS":0.9,"X":0.9}},"isVote":1,"tweetType":1,"viewCount":3831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699335292,"gmtCreate":1639747930518,"gmtModify":1639747931645,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699335292","repostId":"1138605449","repostType":4,"repost":{"id":"1138605449","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639746084,"share":"https://www.laohu8.com/m/news/1138605449?lang=zh_CN&edition=full","pubTime":"2021-12-17 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138605449","media":"Tiger Newspress","summary":"U.S. Stock futures headed for a lower open Friday morning after a rout in technology stocks during T","content":"<p>U.S.&nbsp;Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.</p><p><blockquote>周四常规交易日科技股暴跌后，美国股指期货周五早盘低开，因投资者预期明年货币政策收紧而远离成长型股。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&amp;P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.<img src=\"https://static.tigerbbs.com/120d112226a9ec4591babf844729ca58\" tg-width=\"1080\" tg-height=\"376\" width=\"100%\" height=\"auto\">Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed&nbsp;could hike interest rates three times next year.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini下跌117点，跌幅0.33%，标普500 e-mini下跌24点，跌幅0.52%，纳斯达克100 e-mini下跌153.5点，跌幅0.97%。本周投资者的主要关注点仍然集中在美联储对明年货币政策的最新展望上，央行周中发布的预测表明美联储明年可能加息三次。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a></b> – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DRI\">达顿餐厅</a></b>–Olive Garden、Longhorn Steakhouse和其他连锁餐厅的母公司超出预期5美分，季度收益为每股1.48美元，收入也超出预期。同店销售额增长34.4%，高于StreetAccount编制的32.6%的普遍预期，达顿发布了乐观预测。另外，达顿宣布首席执行官Eugene Lee将于2022年5月退休，由现任总裁兼首席运营官Ricardo Cardenas接任。达顿盘前下跌5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WGO\">Winnebago</a></b> – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WGO\">温尼贝戈</a></b>-这家休闲车制造商在第一财季盈利大幅增长后，盘前交易股价上涨3.4%。温尼贝戈每股收益3.51美元，而市场普遍预期为2.26美元，营收也高于分析师预测。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/FDX\">FedEx</a></b> – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.</p><p><blockquote><b><a href=\"https://laohu8.com/S/FDX\">联邦快递</a></b>-该快递服务公司最近一个季度的营收和利润超出预期，盘前上涨5.9%。联邦快递调整后每股收益为4.83美元，超过市场普遍预期的4.28美元，运费上涨有助于弥补支出的增加。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/RIVN\">Rivian汽车公司。</a></b>-这家电动汽车制造商第三季度亏损12.3亿美元，原因是开始生产电动皮卡车的费用。这是Rivian上市以来的第一份季度报告，首次交付的收入为100万美元。该股在盘前交易中下跌7.9%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/EPAY\">Bottomline</a></b> – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/EPAY\">底线</a></b>–在这家金融科技公司同意被私募股权公司Thoma Bravo以每股57美元现金（即26亿美元）收购后，Bottomline股价在盘前飙升15.1%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that&nbsp;Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.</p><p><blockquote><b><a href=\"https://laohu8.com/S/CERN\">塞尔纳</a></b>–在《华尔街日报》报道甲骨文(ORCL)正在洽谈以300亿美元的潜在交易收购Cerner后，这家医疗保健信息技术公司的股价在盘前交易中飙升18.9%。甲骨文跌4.6%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> – <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> shares fell 2.1% in the premarket after the CDC recommended that adults receive the&nbsp;Pfizer(PFE) or&nbsp;Moderna(MRNA) Covid-19 vaccines rather than the J&amp;J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.</p><p><blockquote><b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>–<b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>在CDC建议成年人接种辉瑞(PFE)或Moderna(MRNA)Covid-19疫苗而不是强生疫苗后，股价在盘前下跌2.1%。疾病预防控制中心引用的新数据显示，凝血状况的水平比之前想象的要高，尽管这种情况仍然很少见。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AFRM\">Affirm Holdings, Inc.</a></b> – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.</p><p><blockquote><b><a href=\"https://laohu8.com/S/AFRM\">确认控股公司。</a></b>–在消费者金融保护局表示正在对提供此类计划的公司展开调查后，这家“先买后付”公司的股价在盘前下跌2.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>–英国《金融时报》报道称，欧洲药品管理局最早可能于下周批准其Covid-19疫苗紧急使用，该制药商股价在盘前上涨1.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/X\">U.S. Steel</a></b> – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.</p><p><blockquote><b><a href=\"https://laohu8.com/S/X\">美国钢铁公司</a></b>-该钢铁制造商的股价在盘前下跌4.4%，此前该公司发布了低于预期的本季度指引，费用增加和谨慎的客户购买模式抵消了钢铁定价的改善。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b> – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b>-这家办公家具制造商公布的第三季度利润和收入低于预期，Steelcase表示其业绩受到供应链问题和成本上升的影响。Steelcase在盘前交易中下跌4.4%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-17 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S.&nbsp;Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.</p><p><blockquote>周四常规交易日科技股暴跌后，美国股指期货周五早盘低开，因投资者预期明年货币政策收紧而远离成长型股。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&amp;P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.<img src=\"https://static.tigerbbs.com/120d112226a9ec4591babf844729ca58\" tg-width=\"1080\" tg-height=\"376\" width=\"100%\" height=\"auto\">Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed&nbsp;could hike interest rates three times next year.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini下跌117点，跌幅0.33%，标普500 e-mini下跌24点，跌幅0.52%，纳斯达克100 e-mini下跌153.5点，跌幅0.97%。本周投资者的主要关注点仍然集中在美联储对明年货币政策的最新展望上，央行周中发布的预测表明美联储明年可能加息三次。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a></b> – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DRI\">达顿餐厅</a></b>–Olive Garden、Longhorn Steakhouse和其他连锁餐厅的母公司超出预期5美分，季度收益为每股1.48美元，收入也超出预期。同店销售额增长34.4%，高于StreetAccount编制的32.6%的普遍预期，达顿发布了乐观预测。另外，达顿宣布首席执行官Eugene Lee将于2022年5月退休，由现任总裁兼首席运营官Ricardo Cardenas接任。达顿盘前下跌5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WGO\">Winnebago</a></b> – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WGO\">温尼贝戈</a></b>-这家休闲车制造商在第一财季盈利大幅增长后，盘前交易股价上涨3.4%。温尼贝戈每股收益3.51美元，而市场普遍预期为2.26美元，营收也高于分析师预测。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/FDX\">FedEx</a></b> – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.</p><p><blockquote><b><a href=\"https://laohu8.com/S/FDX\">联邦快递</a></b>-该快递服务公司最近一个季度的营收和利润超出预期，盘前上涨5.9%。联邦快递调整后每股收益为4.83美元，超过市场普遍预期的4.28美元，运费上涨有助于弥补支出的增加。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/RIVN\">Rivian汽车公司。</a></b>-这家电动汽车制造商第三季度亏损12.3亿美元，原因是开始生产电动皮卡车的费用。这是Rivian上市以来的第一份季度报告，首次交付的收入为100万美元。该股在盘前交易中下跌7.9%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/EPAY\">Bottomline</a></b> – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/EPAY\">底线</a></b>–在这家金融科技公司同意被私募股权公司Thoma Bravo以每股57美元现金（即26亿美元）收购后，Bottomline股价在盘前飙升15.1%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that&nbsp;Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.</p><p><blockquote><b><a href=\"https://laohu8.com/S/CERN\">塞尔纳</a></b>–在《华尔街日报》报道甲骨文(ORCL)正在洽谈以300亿美元的潜在交易收购Cerner后，这家医疗保健信息技术公司的股价在盘前交易中飙升18.9%。甲骨文跌4.6%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> – <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> shares fell 2.1% in the premarket after the CDC recommended that adults receive the&nbsp;Pfizer(PFE) or&nbsp;Moderna(MRNA) Covid-19 vaccines rather than the J&amp;J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.</p><p><blockquote><b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>–<b><a href=\"https://laohu8.com/S/JNJ\">强生公司</a></b>在CDC建议成年人接种辉瑞(PFE)或Moderna(MRNA)Covid-19疫苗而不是强生疫苗后，股价在盘前下跌2.1%。疾病预防控制中心引用的新数据显示，凝血状况的水平比之前想象的要高，尽管这种情况仍然很少见。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AFRM\">Affirm Holdings, Inc.</a></b> – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.</p><p><blockquote><b><a href=\"https://laohu8.com/S/AFRM\">确认控股公司。</a></b>–在消费者金融保护局表示正在对提供此类计划的公司展开调查后，这家“先买后付”公司的股价在盘前下跌2.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>–英国《金融时报》报道称，欧洲药品管理局最早可能于下周批准其Covid-19疫苗紧急使用，该制药商股价在盘前上涨1.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/X\">U.S. Steel</a></b> – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.</p><p><blockquote><b><a href=\"https://laohu8.com/S/X\">美国钢铁公司</a></b>-该钢铁制造商的股价在盘前下跌4.4%，此前该公司发布了低于预期的本季度指引，费用增加和谨慎的客户购买模式抵消了钢铁定价的改善。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b> – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b>-这家办公家具制造商公布的第三季度利润和收入低于预期，Steelcase表示其业绩受到供应链问题和成本上升的影响。Steelcase在盘前交易中下跌4.4%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138605449","content_text":"U.S. Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.\nAt 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed could hike interest rates three times next year.\nStocks making the biggest moves premarket: \nDarden Restaurants – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.\nWinnebago – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.\nFedEx – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.\nRivian Automotive, Inc. – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.\nBottomline – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.\nCerner – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.\nJohnson & Johnson – Johnson & Johnson shares fell 2.1% in the premarket after the CDC recommended that adults receive the Pfizer(PFE) or Moderna(MRNA) Covid-19 vaccines rather than the J&J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.\nAffirm Holdings, Inc. – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.\nNovavax – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.\nU.S. Steel – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.\nSteelcase – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690605469,"gmtCreate":1639660809729,"gmtModify":1639660810880,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690605469","repostId":"1191683541","repostType":4,"repost":{"id":"1191683541","kind":"news","pubTimestamp":1639658241,"share":"https://www.laohu8.com/m/news/1191683541?lang=zh_CN&edition=full","pubTime":"2021-12-16 20:37","market":"us","language":"en","title":"10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191683541","media":"Benzinga","summary":"Stifel cut the price target on Under Armour, Inc.. from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading.RBC Capital lowered the price target on Airbnb, Inc. from $195 to $175. Airbnb shares rose 0.3% to $168.62 in pre-market trading.Morgan Stanley lowered DocuSign, Inc. price target from $350 to $165. DocuSign shares dropped 2.4% to $147.51 in pre-market trading.Barclays cut the price target on Aptiv PLC from $212 to $200. Aptiv shares rose 2.7% to $168.91 in pre-market","content":"<p><div> Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading. RBC Capital lowered the price target on Airbnb, Inc.(NASDAQ...</p><p><blockquote><div>Stifel将Under Armour，Inc.（纽约证券交易所代码：UAA）的目标价从30美元下调至24美元。Under Armour股价在盘前交易中下跌0.7%，至22.22美元。加拿大皇家银行资本下调了Airbnb，Inc.（纳斯达克...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-12-16 20:37</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading. RBC Capital lowered the price target on Airbnb, Inc.(NASDAQ...</p><p><blockquote><div>Stifel将Under Armour，Inc.（纽约证券交易所代码：UAA）的目标价从30美元下调至24美元。Under Armour股价在盘前交易中下跌0.7%，至22.22美元。加拿大皇家银行资本下调了Airbnb，Inc.（纳斯达克...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"At&T","DOCU":"Docusign","ABNB":"爱彼迎"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191683541","content_text":"Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading.\nRBC Capital lowered the price target on Airbnb, Inc.(NASDAQ:ABNB) from $195 to $175. Airbnb shares rose 0.3% to $168.62 in pre-market trading.\nMorgan Stanley cut AT&T Inc.(NYSE:T) price target from $32 to $28. AT&T shares rose 1.7% to $22.55 in pre-market trading.\nMorgan Stanley lowered DocuSign, Inc.(NASDAQ:DOCU) price target from $350 to $165. DocuSign shares dropped 2.4% to $147.51 in pre-market trading.\nBarclays cut the price target on Aptiv PLC(NYSE:APTV) from $212 to $200. Aptiv shares rose 2.7% to $168.91 in pre-market trading.\nRaymond James raised The Progressive Corporation(NYSE:PGR) price target from $105 to $110. Progressive shares rose 4.8% to close at $101.81 on Wednesday.\nWells Fargo boosted the price target for Magna International Inc.(NYSE:MGA) from $84 to $93. Magna International shares rose 1.7% to $79.04 in pre-market trading.\nB of A Securities reduced the price target for Wayfair Inc.(NYSE:W) from $265 to $175. Wayfair shares dropped 2.4% to $202.28 in pre-market trading.\nHC Wainwright & Co. cut IGM Biosciences, Inc.(NASDAQ:IGMS) price target from $114 to $76. IGM Biosciences shares fell 0.1% to close at $28.35 on Wednesday.\nNeedham cut Medtronic plc(NYSE:MDT) price target from $145 to $131. Medtronic shares rose 0.1% to $105.01 in pre-market trading.","news_type":1,"symbols_score_info":{"T":0.9,"DOCU":0.9,"ABNB":0.9}},"isVote":1,"tweetType":1,"viewCount":2727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690608287,"gmtCreate":1639660378795,"gmtModify":1639660378795,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmmm","listText":"Hmmmm","text":"Hmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690608287","repostId":"1142996286","repostType":4,"repost":{"id":"1142996286","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639659703,"share":"https://www.laohu8.com/m/news/1142996286?lang=zh_CN&edition=full","pubTime":"2021-12-16 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142996286","media":"Tiger Newspress","summary":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.$Delta Air Lines$ – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-","content":"<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p><p><blockquote>美国股指期货周四上午上涨，此前市场在前一交易日出现180度大转弯，欢迎美联储决定加快缩减规模并暂时维持利率不变。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini上涨204点，涨幅0.57%，标普500 e-mini上涨31.25点，涨幅0.66%，纳斯达克100 e-mini上涨115.25点，涨幅0.71%。随着美联储周三给市场喘息的机会，交易员将在周四转向劳工部关于每周首次申请失业救济人数的最新数据。首次申请失业救济人数预计将在去年创下52周低点后小幅上升。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DAL\">达美航空</a></b>-达美航空预计第四季度利润为2亿美元，盘前上涨2.3%。市场普遍预测达美航空将出现季度亏损，但该航空公司表示，假期需求强劲，利润有望超过大流行前的水平。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ACN\">埃森哲公司</a></b>-该咨询公司公布最新季度利润和收入好于预期，并上调2022财年盈利指引后，其股价盘前飙升6.7%。埃森哲客户群中四个最大行业集团的收入增长了20%以上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p><p><blockquote><b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>-该制药商表示其抗体鸡尾酒对奥密克戎Covid-19变种失去效力后，其股价在盘前交易中下跌1%。再生元确实说过这种鸡尾酒对德尔塔变异毒株有效。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p><p><blockquote><b><a href=\"https://laohu8.com/S/LEN\">伦纳尔</a></b>-Lennar公布的季度收益为每股3.91美元，低于市场普遍预期的4.15美元，该住宅建筑商的收入也低于预期。Lennar受到木材成本上涨、劳动力成本增加和原材料短缺的影响，导致送货上门延迟。Lennar在盘前下跌6.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVS\">诺华公司</a></b>-诺华启动了一项价值高达150亿美元的新股票回购计划，该制药商计划在2023年底前完成这些回购。股价在盘前交易中上涨4%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/V\">签证</a> </b>–<a href=\"https://laohu8.com/S/V\">签证</a>盘前股价上涨1.1%，此前该公司宣布向其股票回购计划增加120亿美元，使其回购授权总额达到132亿美元。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SJM\">Smucker的</a></b>-Smucker达成协议，以1.1亿美元的价格将其天然饮料和谷物业务出售给私募股权公司Nexus Capital Management，这家食品生产商表示希望将更多资源集中在其核心品牌上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ISRG\">直观手术</a></b>–<a href=\"https://laohu8.com/S/ISRG\">直观手术</a>被添加到高盛的“坚定买入”名单中，这表明该公司即将推出一种新的手术系统。盘前股价上涨1.2%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/T\">AT&amp;T公司</a></b>-摩根士丹利将AT&amp;T的评级从“同等权重”上调至“跑赢大盘”，称该股近期的下滑创造了有吸引力的风险回报状况。该公司表示，还有其他几个关键因素推动了此次升级，包括WarnerMedia/Discovery合并即将完成。AT&amp;T在盘前交易中上涨1.5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WOOF\">Petco健康和保健公司。</a></b>-在Needham开始给予“买入”评级后，这家宠物产品销售商的股价在盘前上涨了1.9%。该公司认为，鉴于Petco在包括兽医医院在内的多个渠道中的存在，它应该会超越宠物类别的竞争对手。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a></b>–Evercore将其评级从“持平”上调至“跑赢大盘”后，该电子商务平台运营商在盘前交易中上涨2.9%。Evercore指出，该股比年度高点低约20%，就增长机会而言，该公司代表着优质资产。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p><p><blockquote>美国股指期货周四上午上涨，此前市场在前一交易日出现180度大转弯，欢迎美联储决定加快缩减规模并暂时维持利率不变。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini上涨204点，涨幅0.57%，标普500 e-mini上涨31.25点，涨幅0.66%，纳斯达克100 e-mini上涨115.25点，涨幅0.71%。随着美联储周三给市场喘息的机会，交易员将在周四转向劳工部关于每周首次申请失业救济人数的最新数据。首次申请失业救济人数预计将在去年创下52周低点后小幅上升。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DAL\">达美航空</a></b>-达美航空预计第四季度利润为2亿美元，盘前上涨2.3%。市场普遍预测达美航空将出现季度亏损，但该航空公司表示，假期需求强劲，利润有望超过大流行前的水平。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ACN\">埃森哲公司</a></b>-该咨询公司公布最新季度利润和收入好于预期，并上调2022财年盈利指引后，其股价盘前飙升6.7%。埃森哲客户群中四个最大行业集团的收入增长了20%以上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p><p><blockquote><b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>-该制药商表示其抗体鸡尾酒对奥密克戎Covid-19变种失去效力后，其股价在盘前交易中下跌1%。再生元确实说过这种鸡尾酒对德尔塔变异毒株有效。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p><p><blockquote><b><a href=\"https://laohu8.com/S/LEN\">伦纳尔</a></b>-Lennar公布的季度收益为每股3.91美元，低于市场普遍预期的4.15美元，该住宅建筑商的收入也低于预期。Lennar受到木材成本上涨、劳动力成本增加和原材料短缺的影响，导致送货上门延迟。Lennar在盘前下跌6.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVS\">诺华公司</a></b>-诺华启动了一项价值高达150亿美元的新股票回购计划，该制药商计划在2023年底前完成这些回购。股价在盘前交易中上涨4%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/V\">签证</a> </b>–<a href=\"https://laohu8.com/S/V\">签证</a>盘前股价上涨1.1%，此前该公司宣布向其股票回购计划增加120亿美元，使其回购授权总额达到132亿美元。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SJM\">Smucker的</a></b>-Smucker达成协议，以1.1亿美元的价格将其天然饮料和谷物业务出售给私募股权公司Nexus Capital Management，这家食品生产商表示希望将更多资源集中在其核心品牌上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ISRG\">直观手术</a></b>–<a href=\"https://laohu8.com/S/ISRG\">直观手术</a>被添加到高盛的“坚定买入”名单中，这表明该公司即将推出一种新的手术系统。盘前股价上涨1.2%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/T\">AT&amp;T公司</a></b>-摩根士丹利将AT&amp;T的评级从“同等权重”上调至“跑赢大盘”，称该股近期的下滑创造了有吸引力的风险回报状况。该公司表示，还有其他几个关键因素推动了此次升级，包括WarnerMedia/Discovery合并即将完成。AT&amp;T在盘前交易中上涨1.5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WOOF\">Petco健康和保健公司。</a></b>-在Needham开始给予“买入”评级后，这家宠物产品销售商的股价在盘前上涨了1.9%。该公司认为，鉴于Petco在包括兽医医院在内的多个渠道中的存在，它应该会超越宠物类别的竞争对手。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a></b>–Evercore将其评级从“持平”上调至“跑赢大盘”后，该电子商务平台运营商在盘前交易中上涨2.9%。Evercore指出，该股比年度高点低约20%，就增长机会而言，该公司代表着优质资产。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142996286","content_text":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.\nAt 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.With the Fed giving markets a breather Wednesday, traders will turn their Thursday to fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after last’s 52-week low.\nStocks making the biggest moves premarket: \nDelta Air Lines – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.\nAccenture PLC – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.\nRegeneron Pharmaceuticals – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.\nLennar – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.\nNovartis AG – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.\nVisa – Visa rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.\nSmucker's – Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.\nIntuitive Surgical – Intuitive Surgical was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.\nAT&T Inc – Morgan Stanley upgraded AT&T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&T gained 1.5% in premarket trading.\nPetco Health and Wellness Company, Inc. – The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.\nShopify – The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":3228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690603041,"gmtCreate":1639660187421,"gmtModify":1639660188515,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690603041","repostId":"1122700546","repostType":4,"repost":{"id":"1122700546","kind":"news","pubTimestamp":1639656448,"share":"https://www.laohu8.com/m/news/1122700546?lang=zh_CN&edition=full","pubTime":"2021-12-16 20:07","market":"us","language":"en","title":"Shopify rallies after Evercore ISI calls out +25% upside potential<blockquote>Evercore ISI评级上涨潜力+25%后Shopify上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122700546","media":"Seeking Alpha","summary":"Evercore ISI upgrades Shopify(NYSE:SHOP)to an Outperform rating after having it lined up at In Line.","content":"<p><ul>  <li>Evercore ISI upgrades Shopify(NYSE:SHOP)to an Outperform rating after having it lined up at In Line.</li>  <li>Analyst Mark Mahaney says the stock is dislocated at 20% off their YTD highs and with a forward EV/sales multiple of 24X that is at a pre-pandemic level. Mahaney and team also view SHOP as one of the highest quality assets in their coverage, noting the 2021-2023 Revenue CAGR of 34% is the fastest among all the Mega and Large Cap coverage. Growth opportunities and option value are also called out.</li>  <li>Shares of SHOP are&nbsp;up 3.08%&nbsp;in premarket action to $1,410.26.</li>  <li>Evercore ISI assigns a price target of $1,770 to rep 29% upside potential and stands above the&nbsp;average Wall Street PT of $1,698.19.</li> </ul></p><p><blockquote><ul><li>Evercore ISI将Shopify(NYSE：SHOP)评级上调至跑赢大盘评级。</li><li>分析师Mark Mahaney表示，该股较年初至今高点下跌20%，远期EV/销售额倍数为24倍，处于大流行前的水平。Mahaney和团队还将SHOP视为其覆盖范围内最优质的资产之一，并指出2021-2023年收入复合年增长率为34%，是所有大型股和大盘股覆盖范围中最快的。增长机会和期权价值也被提及。</li><li>SHOP股价在盘前上涨3.08%，至1,410.26美元。</li><li>Evercore ISI将rep 29%的上涨潜力定为1,770美元，高于华尔街平均PT 1,698.19美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shopify rallies after Evercore ISI calls out +25% upside potential<blockquote>Evercore ISI评级上涨潜力+25%后Shopify上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShopify rallies after Evercore ISI calls out +25% upside potential<blockquote>Evercore ISI评级上涨潜力+25%后Shopify上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-16 20:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul>  <li>Evercore ISI upgrades Shopify(NYSE:SHOP)to an Outperform rating after having it lined up at In Line.</li>  <li>Analyst Mark Mahaney says the stock is dislocated at 20% off their YTD highs and with a forward EV/sales multiple of 24X that is at a pre-pandemic level. Mahaney and team also view SHOP as one of the highest quality assets in their coverage, noting the 2021-2023 Revenue CAGR of 34% is the fastest among all the Mega and Large Cap coverage. Growth opportunities and option value are also called out.</li>  <li>Shares of SHOP are&nbsp;up 3.08%&nbsp;in premarket action to $1,410.26.</li>  <li>Evercore ISI assigns a price target of $1,770 to rep 29% upside potential and stands above the&nbsp;average Wall Street PT of $1,698.19.</li> </ul></p><p><blockquote><ul><li>Evercore ISI将Shopify(NYSE：SHOP)评级上调至跑赢大盘评级。</li><li>分析师Mark Mahaney表示，该股较年初至今高点下跌20%，远期EV/销售额倍数为24倍，处于大流行前的水平。Mahaney和团队还将SHOP视为其覆盖范围内最优质的资产之一，并指出2021-2023年收入复合年增长率为34%，是所有大型股和大盘股覆盖范围中最快的。增长机会和期权价值也被提及。</li><li>SHOP股价在盘前上涨3.08%，至1,410.26美元。</li><li>Evercore ISI将rep 29%的上涨潜力定为1,770美元，高于华尔街平均PT 1,698.19美元。</li></ul></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3780681-shopify-rallies-after-evercore-isi-calls-out-25-upside-potential\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc"},"source_url":"https://seekingalpha.com/news/3780681-shopify-rallies-after-evercore-isi-calls-out-25-upside-potential","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122700546","content_text":"Evercore ISI upgrades Shopify(NYSE:SHOP)to an Outperform rating after having it lined up at In Line.\nAnalyst Mark Mahaney says the stock is dislocated at 20% off their YTD highs and with a forward EV/sales multiple of 24X that is at a pre-pandemic level. Mahaney and team also view SHOP as one of the highest quality assets in their coverage, noting the 2021-2023 Revenue CAGR of 34% is the fastest among all the Mega and Large Cap coverage. Growth opportunities and option value are also called out.\nShares of SHOP are up 3.08% in premarket action to $1,410.26.\nEvercore ISI assigns a price target of $1,770 to rep 29% upside potential and stands above the average Wall Street PT of $1,698.19.","news_type":1,"symbols_score_info":{"SHOP":0.9}},"isVote":1,"tweetType":1,"viewCount":3309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690609850,"gmtCreate":1639660136423,"gmtModify":1639660137549,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690609850","repostId":"1142996286","repostType":4,"repost":{"id":"1142996286","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639659703,"share":"https://www.laohu8.com/m/news/1142996286?lang=zh_CN&edition=full","pubTime":"2021-12-16 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142996286","media":"Tiger Newspress","summary":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.$Delta Air Lines$ – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-","content":"<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p><p><blockquote>美国股指期货周四上午上涨，此前市场在前一交易日出现180度大转弯，欢迎美联储决定加快缩减规模并暂时维持利率不变。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini上涨204点，涨幅0.57%，标普500 e-mini上涨31.25点，涨幅0.66%，纳斯达克100 e-mini上涨115.25点，涨幅0.71%。随着美联储周三给市场喘息的机会，交易员将在周四转向劳工部关于每周首次申请失业救济人数的最新数据。首次申请失业救济人数预计将在去年创下52周低点后小幅上升。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DAL\">达美航空</a></b>-达美航空预计第四季度利润为2亿美元，盘前上涨2.3%。市场普遍预测达美航空将出现季度亏损，但该航空公司表示，假期需求强劲，利润有望超过大流行前的水平。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ACN\">埃森哲公司</a></b>-该咨询公司公布最新季度利润和收入好于预期，并上调2022财年盈利指引后，其股价盘前飙升6.7%。埃森哲客户群中四个最大行业集团的收入增长了20%以上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p><p><blockquote><b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>-该制药商表示其抗体鸡尾酒对奥密克戎Covid-19变种失去效力后，其股价在盘前交易中下跌1%。再生元确实说过这种鸡尾酒对德尔塔变异毒株有效。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p><p><blockquote><b><a href=\"https://laohu8.com/S/LEN\">伦纳尔</a></b>-Lennar公布的季度收益为每股3.91美元，低于市场普遍预期的4.15美元，该住宅建筑商的收入也低于预期。Lennar受到木材成本上涨、劳动力成本增加和原材料短缺的影响，导致送货上门延迟。Lennar在盘前下跌6.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVS\">诺华公司</a></b>-诺华启动了一项价值高达150亿美元的新股票回购计划，该制药商计划在2023年底前完成这些回购。股价在盘前交易中上涨4%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/V\">签证</a> </b>–<a href=\"https://laohu8.com/S/V\">签证</a>盘前股价上涨1.1%，此前该公司宣布向其股票回购计划增加120亿美元，使其回购授权总额达到132亿美元。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SJM\">Smucker的</a></b>-Smucker达成协议，以1.1亿美元的价格将其天然饮料和谷物业务出售给私募股权公司Nexus Capital Management，这家食品生产商表示希望将更多资源集中在其核心品牌上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ISRG\">直观手术</a></b>–<a href=\"https://laohu8.com/S/ISRG\">直观手术</a>被添加到高盛的“坚定买入”名单中，这表明该公司即将推出一种新的手术系统。盘前股价上涨1.2%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/T\">AT&amp;T公司</a></b>-摩根士丹利将AT&amp;T的评级从“同等权重”上调至“跑赢大盘”，称该股近期的下滑创造了有吸引力的风险回报状况。该公司表示，还有其他几个关键因素推动了此次升级，包括WarnerMedia/Discovery合并即将完成。AT&amp;T在盘前交易中上涨1.5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WOOF\">Petco健康和保健公司。</a></b>-在Needham开始给予“买入”评级后，这家宠物产品销售商的股价在盘前上涨了1.9%。该公司认为，鉴于Petco在包括兽医医院在内的多个渠道中的存在，它应该会超越宠物类别的竞争对手。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a></b>–Evercore将其评级从“持平”上调至“跑赢大盘”后，该电子商务平台运营商在盘前交易中上涨2.9%。Evercore指出，该股比年度高点低约20%，就增长机会而言，该公司代表着优质资产。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p><p><blockquote>美国股指期货周四上午上涨，此前市场在前一交易日出现180度大转弯，欢迎美联储决定加快缩减规模并暂时维持利率不变。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p><p><blockquote>截至美国东部时间上午8:00，道指e-mini上涨204点，涨幅0.57%，标普500 e-mini上涨31.25点，涨幅0.66%，纳斯达克100 e-mini上涨115.25点，涨幅0.71%。随着美联储周三给市场喘息的机会，交易员将在周四转向劳工部关于每周首次申请失业救济人数的最新数据。首次申请失业救济人数预计将在去年创下52周低点后小幅上升。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DAL\">达美航空</a></b>-达美航空预计第四季度利润为2亿美元，盘前上涨2.3%。市场普遍预测达美航空将出现季度亏损，但该航空公司表示，假期需求强劲，利润有望超过大流行前的水平。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ACN\">埃森哲公司</a></b>-该咨询公司公布最新季度利润和收入好于预期，并上调2022财年盈利指引后，其股价盘前飙升6.7%。埃森哲客户群中四个最大行业集团的收入增长了20%以上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p><p><blockquote><b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>-该制药商表示其抗体鸡尾酒对奥密克戎Covid-19变种失去效力后，其股价在盘前交易中下跌1%。再生元确实说过这种鸡尾酒对德尔塔变异毒株有效。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p><p><blockquote><b><a href=\"https://laohu8.com/S/LEN\">伦纳尔</a></b>-Lennar公布的季度收益为每股3.91美元，低于市场普遍预期的4.15美元，该住宅建筑商的收入也低于预期。Lennar受到木材成本上涨、劳动力成本增加和原材料短缺的影响，导致送货上门延迟。Lennar在盘前下跌6.3%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/NVS\">诺华公司</a></b>-诺华启动了一项价值高达150亿美元的新股票回购计划，该制药商计划在2023年底前完成这些回购。股价在盘前交易中上涨4%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p><p><blockquote><b><a href=\"https://laohu8.com/S/V\">签证</a> </b>–<a href=\"https://laohu8.com/S/V\">签证</a>盘前股价上涨1.1%，此前该公司宣布向其股票回购计划增加120亿美元，使其回购授权总额达到132亿美元。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SJM\">Smucker的</a></b>-Smucker达成协议，以1.1亿美元的价格将其天然饮料和谷物业务出售给私募股权公司Nexus Capital Management，这家食品生产商表示希望将更多资源集中在其核心品牌上。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ISRG\">直观手术</a></b>–<a href=\"https://laohu8.com/S/ISRG\">直观手术</a>被添加到高盛的“坚定买入”名单中，这表明该公司即将推出一种新的手术系统。盘前股价上涨1.2%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p><p><blockquote><b><a href=\"https://laohu8.com/S/T\">AT&amp;T公司</a></b>-摩根士丹利将AT&amp;T的评级从“同等权重”上调至“跑赢大盘”，称该股近期的下滑创造了有吸引力的风险回报状况。该公司表示，还有其他几个关键因素推动了此次升级，包括WarnerMedia/Discovery合并即将完成。AT&amp;T在盘前交易中上涨1.5%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/WOOF\">Petco健康和保健公司。</a></b>-在Needham开始给予“买入”评级后，这家宠物产品销售商的股价在盘前上涨了1.9%。该公司认为，鉴于Petco在包括兽医医院在内的多个渠道中的存在，它应该会超越宠物类别的竞争对手。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p><p><blockquote><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a></b>–Evercore将其评级从“持平”上调至“跑赢大盘”后，该电子商务平台运营商在盘前交易中上涨2.9%。Evercore指出，该股比年度高点低约20%，就增长机会而言，该公司代表着优质资产。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142996286","content_text":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.\nAt 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.With the Fed giving markets a breather Wednesday, traders will turn their Thursday to fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after last’s 52-week low.\nStocks making the biggest moves premarket: \nDelta Air Lines – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.\nAccenture PLC – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.\nRegeneron Pharmaceuticals – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.\nLennar – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.\nNovartis AG – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.\nVisa – Visa rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.\nSmucker's – Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.\nIntuitive Surgical – Intuitive Surgical was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.\nAT&T Inc – Morgan Stanley upgraded AT&T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&T gained 1.5% in premarket trading.\nPetco Health and Wellness Company, Inc. – The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.\nShopify – The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2448,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607919238,"gmtCreate":1639472743238,"gmtModify":1639472744343,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607919238","repostId":"1114636896","repostType":4,"repost":{"id":"1114636896","kind":"news","pubTimestamp":1639439509,"share":"https://www.laohu8.com/m/news/1114636896?lang=zh_CN&edition=full","pubTime":"2021-12-14 07:51","market":"us","language":"en","title":"Tesla Stock Is in a Bear Market Again. What’s Next for Musk’s EV Firm.<blockquote>特斯拉股票再次陷入熊市。马斯克电动汽车公司的下一步是什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1114636896","media":"Barrons","summary":"Shares of electric-vehicle leader Tesla crossed into bear-market territory today. That statement is ","content":"<p>Shares of electric-vehicle leader&nbsp;Tesla&nbsp;crossed into bear-market territory&nbsp;today. That statement is technically true, but also a little tiring. Stocks, individually, don’t have bear or bull markets. That terms should be reserved for, well, the overall market. Still, the big dip in a mega-cap stock is noteworthy leaving investors wondering what might come next.</p><p><blockquote>电动汽车领导者特斯拉的股价今天进入熊市区域。这种说法在技术上是正确的，但也有点累。就个人而言，股票没有熊市或牛市。这些条款应该留给整个市场。尽管如此，大型股的大幅下跌还是值得注意的，让投资者想知道接下来会发生什么。</blockquote></p><p> Tesla (ticker: TSLA) stock closed down 5% at $966.41. The&nbsp;S&amp;P 500 index&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;both closed down 0.9%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收盘下跌5%，至966.41美元。标普500指数和道琼斯工业平均指数均收跌0.9%。</blockquote></p><p> The Monday dip sent the company’s market cap below $1 trillion based on the number of shares outstanding, excluding management stock options. Shares are down 21% from the Nov. 4 closing high of $1,229.91. Shares are down 22% from the intraday high of $1,243.49.</p><p><blockquote>根据已发行股票数量（不包括管理层股票期权）计算，周一的下跌使该公司的市值跌破1万亿美元。股价较11月4日收盘高点1,229.91美元下跌21%。股价较盘中高点1,243.49美元下跌22%。</blockquote></p><p> Whether or not bear markets should be measured from a closing high or an intraday high is the source of debate on Wall Street. But again, the debate doesn’t really matter in this instance because individual stocks don’t have bull and bear markets.</p><p><blockquote>熊市应该从收盘高点还是盘中高点来衡量是华尔街争论的焦点。但同样，在这种情况下，争论并不重要，因为个股没有牛市和熊市。</blockquote></p><p> Whether it’s a bear market or not isn’t the point for individual investors. The pain of a 20% drop is real.</p><p><blockquote>对于个人投资者来说，是否是熊市并不是重点。下跌20%的痛苦是真实的。</blockquote></p><p> One of the last times Tesla stock closed in bear-market territory was February 2021. (Yes, <i>Barron’s</i> wrote about the single stock bear market then, too.) Back then, interest rates were rising and highly valued tech stocks took it on the chin. Higher rates hurt the valuation of shares of faster-growing companies more than those of slow-growing mature companies—that’s just the way the math of higher interest rates works out.</p><p><blockquote>特斯拉股票最后一次收于熊市区域是在2021年2月。（是的，<i>巴伦周刊</i>当时也写过关于单股熊市的文章。）当时，利率正在上升，高估值的科技股承受了压力。较高的利率对增长较快的公司股票估值的损害大于增长缓慢的成熟公司的股票估值——这正是较高利率的数学计算方式。</blockquote></p><p> Back then it took about six months for the stock to retake its old highs. If that were to happen again, bullish investors would be waiting until June 2022 to see Tesla stock hit $1,300.</p><p><blockquote>当时，该股花了大约六个月的时间才恢复到旧高点。如果这种情况再次发生，看涨的投资者将等到2022年6月才能看到特斯拉股价触及1,300美元。</blockquote></p><p> That would be a long wait for bulls, and while there is no way to know if that scenario will even unfold, there is a lot going on that could move the stock in the coming couple of months. Bullish and bearish Tesla investors will be watching for the startup of two new plants in Germany and Texas, the impact of those new plants on profit margins, the start of deliveries of the Tesla Cybertruck and the overall growth of EVs in the U.S., Europe, and China.</p><p><blockquote>对于多头来说，这将是一个漫长的等待，虽然没有办法知道这种情况是否会发生，但未来几个月有很多事情可能会影响该股。看涨和看跌的特斯拉投资者将关注德国和德克萨斯两家新工厂的启动、这些新工厂对利润率的影响、特斯拉Cybertruck的开始交付以及美国电动汽车的整体增长、欧洲和中国。</blockquote></p><p> With all that coming, it raising the question of why the shares are struggling.</p><p><blockquote>随之而来的是，这引发了一个问题：为什么股价陷入困境。</blockquote></p><p> Two things might be at work. First, CEO Elon Musk is still selling stock. It creates an overhang. Some bulls might wait to buy until the large sales are over. Musk has at least 5 million or 6 million shares left to sell associated with his expiring stock options. He will probably be done selling by the end of 2021, but he might just Tweet out when he’s done. At current pace, we figure by year-end.</p><p><blockquote>可能有两件事在起作用。首先，首席执行官埃隆·马斯克仍在出售股票。它创造了一个悬垂。一些多头可能会等到大规模抛售结束后再买入。马斯克还有至少500万或600万股与他即将到期的股票期权相关的股票可供出售。他可能会在2021年底完成出售，但他可能会在完成后发布推文。按照目前的速度，我们预计到年底。</blockquote></p><p> Second, there is the issue of Musk being named Time’s Person of the Year.Amazon.com&nbsp;(AMZN) founder Jeff Bezos won that distinction in 1999, near a multiyear peak in that stock. Amazon shares went on to slide, and some investors think Tesla stock could do the same.</p><p><blockquote>其次，还有马斯克被《时代》杂志评为年度人物的问题。亚马逊。com(AMZN)创始人杰夫·贝索斯(Mark Zuckerberg)在1999年获得了这一殊荣，当时该股股价接近多年来的峰值。亚马逊股价继续下滑，一些投资者认为特斯拉股价也可能出现同样的情况。</blockquote></p><p> The Amazon comparison with Tesla doesn’t quite match up, however. The two companies are at very different stages of development when their top executives won Time’s distinction. Amazon had a market capitalization of $27 billion back then. Tesla’s market cap is now hovering around $1 trillion.</p><p><blockquote>然而，亚马逊与特斯拉的比较并不完全匹配。当这两家公司的高管赢得《时代》杂志的殊荣时，它们正处于截然不同的发展阶段。亚马逊当时的市值为270亿美元。特斯拉的市值目前徘徊在1万亿美元左右。</blockquote></p><p> Still, it’s a belief, and traders do odd things from time to time, justified or not. When stocks move upward, or downward, momentum traders will jump on the trend for whatever reason.</p><p><blockquote>尽管如此，这仍然是一种信念，交易者时不时会做一些奇怪的事情，无论是否合理。当股票上涨或下跌时，无论出于何种原因，动量交易者都会顺势而为。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Is in a Bear Market Again. What’s Next for Musk’s EV Firm.<blockquote>特斯拉股票再次陷入熊市。马斯克电动汽车公司的下一步是什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Is in a Bear Market Again. What’s Next for Musk’s EV Firm.<blockquote>特斯拉股票再次陷入熊市。马斯克电动汽车公司的下一步是什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-12-14 07:51</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of electric-vehicle leader&nbsp;Tesla&nbsp;crossed into bear-market territory&nbsp;today. That statement is technically true, but also a little tiring. Stocks, individually, don’t have bear or bull markets. That terms should be reserved for, well, the overall market. Still, the big dip in a mega-cap stock is noteworthy leaving investors wondering what might come next.</p><p><blockquote>电动汽车领导者特斯拉的股价今天进入熊市区域。这种说法在技术上是正确的，但也有点累。就个人而言，股票没有熊市或牛市。这些条款应该留给整个市场。尽管如此，大型股的大幅下跌还是值得注意的，让投资者想知道接下来会发生什么。</blockquote></p><p> Tesla (ticker: TSLA) stock closed down 5% at $966.41. The&nbsp;S&amp;P 500 index&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;both closed down 0.9%.</p><p><blockquote>特斯拉（股票代码：TSLA）股价收盘下跌5%，至966.41美元。标普500指数和道琼斯工业平均指数均收跌0.9%。</blockquote></p><p> The Monday dip sent the company’s market cap below $1 trillion based on the number of shares outstanding, excluding management stock options. Shares are down 21% from the Nov. 4 closing high of $1,229.91. Shares are down 22% from the intraday high of $1,243.49.</p><p><blockquote>根据已发行股票数量（不包括管理层股票期权）计算，周一的下跌使该公司的市值跌破1万亿美元。股价较11月4日收盘高点1,229.91美元下跌21%。股价较盘中高点1,243.49美元下跌22%。</blockquote></p><p> Whether or not bear markets should be measured from a closing high or an intraday high is the source of debate on Wall Street. But again, the debate doesn’t really matter in this instance because individual stocks don’t have bull and bear markets.</p><p><blockquote>熊市应该从收盘高点还是盘中高点来衡量是华尔街争论的焦点。但同样，在这种情况下，争论并不重要，因为个股没有牛市和熊市。</blockquote></p><p> Whether it’s a bear market or not isn’t the point for individual investors. The pain of a 20% drop is real.</p><p><blockquote>对于个人投资者来说，是否是熊市并不是重点。下跌20%的痛苦是真实的。</blockquote></p><p> One of the last times Tesla stock closed in bear-market territory was February 2021. (Yes, <i>Barron’s</i> wrote about the single stock bear market then, too.) Back then, interest rates were rising and highly valued tech stocks took it on the chin. Higher rates hurt the valuation of shares of faster-growing companies more than those of slow-growing mature companies—that’s just the way the math of higher interest rates works out.</p><p><blockquote>特斯拉股票最后一次收于熊市区域是在2021年2月。（是的，<i>巴伦周刊</i>当时也写过关于单股熊市的文章。）当时，利率正在上升，高估值的科技股承受了压力。较高的利率对增长较快的公司股票估值的损害大于增长缓慢的成熟公司的股票估值——这正是较高利率的数学计算方式。</blockquote></p><p> Back then it took about six months for the stock to retake its old highs. If that were to happen again, bullish investors would be waiting until June 2022 to see Tesla stock hit $1,300.</p><p><blockquote>当时，该股花了大约六个月的时间才恢复到旧高点。如果这种情况再次发生，看涨的投资者将等到2022年6月才能看到特斯拉股价触及1,300美元。</blockquote></p><p> That would be a long wait for bulls, and while there is no way to know if that scenario will even unfold, there is a lot going on that could move the stock in the coming couple of months. Bullish and bearish Tesla investors will be watching for the startup of two new plants in Germany and Texas, the impact of those new plants on profit margins, the start of deliveries of the Tesla Cybertruck and the overall growth of EVs in the U.S., Europe, and China.</p><p><blockquote>对于多头来说，这将是一个漫长的等待，虽然没有办法知道这种情况是否会发生，但未来几个月有很多事情可能会影响该股。看涨和看跌的特斯拉投资者将关注德国和德克萨斯两家新工厂的启动、这些新工厂对利润率的影响、特斯拉Cybertruck的开始交付以及美国电动汽车的整体增长、欧洲和中国。</blockquote></p><p> With all that coming, it raising the question of why the shares are struggling.</p><p><blockquote>随之而来的是，这引发了一个问题：为什么股价陷入困境。</blockquote></p><p> Two things might be at work. First, CEO Elon Musk is still selling stock. It creates an overhang. Some bulls might wait to buy until the large sales are over. Musk has at least 5 million or 6 million shares left to sell associated with his expiring stock options. He will probably be done selling by the end of 2021, but he might just Tweet out when he’s done. At current pace, we figure by year-end.</p><p><blockquote>可能有两件事在起作用。首先，首席执行官埃隆·马斯克仍在出售股票。它创造了一个悬垂。一些多头可能会等到大规模抛售结束后再买入。马斯克还有至少500万或600万股与他即将到期的股票期权相关的股票可供出售。他可能会在2021年底完成出售，但他可能会在完成后发布推文。按照目前的速度，我们预计到年底。</blockquote></p><p> Second, there is the issue of Musk being named Time’s Person of the Year.Amazon.com&nbsp;(AMZN) founder Jeff Bezos won that distinction in 1999, near a multiyear peak in that stock. Amazon shares went on to slide, and some investors think Tesla stock could do the same.</p><p><blockquote>其次，还有马斯克被《时代》杂志评为年度人物的问题。亚马逊。com(AMZN)创始人杰夫·贝索斯(Mark Zuckerberg)在1999年获得了这一殊荣，当时该股股价接近多年来的峰值。亚马逊股价继续下滑，一些投资者认为特斯拉股价也可能出现同样的情况。</blockquote></p><p> The Amazon comparison with Tesla doesn’t quite match up, however. The two companies are at very different stages of development when their top executives won Time’s distinction. Amazon had a market capitalization of $27 billion back then. Tesla’s market cap is now hovering around $1 trillion.</p><p><blockquote>然而，亚马逊与特斯拉的比较并不完全匹配。当这两家公司的高管赢得《时代》杂志的殊荣时，它们正处于截然不同的发展阶段。亚马逊当时的市值为270亿美元。特斯拉的市值目前徘徊在1万亿美元左右。</blockquote></p><p> Still, it’s a belief, and traders do odd things from time to time, justified or not. When stocks move upward, or downward, momentum traders will jump on the trend for whatever reason.</p><p><blockquote>尽管如此，这仍然是一种信念，交易者时不时会做一些奇怪的事情，无论是否合理。当股票上涨或下跌时，无论出于何种原因，动量交易者都会顺势而为。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/tesla-stock-bear-musk-51639436863?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-bear-musk-51639436863?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114636896","content_text":"Shares of electric-vehicle leader Tesla crossed into bear-market territory today. That statement is technically true, but also a little tiring. Stocks, individually, don’t have bear or bull markets. That terms should be reserved for, well, the overall market. Still, the big dip in a mega-cap stock is noteworthy leaving investors wondering what might come next.\nTesla (ticker: TSLA) stock closed down 5% at $966.41. The S&P 500 index and Dow Jones Industrial Average both closed down 0.9%.\nThe Monday dip sent the company’s market cap below $1 trillion based on the number of shares outstanding, excluding management stock options. Shares are down 21% from the Nov. 4 closing high of $1,229.91. Shares are down 22% from the intraday high of $1,243.49.\nWhether or not bear markets should be measured from a closing high or an intraday high is the source of debate on Wall Street. But again, the debate doesn’t really matter in this instance because individual stocks don’t have bull and bear markets.\nWhether it’s a bear market or not isn’t the point for individual investors. The pain of a 20% drop is real.\nOne of the last times Tesla stock closed in bear-market territory was February 2021. (Yes, Barron’s wrote about the single stock bear market then, too.) Back then, interest rates were rising and highly valued tech stocks took it on the chin. Higher rates hurt the valuation of shares of faster-growing companies more than those of slow-growing mature companies—that’s just the way the math of higher interest rates works out.\nBack then it took about six months for the stock to retake its old highs. If that were to happen again, bullish investors would be waiting until June 2022 to see Tesla stock hit $1,300.\nThat would be a long wait for bulls, and while there is no way to know if that scenario will even unfold, there is a lot going on that could move the stock in the coming couple of months. Bullish and bearish Tesla investors will be watching for the startup of two new plants in Germany and Texas, the impact of those new plants on profit margins, the start of deliveries of the Tesla Cybertruck and the overall growth of EVs in the U.S., Europe, and China.\nWith all that coming, it raising the question of why the shares are struggling.\nTwo things might be at work. First, CEO Elon Musk is still selling stock. It creates an overhang. Some bulls might wait to buy until the large sales are over. Musk has at least 5 million or 6 million shares left to sell associated with his expiring stock options. He will probably be done selling by the end of 2021, but he might just Tweet out when he’s done. At current pace, we figure by year-end.\nSecond, there is the issue of Musk being named Time’s Person of the Year.Amazon.com (AMZN) founder Jeff Bezos won that distinction in 1999, near a multiyear peak in that stock. Amazon shares went on to slide, and some investors think Tesla stock could do the same.\nThe Amazon comparison with Tesla doesn’t quite match up, however. The two companies are at very different stages of development when their top executives won Time’s distinction. Amazon had a market capitalization of $27 billion back then. Tesla’s market cap is now hovering around $1 trillion.\nStill, it’s a belief, and traders do odd things from time to time, justified or not. When stocks move upward, or downward, momentum traders will jump on the trend for whatever reason.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604284528,"gmtCreate":1639403527473,"gmtModify":1639403980729,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604284528","repostId":"1101330061","repostType":4,"repost":{"id":"1101330061","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639402663,"share":"https://www.laohu8.com/m/news/1101330061?lang=zh_CN&edition=full","pubTime":"2021-12-13 21:37","market":"us","language":"en","title":"Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101330061","media":"Tiger Newspress","summary":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today ann","content":"<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 21:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERU":"Veru Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101330061","content_text":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).\nENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.","news_type":1,"symbols_score_info":{"VERU":0.9}},"isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605640297,"gmtCreate":1639160477225,"gmtModify":1639160478352,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605640297","repostId":"1133027099","repostType":4,"repost":{"id":"1133027099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639152670,"share":"https://www.laohu8.com/m/news/1133027099?lang=zh_CN&edition=full","pubTime":"2021-12-11 00:11","market":"us","language":"en","title":"Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133027099","media":"Tiger Newspress","summary":"Sea Ltd stock dropped more than 5% in morning trading.","content":"<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-11 00:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133027099","content_text":"Sea Ltd stock dropped more than 5% in morning trading.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":985,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602877662,"gmtCreate":1639010952150,"gmtModify":1639010953069,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602877662","repostId":"1192089081","repostType":4,"repost":{"id":"1192089081","kind":"news","pubTimestamp":1639008258,"share":"https://www.laohu8.com/m/news/1192089081?lang=zh_CN&edition=full","pubTime":"2021-12-09 08:04","market":"sg","language":"en","title":"Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192089081","media":"RTTNews","summary":"The Singapore stock market on Wednesday snapped the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just beneath the 3,130-point plateau although it may tick higher again on Thursday.The global forecast for the Asian markets is cautiously optimistic, again supported by oil and technology companies. The European markets were down and the U.S. bourses were up and the Asian markets figure to follow the latter lead.The STI finished","content":"<p>The Singapore stock market on Wednesday snapped the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just beneath the 3,130-point plateau although it may tick higher again on Thursday.</p><p><blockquote>新加坡股市周三结束了连续三天的上涨，上涨了近45点或1.4%。海峡时报指数目前略低于3,130点的高位，尽管周四可能会再次走高。</blockquote></p><p> The global forecast for the Asian markets is cautiously optimistic, again supported by oil and technology companies. The European markets were down and the U.S. bourses were up and the Asian markets figure to follow the latter lead.</p><p><blockquote>全球对亚洲市场的预测谨慎乐观，再次得到石油和科技公司的支持。欧洲股市下跌，美国股市上涨，亚洲市场预计将追随后者的脚步。</blockquote></p><p> The STI finished slightly lower on Wednesday following mixed performances from the financial shares and industrial stocks.</p><p><blockquote>由于金融股和工业股表现不一，海指周三小幅收低。</blockquote></p><p> For the day, the index dipped 4.89 points or 0.16 percent to finish at 3,129.77 after trading between 3,124.31 and 3,140.75. Volume was 1.11 billion shares worth 1.04 billion Singapore dollars. There were 223 gainers and 202 decliners.</p><p><blockquote>当天，该指数在3,124.31点至3,140.75点之间交易后，下跌4.89点或0.16%，收于3,129.77点。成交量为11.1亿股，价值10.4亿新元。上涨223家，下跌202家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust sank 0.49 percent, while City Developments was up 0.14 percent, Comfort DelGro retreated 0.71 percent, DBS Group dipped 0.22 percent, Genting Singapore added 0.65 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation fell 0.26 percent, SATS tanked 1.27 percent, SembCorp Industries tumbled 1.00 percent, Singapore Airlines gained 0.40 percent, Singapore Exchange declined 0.95 percent, Singapore Press Holdings lost 0.43 percent, Singapore Technologies Engineering skidded 0.53 percent, SingTel jumped 1.24 percent, United Overseas Bank collected 0.41 percent, Wilmar International dropped 0.48 percent, Yangzijiang Shipbuilding plunged 1.52 percent and Dairy Farm International, Mapletree Commercial Trust, Mapletree Logistics Trust, Ascendas REIT and Thai Beverage were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托下跌0.49%，City Developments上涨0.14%，Comfort DelGro下跌0.71%，星展集团下跌0.22%，云顶新加坡上涨0.65%，吉宝企业上涨0.39%，华侨银行下跌0.26%，SATS下跌1.27%，胜科工业下跌1.00%，新加坡航空上涨0.40%，新加坡交易所下跌0.95%，新加坡报业控股下跌0.43%，新加坡科技工程下跌0.53%，新加坡电信上涨1.24%，大华银行收跌0.41%，丰益国际下跌0.48%，扬子江造船下跌1.42%，奶牛场国际、丰树商业信托、丰树物流信托、腾飞房地产投资信托和泰国饮料持平。</blockquote></p><p> The lead from Wall Street is positive as the major averages opened mixed on Wednesday, shook off a midday slump and finished in the green.</p><p><blockquote>华尔街的领先是积极的，主要股指周三开盘涨跌不一，摆脱了午盘的暴跌并以绿色收盘。</blockquote></p><p> The Dow added 35.32 points or 0.10 percent to finish at 35,754.75, while the NASDAQ jumped 100.07 points or 0.64 percent to end at 15,786.99 and the S&amp;P 500 rose 14.46 points or 0.31 percent to close at 4,701.21.</p><p><blockquote>道琼斯指数上涨35.32点，涨幅0.10%，收于35,754.75点；纳斯达克上涨100.07点，涨幅0.64%，收于15,786.99点；标普500上涨14.46点，涨幅0.31%，收于4,701.21点。</blockquote></p><p> The choppy trading seen for most of the day came as traders expressed some uncertainty about the near-term outlook for the markets following recent volatility.</p><p><blockquote>在最近的波动之后，交易员对市场的近期前景表示了一些不确定性，因此当天大部分时间都出现了波动。</blockquote></p><p> With concerns about the impact of the Omicron variant easing, traders are now looking ahead to next week's Federal Reserve's monetary policy announcement. Reports suggest the Fed could decide to double the pace of tapering its asset purchase program to $30 billion per month.</p><p><blockquote>由于担心奥密克戎变体宽松的影响，交易员现在期待下周美联储的货币政策公告。有报道称，美联储可能决定将缩减资产购买计划的步伐提高一倍，至每月300亿美元。</blockquote></p><p> Some positive sentiment was generated by comments from Pfizer (PFE) and BioNTech (BNTX) regarding the effectiveness of their Covid vaccine as preliminary laboratory studies have demonstrated that three doses of their vaccine neutralize the Omicron variant.</p><p><blockquote>辉瑞(PFE)和BioNTech(BNTX)对其新冠疫苗有效性的评论产生了一些积极情绪，因为初步实验室研究表明，三剂疫苗可以中和奥密克戎病毒变种。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) reported a drop in U.S. crude inventories last week. West Texas Intermediate Crude oil futures for January ended higher by $0.31 or 0.4 percent at $72.36 a barrel.</p><p><blockquote>美国能源信息署（EIA）公布上周美国原油库存下降后，原油期货周三收高。西德克萨斯中质原油1月期货收高0.31美元或0.4%，报每桶72.36美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-09 08:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market on Wednesday snapped the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just beneath the 3,130-point plateau although it may tick higher again on Thursday.</p><p><blockquote>新加坡股市周三结束了连续三天的上涨，上涨了近45点或1.4%。海峡时报指数目前略低于3,130点的高位，尽管周四可能会再次走高。</blockquote></p><p> The global forecast for the Asian markets is cautiously optimistic, again supported by oil and technology companies. The European markets were down and the U.S. bourses were up and the Asian markets figure to follow the latter lead.</p><p><blockquote>全球对亚洲市场的预测谨慎乐观，再次得到石油和科技公司的支持。欧洲股市下跌，美国股市上涨，亚洲市场预计将追随后者的脚步。</blockquote></p><p> The STI finished slightly lower on Wednesday following mixed performances from the financial shares and industrial stocks.</p><p><blockquote>由于金融股和工业股表现不一，海指周三小幅收低。</blockquote></p><p> For the day, the index dipped 4.89 points or 0.16 percent to finish at 3,129.77 after trading between 3,124.31 and 3,140.75. Volume was 1.11 billion shares worth 1.04 billion Singapore dollars. There were 223 gainers and 202 decliners.</p><p><blockquote>当天，该指数在3,124.31点至3,140.75点之间交易后，下跌4.89点或0.16%，收于3,129.77点。成交量为11.1亿股，价值10.4亿新元。上涨223家，下跌202家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust sank 0.49 percent, while City Developments was up 0.14 percent, Comfort DelGro retreated 0.71 percent, DBS Group dipped 0.22 percent, Genting Singapore added 0.65 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation fell 0.26 percent, SATS tanked 1.27 percent, SembCorp Industries tumbled 1.00 percent, Singapore Airlines gained 0.40 percent, Singapore Exchange declined 0.95 percent, Singapore Press Holdings lost 0.43 percent, Singapore Technologies Engineering skidded 0.53 percent, SingTel jumped 1.24 percent, United Overseas Bank collected 0.41 percent, Wilmar International dropped 0.48 percent, Yangzijiang Shipbuilding plunged 1.52 percent and Dairy Farm International, Mapletree Commercial Trust, Mapletree Logistics Trust, Ascendas REIT and Thai Beverage were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托下跌0.49%，City Developments上涨0.14%，Comfort DelGro下跌0.71%，星展集团下跌0.22%，云顶新加坡上涨0.65%，吉宝企业上涨0.39%，华侨银行下跌0.26%，SATS下跌1.27%，胜科工业下跌1.00%，新加坡航空上涨0.40%，新加坡交易所下跌0.95%，新加坡报业控股下跌0.43%，新加坡科技工程下跌0.53%，新加坡电信上涨1.24%，大华银行收跌0.41%，丰益国际下跌0.48%，扬子江造船下跌1.42%，奶牛场国际、丰树商业信托、丰树物流信托、腾飞房地产投资信托和泰国饮料持平。</blockquote></p><p> The lead from Wall Street is positive as the major averages opened mixed on Wednesday, shook off a midday slump and finished in the green.</p><p><blockquote>华尔街的领先是积极的，主要股指周三开盘涨跌不一，摆脱了午盘的暴跌并以绿色收盘。</blockquote></p><p> The Dow added 35.32 points or 0.10 percent to finish at 35,754.75, while the NASDAQ jumped 100.07 points or 0.64 percent to end at 15,786.99 and the S&amp;P 500 rose 14.46 points or 0.31 percent to close at 4,701.21.</p><p><blockquote>道琼斯指数上涨35.32点，涨幅0.10%，收于35,754.75点；纳斯达克上涨100.07点，涨幅0.64%，收于15,786.99点；标普500上涨14.46点，涨幅0.31%，收于4,701.21点。</blockquote></p><p> The choppy trading seen for most of the day came as traders expressed some uncertainty about the near-term outlook for the markets following recent volatility.</p><p><blockquote>在最近的波动之后，交易员对市场的近期前景表示了一些不确定性，因此当天大部分时间都出现了波动。</blockquote></p><p> With concerns about the impact of the Omicron variant easing, traders are now looking ahead to next week's Federal Reserve's monetary policy announcement. Reports suggest the Fed could decide to double the pace of tapering its asset purchase program to $30 billion per month.</p><p><blockquote>由于担心奥密克戎变体宽松的影响，交易员现在期待下周美联储的货币政策公告。有报道称，美联储可能决定将缩减资产购买计划的步伐提高一倍，至每月300亿美元。</blockquote></p><p> Some positive sentiment was generated by comments from Pfizer (PFE) and BioNTech (BNTX) regarding the effectiveness of their Covid vaccine as preliminary laboratory studies have demonstrated that three doses of their vaccine neutralize the Omicron variant.</p><p><blockquote>辉瑞(PFE)和BioNTech(BNTX)对其新冠疫苗有效性的评论产生了一些积极情绪，因为初步实验室研究表明，三剂疫苗可以中和奥密克戎病毒变种。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) reported a drop in U.S. crude inventories last week. West Texas Intermediate Crude oil futures for January ended higher by $0.31 or 0.4 percent at $72.36 a barrel.</p><p><blockquote>美国能源信息署（EIA）公布上周美国原油库存下降后，原油期货周三收高。西德克萨斯中质原油1月期货收高0.31美元或0.4%，报每桶72.36美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3247905/rebound-anticipated-for-singapore-stock-market.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3247905/rebound-anticipated-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192089081","content_text":"The Singapore stock market on Wednesday snapped the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just beneath the 3,130-point plateau although it may tick higher again on Thursday.\nThe global forecast for the Asian markets is cautiously optimistic, again supported by oil and technology companies. The European markets were down and the U.S. bourses were up and the Asian markets figure to follow the latter lead.\nThe STI finished slightly lower on Wednesday following mixed performances from the financial shares and industrial stocks.\nFor the day, the index dipped 4.89 points or 0.16 percent to finish at 3,129.77 after trading between 3,124.31 and 3,140.75. Volume was 1.11 billion shares worth 1.04 billion Singapore dollars. There were 223 gainers and 202 decliners.\nAmong the actives, CapitaLand Integrated Commercial Trust sank 0.49 percent, while City Developments was up 0.14 percent, Comfort DelGro retreated 0.71 percent, DBS Group dipped 0.22 percent, Genting Singapore added 0.65 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation fell 0.26 percent, SATS tanked 1.27 percent, SembCorp Industries tumbled 1.00 percent, Singapore Airlines gained 0.40 percent, Singapore Exchange declined 0.95 percent, Singapore Press Holdings lost 0.43 percent, Singapore Technologies Engineering skidded 0.53 percent, SingTel jumped 1.24 percent, United Overseas Bank collected 0.41 percent, Wilmar International dropped 0.48 percent, Yangzijiang Shipbuilding plunged 1.52 percent and Dairy Farm International, Mapletree Commercial Trust, Mapletree Logistics Trust, Ascendas REIT and Thai Beverage were unchanged.\nThe lead from Wall Street is positive as the major averages opened mixed on Wednesday, shook off a midday slump and finished in the green.\nThe Dow added 35.32 points or 0.10 percent to finish at 35,754.75, while the NASDAQ jumped 100.07 points or 0.64 percent to end at 15,786.99 and the S&P 500 rose 14.46 points or 0.31 percent to close at 4,701.21.\nThe choppy trading seen for most of the day came as traders expressed some uncertainty about the near-term outlook for the markets following recent volatility.\nWith concerns about the impact of the Omicron variant easing, traders are now looking ahead to next week's Federal Reserve's monetary policy announcement. Reports suggest the Fed could decide to double the pace of tapering its asset purchase program to $30 billion per month.\nSome positive sentiment was generated by comments from Pfizer (PFE) and BioNTech (BNTX) regarding the effectiveness of their Covid vaccine as preliminary laboratory studies have demonstrated that three doses of their vaccine neutralize the Omicron variant.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) reported a drop in U.S. crude inventories last week. West Texas Intermediate Crude oil futures for January ended higher by $0.31 or 0.4 percent at $72.36 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606465004,"gmtCreate":1638921201264,"gmtModify":1638921202238,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606465004","repostId":"1142645155","repostType":4,"repost":{"id":"1142645155","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638890012,"share":"https://www.laohu8.com/m/news/1142645155?lang=zh_CN&edition=full","pubTime":"2021-12-07 23:13","market":"us","language":"en","title":"Pinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142645155","media":"Tiger Newspress","summary":"Pinduoduo shares surged 11% in morning trading after Macquarie gave pinduoduo a market beating ratin","content":"<p>Pinduoduo shares surged 11% in morning trading&nbsp;after&nbsp;Macquarie gave pinduoduo a market beating rating with a target price of $95.</p><p><blockquote>麦格理给予拼多多跑赢大盘的评级，目标价95美元后，拼多多股价早盘飙升11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/38c15dca491bd8741f8ac3af099bdeb7\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 23:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pinduoduo shares surged 11% in morning trading&nbsp;after&nbsp;Macquarie gave pinduoduo a market beating rating with a target price of $95.</p><p><blockquote>麦格理给予拼多多跑赢大盘的评级，目标价95美元后，拼多多股价早盘飙升11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/38c15dca491bd8741f8ac3af099bdeb7\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PDD":"拼多多"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142645155","content_text":"Pinduoduo shares surged 11% in morning trading after Macquarie gave pinduoduo a market beating rating with a target price of $95.","news_type":1,"symbols_score_info":{"PDD":0.9}},"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606185457,"gmtCreate":1638843254914,"gmtModify":1638843255865,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606185457","repostId":"1133458146","repostType":4,"repost":{"id":"1133458146","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638837591,"share":"https://www.laohu8.com/m/news/1133458146?lang=zh_CN&edition=full","pubTime":"2021-12-07 08:39","market":"us","language":"en","title":"Intel shares surged more than 7% in after-hours trading<blockquote>英特尔股价在盘后交易中飙升逾7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133458146","media":"Tiger Newspress","summary":"Intel shares surged more than 7% in after-hours trading.Intel Corp is planning to publicly list shar","content":"<p>Intel&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;7%&nbsp;in&nbsp;after-hours&nbsp;trading.<img src=\"https://static.tigerbbs.com/6646a6cbd4f0e04c695a379c7768d260\" tg-width=\"735\" tg-height=\"649\" width=\"100%\" height=\"auto\">Intel Corp&nbsp;is planning to publicly list shares in its self-driving-car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>, which could value the unit at north of $50 billion ,the Wall Street Journal reported on Monday, citing people familiar with the matter.</p><p><blockquote>英特尔股价在盘后交易中飙升逾7%。英特尔公司计划公开上市其自动驾驶汽车部门的股票<a href=\"https://laohu8.com/S/MBLY\">移动眼</a>《华尔街日报》周一援引知情人士的话报道称，该部门的估值可能超过500亿美元。</blockquote></p><p> However, there are no guarantees Intel will ultimately follow through with an offering, the report said&nbsp;adding that the announcement is expected as soon as this week.</p><p><blockquote>然而，报告称，不能保证英特尔最终会完成发行，并补充说，预计最快将于本周宣布。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel shares surged more than 7% in after-hours trading<blockquote>英特尔股价在盘后交易中飙升逾7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel shares surged more than 7% in after-hours trading<blockquote>英特尔股价在盘后交易中飙升逾7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 08:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Intel&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;7%&nbsp;in&nbsp;after-hours&nbsp;trading.<img src=\"https://static.tigerbbs.com/6646a6cbd4f0e04c695a379c7768d260\" tg-width=\"735\" tg-height=\"649\" width=\"100%\" height=\"auto\">Intel Corp&nbsp;is planning to publicly list shares in its self-driving-car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>, which could value the unit at north of $50 billion ,the Wall Street Journal reported on Monday, citing people familiar with the matter.</p><p><blockquote>英特尔股价在盘后交易中飙升逾7%。英特尔公司计划公开上市其自动驾驶汽车部门的股票<a href=\"https://laohu8.com/S/MBLY\">移动眼</a>《华尔街日报》周一援引知情人士的话报道称，该部门的估值可能超过500亿美元。</blockquote></p><p> However, there are no guarantees Intel will ultimately follow through with an offering, the report said&nbsp;adding that the announcement is expected as soon as this week.</p><p><blockquote>然而，报告称，不能保证英特尔最终会完成发行，并补充说，预计最快将于本周宣布。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133458146","content_text":"Intel shares surged more than 7% in after-hours trading.Intel Corp is planning to publicly list shares in its self-driving-car unit Mobileye, which could value the unit at north of $50 billion ,the Wall Street Journal reported on Monday, citing people familiar with the matter.\nHowever, there are no guarantees Intel will ultimately follow through with an offering, the report said adding that the announcement is expected as soon as this week.","news_type":1,"symbols_score_info":{"INTC":0.9}},"isVote":1,"tweetType":1,"viewCount":1105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608448102,"gmtCreate":1638783361438,"gmtModify":1638783366193,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608448102","repostId":"1178940634","repostType":4,"repost":{"id":"1178940634","kind":"news","pubTimestamp":1638748983,"share":"https://www.laohu8.com/m/news/1178940634?lang=zh_CN&edition=full","pubTime":"2021-12-06 08:03","market":"sg","language":"en","title":"Singapore Bourse Expected To Remain Rangebound On Monday<blockquote>新加坡证券交易所预计周一将保持区间震荡</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1178940634","media":"RTTNews","summary":"The Singapore stock market has moved higher in two of three trading days since the end of the six-da","content":"<p>The Singapore stock market has moved higher in two of three trading days since the end of the six-day losing streak in which it had plummeted almost 200 points or 6.4 percent. The Straits Times Index now sits just above the 3,100-point plateau although it's expected to turn lower again on Monday.</p><p><blockquote>自结束连续六天下跌近200点或6.4%以来，新加坡股市在三个交易日中有两个交易日上涨。海峡时报指数目前略高于3,100点，但预计周一将再次走低。</blockquote></p><p> The global forecast for the Asian markets is negative on coronavirus and economic concerns, with oil and technology stocks likely to lead the way lower. The European and U.S. markets finished solidly under water and the Asian markets are expected to open in similar fashion.</p><p><blockquote>由于冠状病毒和经济担忧，全球对亚洲市场的预测是负面的，石油和科技股可能会领跌。欧洲和美国市场在水下收盘，预计亚洲市场也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly higher on Friday following gains from the industrials and properties, while the financials were mixed.</p><p><blockquote>继工业和房地产股上涨后，海指周五小幅收高，而金融股则涨跌互现。</blockquote></p><p> For the day, the index rose 9.82 points or 0.32 percent to finish at 3,101.93 after trading between 3,080.29 and 3,109.64. Volume was 1.04 billion shares worth 1.13 billion Singapore dollars. There were 269 gainers and 194 decliners.</p><p><blockquote>当天，该指数在3,080.29点至3,109.64点之间交易后，上涨9.82点或0.32%，收于3,101.93点。成交量为10.4亿股，价值11.3亿新元。上涨269家，下跌194家。</blockquote></p><p> Among the actives, Ascendas REIT added 0.68 percent, while CapitaLand Integrated Commercial Trust shed 0.48 percent, City Developments and Wilmar International both advanced 0.74 percent, Comfort DelGro accelerated 2.19 percent, Dairy Farm International and Genting Singapore both jumped 2.01 percent, DBS Group lost 0.25 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS surged 2.62 percent, SembCorp Industries soared 2.58 percent, Singapore Airlines gained 0.62 percent, Singapore Exchange spiked 2.43 percent, Singapore Technologies Engineering increased 0.27 percent, Thai Beverage rallied 0.76 percent, United Overseas Bank collected 0.46 percent, Yangzijiang Shipbuilding climbed 0.78 percent and Mapletree Commercial Trust, Mapletree Logistics Trust, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托下跌0.48%，City Developments和丰益国际均上涨0.74%，Comfort DelGro加速上涨2.19%，Dairy Farm International和云顶新加坡均上涨2.01%，星展集团下跌0.25%，吉宝企业上涨0.39%，华侨银行下跌0.09%，胜科工业飙升2.58%，新加坡航空上涨0.62%，新加坡科技工程上涨0.27%，泰国饮料上涨0.76%，扬子江造船上涨0.78%，丰树商业信托、丰树物流信托、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is soft as the major averages opened slightly higher on Friday but quickly turned lower and spent the remainder of the day in negative territory.</p><p><blockquote>华尔街的领先优势较弱，主要股指周五开盘小幅走高，但很快转跌，并在当天剩余时间内处于负值区域。</blockquote></p><p> The Dow shed 59/72 points or 0.17 percent to finish at 34,580.08, while the NASDAQ plummeted 295.83 points or 1.92 percent to close at 15,085.47 and the S&amp;P 500 lost 38.67 points or 0.84 percent to end at 4,538.43. For the week, the NASDAQ tumbled 2.6 percent, the S&amp;P lost 1.2 percent and the Dow fell 0.9 percent.</p><p><blockquote>道琼斯指数下跌59/72点，跌幅0.17%，收于34580.08点；纳斯达克指数暴跌295.83点，跌幅1.92%，收于15085.47点；标普500指数下跌38.67点，跌幅0.84%，收于4538.43点。本周，纳斯达克下跌2.6%，标准普尔指数下跌1.2%，道琼斯指数下跌0.9%。</blockquote></p><p> The losses extended the volatility seen throughout the week, with stocks showing wild swings in reaction to the Omicron variant of the coronavirus. After the first confirmed case in the U.S. earlier in the week, the new variant has now been detected in at least five states.</p><p><blockquote>这些损失扩大了整个星期的波动性，股市因冠状病毒的奥密克戎变种而出现剧烈波动。在本周早些时候美国出现首例确诊病例后，目前已在至少五个州发现了这种新变种。</blockquote></p><p> Traders also reacted to the Labor Department report showing weaker than expected U.S. job growth in November, although the jobless rate fell to 4.2 percent - its lowest since February 2020.</p><p><blockquote>交易员还对劳工部的报告做出了反应，该报告显示美国11月份就业增长弱于预期，尽管失业率降至4.2%，为2020年2月以来的最低水平。</blockquote></p><p> While the disappointing job growth has raised some concerns about the economic outlook amid the emergence of the Omicron variant, the Federal Reserve is not expected to deviate from accelerating the tapering of its asset purchases.</p><p><blockquote>尽管在奥密克戎变种的出现下，令人失望的就业增长引发了人们对经济前景的一些担忧，但预计美联储不会偏离加速缩减资产购买规模。</blockquote></p><p> Crude oil futures pared early gains and settled lower Friday amid uncertainty about the outlook for energy demand due to fresh restrictions following the spread of the new coronavirus variant Omicron in several countries. West Texas Intermediate Crude oil futures for January ended down by $0.24 or 0.4 percent at $66.26 a barrel.</p><p><blockquote>由于新型冠状病毒变种奥密克戎在多个国家传播后实施了新的限制措施，能源需求前景存在不确定性，原油期货周五回吐早盘涨幅并收低。西德克萨斯中质原油1月期货收跌0.24美元或0.4%，报每桶66.26美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Bourse Expected To Remain Rangebound On Monday<blockquote>新加坡证券交易所预计周一将保持区间震荡</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Bourse Expected To Remain Rangebound On Monday<blockquote>新加坡证券交易所预计周一将保持区间震荡</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-06 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has moved higher in two of three trading days since the end of the six-day losing streak in which it had plummeted almost 200 points or 6.4 percent. The Straits Times Index now sits just above the 3,100-point plateau although it's expected to turn lower again on Monday.</p><p><blockquote>自结束连续六天下跌近200点或6.4%以来，新加坡股市在三个交易日中有两个交易日上涨。海峡时报指数目前略高于3,100点，但预计周一将再次走低。</blockquote></p><p> The global forecast for the Asian markets is negative on coronavirus and economic concerns, with oil and technology stocks likely to lead the way lower. The European and U.S. markets finished solidly under water and the Asian markets are expected to open in similar fashion.</p><p><blockquote>由于冠状病毒和经济担忧，全球对亚洲市场的预测是负面的，石油和科技股可能会领跌。欧洲和美国市场在水下收盘，预计亚洲市场也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly higher on Friday following gains from the industrials and properties, while the financials were mixed.</p><p><blockquote>继工业和房地产股上涨后，海指周五小幅收高，而金融股则涨跌互现。</blockquote></p><p> For the day, the index rose 9.82 points or 0.32 percent to finish at 3,101.93 after trading between 3,080.29 and 3,109.64. Volume was 1.04 billion shares worth 1.13 billion Singapore dollars. There were 269 gainers and 194 decliners.</p><p><blockquote>当天，该指数在3,080.29点至3,109.64点之间交易后，上涨9.82点或0.32%，收于3,101.93点。成交量为10.4亿股，价值11.3亿新元。上涨269家，下跌194家。</blockquote></p><p> Among the actives, Ascendas REIT added 0.68 percent, while CapitaLand Integrated Commercial Trust shed 0.48 percent, City Developments and Wilmar International both advanced 0.74 percent, Comfort DelGro accelerated 2.19 percent, Dairy Farm International and Genting Singapore both jumped 2.01 percent, DBS Group lost 0.25 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS surged 2.62 percent, SembCorp Industries soared 2.58 percent, Singapore Airlines gained 0.62 percent, Singapore Exchange spiked 2.43 percent, Singapore Technologies Engineering increased 0.27 percent, Thai Beverage rallied 0.76 percent, United Overseas Bank collected 0.46 percent, Yangzijiang Shipbuilding climbed 0.78 percent and Mapletree Commercial Trust, Mapletree Logistics Trust, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托下跌0.48%，City Developments和丰益国际均上涨0.74%，Comfort DelGro加速上涨2.19%，Dairy Farm International和云顶新加坡均上涨2.01%，星展集团下跌0.25%，吉宝企业上涨0.39%，华侨银行下跌0.09%，胜科工业飙升2.58%，新加坡航空上涨0.62%，新加坡科技工程上涨0.27%，泰国饮料上涨0.76%，扬子江造船上涨0.78%，丰树商业信托、丰树物流信托、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is soft as the major averages opened slightly higher on Friday but quickly turned lower and spent the remainder of the day in negative territory.</p><p><blockquote>华尔街的领先优势较弱，主要股指周五开盘小幅走高，但很快转跌，并在当天剩余时间内处于负值区域。</blockquote></p><p> The Dow shed 59/72 points or 0.17 percent to finish at 34,580.08, while the NASDAQ plummeted 295.83 points or 1.92 percent to close at 15,085.47 and the S&amp;P 500 lost 38.67 points or 0.84 percent to end at 4,538.43. For the week, the NASDAQ tumbled 2.6 percent, the S&amp;P lost 1.2 percent and the Dow fell 0.9 percent.</p><p><blockquote>道琼斯指数下跌59/72点，跌幅0.17%，收于34580.08点；纳斯达克指数暴跌295.83点，跌幅1.92%，收于15085.47点；标普500指数下跌38.67点，跌幅0.84%，收于4538.43点。本周，纳斯达克下跌2.6%，标准普尔指数下跌1.2%，道琼斯指数下跌0.9%。</blockquote></p><p> The losses extended the volatility seen throughout the week, with stocks showing wild swings in reaction to the Omicron variant of the coronavirus. After the first confirmed case in the U.S. earlier in the week, the new variant has now been detected in at least five states.</p><p><blockquote>这些损失扩大了整个星期的波动性，股市因冠状病毒的奥密克戎变种而出现剧烈波动。在本周早些时候美国出现首例确诊病例后，目前已在至少五个州发现了这种新变种。</blockquote></p><p> Traders also reacted to the Labor Department report showing weaker than expected U.S. job growth in November, although the jobless rate fell to 4.2 percent - its lowest since February 2020.</p><p><blockquote>交易员还对劳工部的报告做出了反应，该报告显示美国11月份就业增长弱于预期，尽管失业率降至4.2%，为2020年2月以来的最低水平。</blockquote></p><p> While the disappointing job growth has raised some concerns about the economic outlook amid the emergence of the Omicron variant, the Federal Reserve is not expected to deviate from accelerating the tapering of its asset purchases.</p><p><blockquote>尽管在奥密克戎变种的出现下，令人失望的就业增长引发了人们对经济前景的一些担忧，但预计美联储不会偏离加速缩减资产购买规模。</blockquote></p><p> Crude oil futures pared early gains and settled lower Friday amid uncertainty about the outlook for energy demand due to fresh restrictions following the spread of the new coronavirus variant Omicron in several countries. West Texas Intermediate Crude oil futures for January ended down by $0.24 or 0.4 percent at $66.26 a barrel.</p><p><blockquote>由于新型冠状病毒变种奥密克戎在多个国家传播后实施了新的限制措施，能源需求前景存在不确定性，原油期货周五回吐早盘涨幅并收低。西德克萨斯中质原油1月期货收跌0.24美元或0.4%，报每桶66.26美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3246867/singapore-bourse-expected-to-remain-rangebound-on-monday.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3246867/singapore-bourse-expected-to-remain-rangebound-on-monday.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178940634","content_text":"The Singapore stock market has moved higher in two of three trading days since the end of the six-day losing streak in which it had plummeted almost 200 points or 6.4 percent. The Straits Times Index now sits just above the 3,100-point plateau although it's expected to turn lower again on Monday.\n\nThe global forecast for the Asian markets is negative on coronavirus and economic concerns, with oil and technology stocks likely to lead the way lower. The European and U.S. markets finished solidly under water and the Asian markets are expected to open in similar fashion.\n\nThe STI finished modestly higher on Friday following gains from the industrials and properties, while the financials were mixed.\n\nFor the day, the index rose 9.82 points or 0.32 percent to finish at 3,101.93 after trading between 3,080.29 and 3,109.64. Volume was 1.04 billion shares worth 1.13 billion Singapore dollars. There were 269 gainers and 194 decliners.\n\nAmong the actives, Ascendas REIT added 0.68 percent, while CapitaLand Integrated Commercial Trust shed 0.48 percent, City Developments and Wilmar International both advanced 0.74 percent, Comfort DelGro accelerated 2.19 percent, Dairy Farm International and Genting Singapore both jumped 2.01 percent, DBS Group lost 0.25 percent, Keppel Corp rose 0.39 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS surged 2.62 percent, SembCorp Industries soared 2.58 percent, Singapore Airlines gained 0.62 percent, Singapore Exchange spiked 2.43 percent, Singapore Technologies Engineering increased 0.27 percent, Thai Beverage rallied 0.76 percent, United Overseas Bank collected 0.46 percent, Yangzijiang Shipbuilding climbed 0.78 percent and Mapletree Commercial Trust, Mapletree Logistics Trust, Singapore Press Holdings and SingTel were unchanged.\n\nThe lead from Wall Street is soft as the major averages opened slightly higher on Friday but quickly turned lower and spent the remainder of the day in negative territory.\n\nThe Dow shed 59/72 points or 0.17 percent to finish at 34,580.08, while the NASDAQ plummeted 295.83 points or 1.92 percent to close at 15,085.47 and the S&P 500 lost 38.67 points or 0.84 percent to end at 4,538.43. For the week, the NASDAQ tumbled 2.6 percent, the S&P lost 1.2 percent and the Dow fell 0.9 percent.\n\nThe losses extended the volatility seen throughout the week, with stocks showing wild swings in reaction to the Omicron variant of the coronavirus. After the first confirmed case in the U.S. earlier in the week, the new variant has now been detected in at least five states.\n\nTraders also reacted to the Labor Department report showing weaker than expected U.S. job growth in November, although the jobless rate fell to 4.2 percent - its lowest since February 2020.\n\nWhile the disappointing job growth has raised some concerns about the economic outlook amid the emergence of the Omicron variant, the Federal Reserve is not expected to deviate from accelerating the tapering of its asset purchases.\n\nCrude oil futures pared early gains and settled lower Friday amid uncertainty about the outlook for energy demand due to fresh restrictions following the spread of the new coronavirus variant Omicron in several countries. West Texas Intermediate Crude oil futures for January ended down by $0.24 or 0.4 percent at $66.26 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":1020,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601390339,"gmtCreate":1638489328116,"gmtModify":1638489328586,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601390339","repostId":"2188548587","repostType":4,"isVote":1,"tweetType":1,"viewCount":956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603520446,"gmtCreate":1638429891300,"gmtModify":1638429904315,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603520446","repostId":"1197973971","repostType":4,"repost":{"id":"1197973971","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638429281,"share":"https://www.laohu8.com/m/news/1197973971?lang=zh_CN&edition=full","pubTime":"2021-12-02 15:14","market":"us","language":"en","title":"Glaxo says its vaccine retains activity against key Omicron mutations<blockquote>葛兰素史克表示其疫苗保留了针对关键奥密克戎突变的活性</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197973971","media":"Tiger Newspress","summary":"GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced an update to bioRxiv, a preprint ser","content":"<p>GlaxoSmithKline plc&nbsp;and Vir Biotechnology, Inc.&nbsp;today announced an update to bioRxiv, a preprint server, with preclinical data demonstrating that sotrovimab, an investigational monoclonal antibody, retains activity against key mutations[1]&nbsp;of the new Omicron SARS-CoV-2 variant (B.1.1.529), including those found in the binding site of sotrovimab. These data were generated through pseudo-virus testing of specific individual mutations found in Omicron. To date, sotrovimab has demonstrated ongoing activity against all tested variants of concern and interest defined by the World Health Organization (WHO). The companies are now completing in vitro pseudo-virus testing to confirm the neutralising activity of sotrovimab against the combination of all the Omicron mutations with the intent to provide an update by the end of 2021.</p><p><blockquote>葛兰素史克公司和Vir Biotechnology，Inc.今天宣布更新预印本服务器bioRxiv，临床前数据表明，研究中的单克隆抗体sotrovimab保留了针对新奥密克戎新型冠状病毒病毒变异体（B.1.1.529）关键突变[1]的活性，包括在sotrovimab结合位点发现的突变。这些数据是通过对在奥密克戎发现的特定个体突变进行假病毒测试而产生的。迄今为止，sotrovimab已证明对世界卫生组织(WHO)定义的所有受关注和感兴趣的测试变体具有持续的活性。两家公司目前正在完成体外假病毒测试，以确认sotrovimab对所有奥密克戎突变组合的中和活性，并打算在2021年底前提供更新。</blockquote></p><p> <b>George Scangos, PhD, Chief Executive Officer of Vir, said:</b>“Sotrovimab was deliberately designed with a mutating virus in mind. By targeting a highly conserved region of the spike protein that is less likely to mutate, we hoped to address both the current SARS-CoV-2 virus and future variants that we expected would be inevitable. This hypothesis has borne out again and again – with its ongoing ability to maintain activity against all tested variants of concern and interest to date, including key mutations found in Omicron, as demonstrated by preclinical data. We have every expectation that this positive trend will continue and are working rapidly to confirm its activity against the full combination sequence of Omicron.”</p><p><blockquote><b>Vir首席执行官George Scangos博士表示：</b>“Sotrovimab在设计时考虑到了一种突变病毒。通过靶向刺突蛋白中不太可能突变的高度保守区域，我们希望解决当前的新型冠状病毒病毒和我们预计不可避免的未来变种。这一假设已经一次又一次地得到证实——正如临床前数据所证明的那样，它能够持续保持针对迄今为止所有受关注和感兴趣的测试变种的活性，包括在奥密克戎发现的关键突变。我们完全预计这种积极趋势将持续下去，并正在迅速努力确认其针对奥密克戎全组合序列的活性。”</blockquote></p><p> <b>Dr Hal Barron, Chief Scientific Officer and President R&amp;D, GSK, said:</b>“Since the beginning of the pandemic, we have been working with Vir to combine our scientific expertise and technologies to deliver an enduring treatment option for patients with COVID-19. Though very early, these pre-clinical data support our long-held view on the potential for sotrovimab to maintain its activity as the virus continues to mutate. We are pleased that this treatment option is available to patients in the US and many other countries, and are working to expand access worldwide.”</p><p><blockquote><b>葛兰素史克首席科学官兼研发总裁Hal Barron博士表示：</b>“自大流行开始以来，我们一直与Vir合作，结合我们的科学专业知识和技术，为COVID-19患者提供持久的治疗选择。虽然还为时过早，但这些临床前数据支持了我们长期以来的观点随着病毒的不断变异，sotrovimab有可能保持其活性。我们很高兴美国和许多其他国家的患者可以使用这种治疗方案，并正在努力扩大全球范围。”</blockquote></p><p> <b>About sotrovimab</b></p><p><blockquote><b>关于sotrovimab</b></blockquote></p><p> Sotrovimab is an investigational SARS-CoV-2 neutralising monoclonal antibody. The antibody binds to an epitope on SARS-CoV-2 shared with SARS-CoV-1 (the virus that causes SARS), indicating that the epitope is highly conserved, which may make it more difficult for resistance to develop. Sotrovimab, which incorporates Xencor’s Xtend™ technology, has also been designed to achieve high concentration in the lungs to ensure optimal penetration into airway tissues affected by SARS-CoV-2 and to have an extended half-life.</p><p><blockquote>Sotrovimab是一种在研新型冠状病毒中和单克隆抗体。该抗体与新型冠状病毒上与SARS-CoV-1（导致SARS的病毒）共有的表位结合，表明该表位高度保守，这可能会使耐药性更难产生。Sotrovimab，结合了Xencor的Xtend™技术，也被设计成在肺中实现高浓度，以确保最佳渗透到受新型冠状病毒病影响的气道组织中，并具有延长的半衰期。</blockquote></p><p> Updated in vitro data, published in bioRxiv, demonstrate that sotrovimab retains activity against all current tested variants of concern and interest of the SARS-CoV-2 virus as defined by WHO, plus others, including but not limited to Delta (B.1.617.2), Delta Plus (AY.1 or AY.2), Mu (B.1.621) and key mutations of Omicron (B.1.1.529).</p><p><blockquote>发表在bioRxiv上的更新体外数据表明，sotrovimab保留了针对世卫组织定义的所有当前测试的受关注和感兴趣的新型冠状病毒病毒变体以及其他变体的活性，包括但不限于Delta(B.1.617.2)、Delta Plus(AY.1或AY.2)、Mu(B.1.621)和奥密克戎病毒的关键突变(B.1.1.529)。</blockquote></p><p> <b>About the sotrovimab clinical development programme</b></p><p><blockquote><b>关于sotrovimab临床开发项目</b></blockquote></p><p></p><p> <ul>  <li>COMET-ICE: a Phase III, multi-centre, double-blind, placebo-controlled trial investigated an intravenous (IV) infusion of sotrovimab in adults with mild-to-moderate COVID-19 at high risk of progression to severe disease, who are not hospitalised and not requiring oxygen. The final COMET-ICE trial results in the full trial population of 1,057 participants demonstrated a 79% reduction (adjusted relative risk reduction) (p&lt;0.001) in hospitalisation for more than 24 hours or death due to any cause by Day 29 compared to placebo, meeting the primary endpoint of the trial. Interim data were published in<i>The New England Journal of Medicine</i>on 27 October 2021 and final data were pre-published on 8 November 2021 on<i>medRxiv</i>.</li>  <li>COMET-TAIL: a Phase III, randomised, multi-centre, open-label, non-inferiority trial of intramuscular (IM) versus IV administration of sotrovimab for the early treatment of mild-to-moderate COVID-19 in high-risk non-hospitalised adult and paediatric patients (12 years of age and older). The trial’s primary endpoint was met, and headline data demonstrated that intramuscularly administered sotrovimab was non-inferior and offered similar efficacy to intravenous administration for high-risk populations. The companies plan to submit the complete COMET-TAIL data set to a peer-reviewed journal for publication in the first quarter of 2022.</li>  <li>COMET-PEAK: a Phase II, randomised, multi-centre, parallel-group trial evaluating IV and IM administration of sotrovimab in outpatients with mild-to-moderate COVID-19. Data available to date from open-label Part B of the trial (500mg IV vs. 500mg IM) demonstrated equivalence on the virological response between the IM and IV arms. The companies plan to submit the complete COMET-PEAK data set to a peer-reviewed journal for publication in due course.</li>  <li>GSK and Vir are also partnering to investigate the use of sotrovimab in uninfected immunocompromised adults to determine whether sotrovimab can prevent symptomatic COVID-19 infection. GSK and Vir are supporting investigator-sponsored studies and fostering scientific collaborations with experienced investigators and networks involved in the continuum of care of immunocompromised patients, to understand the role sotrovimab for prophylaxis could play in this population. Discussions with regulatory authorities regarding the prophylaxis programme will take place in due course.</li> </ul> <b>About global access to sotrovimab</b></p><p><blockquote><ul><li>COMET-ICE：一项III期、多中心、双盲、安慰剂对照试验研究了在进展为严重疾病的高风险、未住院且不需要氧气的轻度至中度新冠肺炎成人中静脉（IV）输注sotrovimab。在1,057名参与者的完整试验人群中，最终COMET-ICE试验结果显示，与安慰剂相比，第29天住院超过24小时或因任何原因死亡的人数减少了79%（调整后的相对风险降低）（p&lt;0.001），达到了试验的主要终点。中期数据发表于<i>新英格兰医学杂志</i>于二零二一年十月二十七日及最终数据于二零二一年十一月八日预先公布<i>medRxiv</i>.</li><li>COMET-TAIL：一项III期、随机、多中心、开放标签、非劣效性试验，在高危非住院成人和儿童患者（12岁及以上）中，肌肉注射（IM）与静脉注射sotrovimab用于早期治疗轻度至中度新冠肺炎。该试验的主要终点达到了，主要数据表明，对于高危人群，肌肉注射sotrovimab并不劣效，并且提供了与静脉注射相似的疗效。两家公司计划将完整的彗尾数据集提交给同行评审期刊，以便于2022年第一季度发表。</li><li>COMET-PEAK：一项II期、随机、多中心、平行组试验，评估轻度至中度新冠肺炎门诊患者静脉注射和肌肉注射sotrovimab。迄今为止，来自试验开放标签B部分的可用数据（500mg IV vs.500mg IM）证明了IM组和IV组之间的病毒学应答等效。两家公司计划将完整的彗星峰值数据集提交给同行评审期刊，以便在适当的时候发表。</li><li>GSK和Vir还合作研究sotrovimab在未感染的免疫功能低下成人中的使用情况，以确定sotrovimab是否可以预防有症状的新冠肺炎感染。GSK和Vir正在支持研究者赞助的研究，并促进与参与免疫功能低下患者连续护理的经验丰富的研究者和网络的科学合作，以了解sotrovimab在该人群中的预防作用。将在适当的时候与监管机构讨论预防计划。</li></ul><b>关于sotrovimab的全球准入</b></blockquote></p><p> <ul>  <li>Sotrovimab is authorised for emergency use in the United States. Xevudy (sotrovimab) received apositive scientific opinionunder Article 5(3) of Regulation 726/2004 from the Committee for Human Medicinal Products (CHMP) in the EU, has been granted a provisional marketing authorisation in Australia, and conditional marketing authorisation in Saudi Arabia. In Japan, it has been approved via the Special Approval for Emergency Pathway. Temporary authorisations for sotrovimab have been granted in a dozen countries.</li>  <li>GSK and Vir also recently submitted the Marketing Authorisation Application (MAA) to the European Medicines Agency for Xevudy (sotrovimab) for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (COVID-19) who do not require oxygen supplementation and who are at risk of progressing to severe</li>  <li>COVID-19.</li>  <li>Sotrovimab is supplied in several countries worldwide, including through national agreements in the United States, United Kingdom, Japan, Australia, Canada, Singapore, Switzerland and United Arab Emirates. We have also signed a Joint Procurement Agreement with the European Commission to supply doses of sotrovimab. Additional agreements are yet to be announced due to confidentiality or regulatory requirements.</li> </ul> <b>Sotrovimab in the United States</b></p><p><blockquote><ul><li>Sotrovimab在美国被授权紧急使用。Xevudy(sotrovimab)根据欧盟人类药品委员会(CHMP)第726/2004号法规第5(3)条获得了积极的科学意见，已在澳大利亚获得临时营销授权，在沙特阿拉伯获得有条件营销授权。在日本，它已通过紧急途径的特别批准获得批准。sotrovimab已在十几个国家获得临时授权。</li><li>GSK和Vir最近还向欧洲药品管理局提交了Xevudy（sotrovimab）的上市许可申请（MAA），用于治疗患有冠状病毒疾病2019（COVID-19）的成人和青少年（12岁及以上，体重至少40公斤），这些人不需要补充氧气，并且有进展为严重的风险</li><li>新冠肺炎。</li><li>Sotrovimab在全球多个国家供应，包括通过美国、英国、日本、澳大利亚、加拿大、新加坡、瑞士和阿拉伯联合酋长国的国家协议。我们还与欧盟委员会签署了一项联合采购协议，以供应sotrovimab的剂量。由于保密或监管要求，其他协议尚未公布。</li></ul><b>Sotrovimab在美国</b></blockquote></p><p> The following is a summary of information for sotrovimab. Healthcare providers in the U.S. should review the Fact Sheets for information about the authorised use of sotrovimab and mandatory requirements of the EUA. Please see theFood and Drug Administration (FDA) Letter of Authorization, fullFact Sheet for Healthcare Providers, and fullFact Sheet for Patients, Parents, and Caregivers.</p><p><blockquote>以下是sotrovimab的信息总结。美国的医疗保健提供者应查看情况说明书，了解有关sotrovimab授权使用和EUA强制性要求的信息。请参见食品药品监督管理局（FDA）的授权书、医疗保健提供者的完整情况说明书和患者、父母和护理人员的完整情况说明书。</blockquote></p><p> Sotrovimab has been authorized by the U.S. FDA for the emergency use described below. Sotrovimab is not FDA-approved for this use.</p><p><blockquote>Sotrovimab已获得美国FDA的紧急使用授权，如下所述。Sotrovimab未被FDA批准用于此用途。</blockquote></p><p> Sotrovimab is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of sotrovimab under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.</p><p><blockquote>Sotrovimab仅在根据法案第564（b）（1）节，21 U.S.C.360BBB-3（b）（1）宣布存在证明授权紧急使用Sotrovimab的情况期间获得授权，除非授权提前终止或撤销。</blockquote></p><p> <b>Authorized Use</b></p><p><blockquote><b>授权使用</b></blockquote></p><p></p><p> The U.S. FDA has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.</p><p><blockquote>美国FDA已发布紧急使用授权（EUA），允许紧急使用未经批准的产品sotrovimab，用于治疗成人和儿科患者（12岁及以上，体重至少40公斤）的轻中度冠状病毒疾病2019（COVID-19），这些患者直接新型冠状病毒病毒检测结果呈阳性，并且有进展为严重COVID-19（包括住院或死亡）的高风险。</blockquote></p><p> <b>Limitations of Authorized Use</b></p><p><blockquote><b>授权使用的限制</b></blockquote></p><p> Sotrovimab is not authorized for use in patients:</p><p><blockquote>Sotrovimab未被授权用于以下患者：</blockquote></p><p> <ul>  <li>who are hospitalized due to COVID-19, OR</li>  <li>who require oxygen therapy due to COVID-19, OR</li>  <li>who require an increase in baseline oxygen flow rate due to COVID-19 (in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity)</li> </ul> Benefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID 19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID 19 requiring high flow oxygen or mechanical ventilation.</p><p><blockquote><ul><li>因COVID-19住院的人，或</li><li>因COVID-19需要氧疗的人，或</li><li>因新冠肺炎而需要增加基线氧流量的人（因潜在的非新冠肺炎相关合并症而接受慢性氧疗的人）</li></ul>在因COVID 19住院的患者中未观察到sotrovimab治疗的益处。当给予需要高流量氧气或机械通气的COVID 19住院患者时，新型冠状病毒单克隆抗体可能与更差的临床结局相关。</blockquote></p><p> <b>Important Safety Information</b></p><p><blockquote><b>重要安全信息</b></blockquote></p><p> <b>CONTRAINDICATIONS</b></p><p><blockquote><b>禁忌证</b></blockquote></p><p> Sotrovimab is contraindicated in patients who have a history of anaphylaxis to sotrovimab or to any of the excipients in the formulation.</p><p><blockquote>对sotrovimab或制剂中的任何赋形剂有过敏反应史的患者禁用sotrovimab。</blockquote></p><p> <b>WARNINGS AND PRECAUTIONS</b></p><p><blockquote><b>警告和注意事项</b></blockquote></p><p> There are limited clinical data available for sotrovimab. Serious and unexpected adverse events may occur that have not been previously reported with sotrovimab use.</p><p><blockquote>sotrovimab的可用临床数据有限。使用sotrovimab可能会发生以前未报告的严重和意外不良事件。</blockquote></p><p> <b>Hypersensitivity Including Anaphylaxis and Infusion-Related Reactions</b></p><p><blockquote><b>超敏反应，包括过敏反应和输液相关反应</b></blockquote></p><p> Serious hypersensitivity reactions, including anaphylaxis, have been observed with administration of sotrovimab. If signs and symptoms of a clinically significant hypersensitivity reaction or anaphylaxis occur, immediately discontinue administration and initiate appropriate medications and/or supportive care.</p><p><blockquote>服用sotrovimab后观察到严重的超敏反应，包括过敏反应。如果出现临床上显著的超敏反应或过敏反应的体征和症状，立即停止给药并开始适当的药物和/或支持性护理。</blockquote></p><p> Infusion-related reactions, occurring during the infusion and up to 24 hours after the infusion, have been observed with administration of sotrovimab. These reactions may be severe or life threatening.</p><p><blockquote>服用sotrovimab时观察到输注期间和输注后24小时内发生的输注相关反应。这些反应可能很严重或危及生命。</blockquote></p><p> Signs and symptoms of infusion-related reactions may include: fever, difficulty breathing, reduced oxygen saturation, chills, fatigue, arrhythmia (eg, atrial fibrillation, sinus tachycardia, bradycardia), chest pain or discomfort, weakness, altered mental status, nausea, headache, bronchospasm, hypotension, hypertension, angioedema, throat irritation, rash including urticaria, pruritus, myalgia, vaso-vagal reactions (eg, pre-syncope, syncope), dizziness and diaphoresis.</p><p><blockquote>输注相关反应的体征和症状可能包括：发热、呼吸困难、氧饱和度降低、寒战、疲劳、心律失常（如房颤、窦性心动过速、心动过缓）、胸痛或不适、虚弱、精神状态改变、恶心、头痛、支气管痉挛、低血压、高血压、血管水肿、咽喉刺激、皮疹（包括荨麻疹）、瘙痒、肌痛、血管迷走神经反应（如晕厥前、晕厥）、头晕和出汗。</blockquote></p><p> Consider slowing or stopping the infusion and administer appropriate medications and/or supportive care if an infusion-related reaction occurs.</p><p><blockquote>如果发生输注相关反应，考虑减慢或停止输注，并给予适当的药物和/或支持性护理。</blockquote></p><p> Hypersensitivity reactions occurring more than 24 hours after the infusion have also been reported with the use of SARS-CoV-2 monoclonal antibodies under Emergency Use Authorization.</p><p><blockquote>在紧急使用授权下使用新型冠状病毒单克隆抗体时，也报告了输注后超过24小时发生的超敏反应。</blockquote></p><p> <b>Clinical Worsening After SARS-CoV-2 Monoclonal Antibody Administration</b></p><p><blockquote><b>新型冠状病毒单克隆抗体给药后临床恶化</b></blockquote></p><p> Clinical worsening of COVID‑19 after administration of SARS-CoV-2 monoclonal antibody treatment has been reported and may include signs or symptoms of fever, hypoxia or increased respiratory difficulty, arrhythmia (eg, atrial fibrillation, tachycardia, bradycardia), fatigue, and altered mental status. Some of these events required hospitalization. It is not known if these events were related to SARS-CoV-2 monoclonal antibody use or were due to progression of COVID‑19.</p><p><blockquote>据报道，接受新型冠状病毒单克隆抗体治疗后，COVID-19的临床恶化可能包括发热、缺氧或呼吸困难增加、心律失常（如房颤、心动过速、心动过缓）、疲劳和精神状态改变的体征或症状。其中一些事件需要住院治疗。尚不清楚这些事件是与新型冠状病毒单克隆抗体的使用有关，还是由于COVID-19的进展。</blockquote></p><p> <b>Limitations of Benefit and Potential for Risk in Patients with Severe COVID‑19</b></p><p><blockquote><b>重症COVID-19患者的获益限制和潜在风险</b></blockquote></p><p> Benefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID‑19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID‑19 requiring high flow oxygen or mechanical ventilation. Therefore, sotrovimab is not authorized for use in patients: who are hospitalized due to COVID‑19, OR who require oxygen therapy due to COVID‑19, OR who require an increase in baseline oxygen flow rate due to COVID‑19 in those on chronic oxygen therapy due to underlying non‑COVID‑19 related comorbidity.</p><p><blockquote>在因COVID-19住院的患者中未观察到sotrovimab治疗的益处。当给予需要高流量氧气或机械通气的COVID-19住院患者时，新型冠状病毒单克隆抗体可能与更差的临床结局相关。因此，sotrovimab未被授权用于以下患者：因新冠肺炎住院的患者，或因新冠肺炎需要氧疗的患者，或因新冠肺炎需要增加基线氧流量的患者，以及因潜在的非新冠肺炎相关合并症而接受慢性氧疗的患者。</blockquote></p><p> <b>ADVERSE EVENTS</b></p><p><blockquote><b>不良事件</b></blockquote></p><p> Hypersensitivity adverse reactions have been observed in 2% of patients treated with sotrovimab and 1% with placebo in COMET-ICE.</p><p><blockquote>在COMET-ICE中，在2%接受sotrovimab治疗的患者和1%接受安慰剂治疗的患者中观察到超敏反应。</blockquote></p><p> The most common treatment-emergent adverse events observed in the sotrovimab treatment group in COMET-ICE were rash (1%) and diarrhea (2%), all of which were Grade 1 (mild) or Grade 2 (moderate). No other treatment-emergent adverse events were reported at a higher rate with sotrovimab compared to placebo.</p><p><blockquote>COMET-ICE中sotrovimab治疗组观察到的最常见的治疗后出现的不良事件为皮疹（1%）和腹泻（2%），均为1级（轻度）或2级（中度）。与安慰剂相比，sotrovimab组未报告其他治疗中出现的不良事件发生率更高。</blockquote></p><p> <b>USE IN SPECIFIC POPULATIONS</b></p><p><blockquote><b>用于特定人群</b></blockquote></p><p> <b>Pregnancy</b></p><p><blockquote><b>妊娠</b></blockquote></p><p></p><p> There are insufficient data to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome. Sotrovimab should be used during pregnancy only if the potential benefit justifies the potential risk for the mother and the fetus.</p><p><blockquote>没有足够的数据来评估药物相关的重大出生缺陷、流产或不良母体或胎儿结局的风险。只有当潜在益处证明对母亲和胎儿的潜在风险合理时，才应在妊娠期间使用Sotrovimab。</blockquote></p><p> <b>Lactation</b></p><p><blockquote><b>哺乳期</b></blockquote></p><p> There are no available data on the presence of sotrovimab in human milk, the effects on the breastfed infant, or the effects on milk production. Individuals with COVID-19 who are breastfeeding should follow practices according to clinical guidelines to avoid exposing the infant to COVID-19.</p><p><blockquote>没有关于母乳中sotrovimab的存在、对母乳喂养婴儿的影响或对产奶量的影响的可用数据。正在母乳喂养的新冠肺炎患者应遵循临床指南的做法，以避免婴儿接触新冠肺炎。</blockquote></p><p> <b>About the GSK and Vir collaboration</b></p><p><blockquote><b>关于GSK与Vir的合作</b></blockquote></p><p> In April 2020, GSK and Vir entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration uses Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventive options to help address the current COVID-19 pandemic and future outbreaks. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to identify anti-coronavirus compounds that target cellular host genes. They will also apply their combined expertise to research SARS-CoV-2 and other coronavirus vaccines.</p><p><blockquote>2020年4月，葛兰素史克和Vir达成合作，研究和开发冠状病毒的解决方案，包括导致COVID-19的新型冠状病毒病毒。此次合作使用Vir专有的单克隆抗体平台技术来加速现有的和识别新的抗病毒抗体，这些抗体可用作治疗或预防选择，以帮助应对当前的新冠肺炎疫情和未来的疫情。两家公司将利用GSK在功能基因组学方面的专业知识，并结合其在CRISPR筛选和人工智能方面的能力，以识别靶向细胞宿主基因的抗冠状病毒化合物。他们还将运用他们的综合专业知识来研究新型冠状病毒和其他冠状病毒疫苗。</blockquote></p><p> <b>GSK commitment to tackling COVID-19</b></p><p><blockquote><b>葛兰素史克致力于应对COVID-19</b></blockquote></p><p> GSK’s response to COVID-19 has been one of the broadest in the industry, with potential treatments in addition to our vaccine candidates in development with partner organisations.</p><p><blockquote>葛兰素史克对新冠肺炎的反应是业内最广泛的反应之一，除了我们与合作伙伴组织正在开发的候选疫苗之外，还有潜在的治疗方法。</blockquote></p><p> GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our adjuvant technology. We are working with Sanofi S.A., Medicago Inc. and SK bioscience Co., Ltd. to develop adjuvanted, protein-based vaccine candidates, and all are now in Phase III clinical trials. The use of an adjuvant can be of particular importance in a pandemic since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and contributing to protecting more people in need.</p><p><blockquote>葛兰素史克正在与几个组织合作开发新冠肺炎疫苗，提供我们的佐剂技术。我们正在与Sanofi S.A.、Medicago Inc.和SK bioscience Co., Ltd.合作开发基于佐剂的蛋白质候选疫苗，目前均处于III期临床试验。佐剂的使用在大流行中可能特别重要，因为它可以减少每剂所需的疫苗蛋白的量，允许生产更多的疫苗剂量并有助于保护更多有需要的人。</blockquote></p><p> GSK is also working with mRNA specialist, CureVac N.V., to jointly develop next-generation, optimised mRNA vaccines for COVID-19 with the potential to address multiple emerging variants in one vaccine.</p><p><blockquote>葛兰素史克还与mRNA专家CureVac N.V.合作，共同开发下一代优化的新冠肺炎mRNA疫苗，有可能在一种疫苗中解决多种新出现的变异。</blockquote></p><p> GSK is also exploring treatments for COVID-19 patients, collaborating with Vir Biotechnology to investigate monoclonal antibodies that could be used as therapeutic or preventive options for COVID-19.</p><p><blockquote>葛兰素史克还在探索新冠肺炎患者的治疗方法，与Vir Biotechnology合作研究可用作新冠肺炎治疗或预防选择的单克隆抗体。</blockquote></p><p> <b>Vir’s commitment to COVID-19</b></p><p><blockquote><b>Vir对COVID-19的承诺</b></blockquote></p><p> Vir was founded with the mission of addressing the world’s most serious infectious diseases. In 2020, Vir responded rapidly to the COVID-19 pandemic by leveraging our unique scientific insights and industry-leading antibody platform to explore multiple monoclonal antibodies as potential therapeutic or preventive options for COVID-19. Sotrovimab is the first SARS-CoV-2-targeting antibody Vir advanced into the clinic. It was carefully selected for its demonstrated promise in preclinical research, including an anticipated high barrier to resistance and potential ability to both block the virus from entering healthy cells and clear infected cells. Vir is continuing to pursue novel therapeutic and prophylactic solutions to combat SARS-CoV-2 and future coronavirus pandemics, both independently and in collaboration with its partners.</p><p><blockquote>Vir成立的使命是解决世界上最严重的传染病。2020年，Vir利用我们独特的科学见解和行业领先的抗体平台，探索多种单克隆抗体作为COVID-19的潜在治疗或预防选择，迅速应对COVID-19大流行。Sotrovimab是第一个挺进临床的新型冠状病毒靶向抗体Vir。它被精心选择是因为它在临床前研究中表现出的前景，包括预期的高耐药性屏障和阻止病毒进入健康细胞和清除受感染细胞的潜在能力。Vir正在继续寻求新的治疗和预防解决方案，以应对新型冠状病毒和未来的冠状病毒大流行，无论是独立还是与其合作伙伴合作。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Glaxo says its vaccine retains activity against key Omicron mutations<blockquote>葛兰素史克表示其疫苗保留了针对关键奥密克戎突变的活性</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlaxo says its vaccine retains activity against key Omicron mutations<blockquote>葛兰素史克表示其疫苗保留了针对关键奥密克戎突变的活性</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-02 15:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>GlaxoSmithKline plc&nbsp;and Vir Biotechnology, Inc.&nbsp;today announced an update to bioRxiv, a preprint server, with preclinical data demonstrating that sotrovimab, an investigational monoclonal antibody, retains activity against key mutations[1]&nbsp;of the new Omicron SARS-CoV-2 variant (B.1.1.529), including those found in the binding site of sotrovimab. These data were generated through pseudo-virus testing of specific individual mutations found in Omicron. To date, sotrovimab has demonstrated ongoing activity against all tested variants of concern and interest defined by the World Health Organization (WHO). The companies are now completing in vitro pseudo-virus testing to confirm the neutralising activity of sotrovimab against the combination of all the Omicron mutations with the intent to provide an update by the end of 2021.</p><p><blockquote>葛兰素史克公司和Vir Biotechnology，Inc.今天宣布更新预印本服务器bioRxiv，临床前数据表明，研究中的单克隆抗体sotrovimab保留了针对新奥密克戎新型冠状病毒病毒变异体（B.1.1.529）关键突变[1]的活性，包括在sotrovimab结合位点发现的突变。这些数据是通过对在奥密克戎发现的特定个体突变进行假病毒测试而产生的。迄今为止，sotrovimab已证明对世界卫生组织(WHO)定义的所有受关注和感兴趣的测试变体具有持续的活性。两家公司目前正在完成体外假病毒测试，以确认sotrovimab对所有奥密克戎突变组合的中和活性，并打算在2021年底前提供更新。</blockquote></p><p> <b>George Scangos, PhD, Chief Executive Officer of Vir, said:</b>“Sotrovimab was deliberately designed with a mutating virus in mind. By targeting a highly conserved region of the spike protein that is less likely to mutate, we hoped to address both the current SARS-CoV-2 virus and future variants that we expected would be inevitable. This hypothesis has borne out again and again – with its ongoing ability to maintain activity against all tested variants of concern and interest to date, including key mutations found in Omicron, as demonstrated by preclinical data. We have every expectation that this positive trend will continue and are working rapidly to confirm its activity against the full combination sequence of Omicron.”</p><p><blockquote><b>Vir首席执行官George Scangos博士表示：</b>“Sotrovimab在设计时考虑到了一种突变病毒。通过靶向刺突蛋白中不太可能突变的高度保守区域，我们希望解决当前的新型冠状病毒病毒和我们预计不可避免的未来变种。这一假设已经一次又一次地得到证实——正如临床前数据所证明的那样，它能够持续保持针对迄今为止所有受关注和感兴趣的测试变种的活性，包括在奥密克戎发现的关键突变。我们完全预计这种积极趋势将持续下去，并正在迅速努力确认其针对奥密克戎全组合序列的活性。”</blockquote></p><p> <b>Dr Hal Barron, Chief Scientific Officer and President R&amp;D, GSK, said:</b>“Since the beginning of the pandemic, we have been working with Vir to combine our scientific expertise and technologies to deliver an enduring treatment option for patients with COVID-19. Though very early, these pre-clinical data support our long-held view on the potential for sotrovimab to maintain its activity as the virus continues to mutate. We are pleased that this treatment option is available to patients in the US and many other countries, and are working to expand access worldwide.”</p><p><blockquote><b>葛兰素史克首席科学官兼研发总裁Hal Barron博士表示：</b>“自大流行开始以来，我们一直与Vir合作，结合我们的科学专业知识和技术，为COVID-19患者提供持久的治疗选择。虽然还为时过早，但这些临床前数据支持了我们长期以来的观点随着病毒的不断变异，sotrovimab有可能保持其活性。我们很高兴美国和许多其他国家的患者可以使用这种治疗方案，并正在努力扩大全球范围。”</blockquote></p><p> <b>About sotrovimab</b></p><p><blockquote><b>关于sotrovimab</b></blockquote></p><p> Sotrovimab is an investigational SARS-CoV-2 neutralising monoclonal antibody. The antibody binds to an epitope on SARS-CoV-2 shared with SARS-CoV-1 (the virus that causes SARS), indicating that the epitope is highly conserved, which may make it more difficult for resistance to develop. Sotrovimab, which incorporates Xencor’s Xtend™ technology, has also been designed to achieve high concentration in the lungs to ensure optimal penetration into airway tissues affected by SARS-CoV-2 and to have an extended half-life.</p><p><blockquote>Sotrovimab是一种在研新型冠状病毒中和单克隆抗体。该抗体与新型冠状病毒上与SARS-CoV-1（导致SARS的病毒）共有的表位结合，表明该表位高度保守，这可能会使耐药性更难产生。Sotrovimab，结合了Xencor的Xtend™技术，也被设计成在肺中实现高浓度，以确保最佳渗透到受新型冠状病毒病影响的气道组织中，并具有延长的半衰期。</blockquote></p><p> Updated in vitro data, published in bioRxiv, demonstrate that sotrovimab retains activity against all current tested variants of concern and interest of the SARS-CoV-2 virus as defined by WHO, plus others, including but not limited to Delta (B.1.617.2), Delta Plus (AY.1 or AY.2), Mu (B.1.621) and key mutations of Omicron (B.1.1.529).</p><p><blockquote>发表在bioRxiv上的更新体外数据表明，sotrovimab保留了针对世卫组织定义的所有当前测试的受关注和感兴趣的新型冠状病毒病毒变体以及其他变体的活性，包括但不限于Delta(B.1.617.2)、Delta Plus(AY.1或AY.2)、Mu(B.1.621)和奥密克戎病毒的关键突变(B.1.1.529)。</blockquote></p><p> <b>About the sotrovimab clinical development programme</b></p><p><blockquote><b>关于sotrovimab临床开发项目</b></blockquote></p><p></p><p> <ul>  <li>COMET-ICE: a Phase III, multi-centre, double-blind, placebo-controlled trial investigated an intravenous (IV) infusion of sotrovimab in adults with mild-to-moderate COVID-19 at high risk of progression to severe disease, who are not hospitalised and not requiring oxygen. The final COMET-ICE trial results in the full trial population of 1,057 participants demonstrated a 79% reduction (adjusted relative risk reduction) (p&lt;0.001) in hospitalisation for more than 24 hours or death due to any cause by Day 29 compared to placebo, meeting the primary endpoint of the trial. Interim data were published in<i>The New England Journal of Medicine</i>on 27 October 2021 and final data were pre-published on 8 November 2021 on<i>medRxiv</i>.</li>  <li>COMET-TAIL: a Phase III, randomised, multi-centre, open-label, non-inferiority trial of intramuscular (IM) versus IV administration of sotrovimab for the early treatment of mild-to-moderate COVID-19 in high-risk non-hospitalised adult and paediatric patients (12 years of age and older). The trial’s primary endpoint was met, and headline data demonstrated that intramuscularly administered sotrovimab was non-inferior and offered similar efficacy to intravenous administration for high-risk populations. The companies plan to submit the complete COMET-TAIL data set to a peer-reviewed journal for publication in the first quarter of 2022.</li>  <li>COMET-PEAK: a Phase II, randomised, multi-centre, parallel-group trial evaluating IV and IM administration of sotrovimab in outpatients with mild-to-moderate COVID-19. Data available to date from open-label Part B of the trial (500mg IV vs. 500mg IM) demonstrated equivalence on the virological response between the IM and IV arms. The companies plan to submit the complete COMET-PEAK data set to a peer-reviewed journal for publication in due course.</li>  <li>GSK and Vir are also partnering to investigate the use of sotrovimab in uninfected immunocompromised adults to determine whether sotrovimab can prevent symptomatic COVID-19 infection. GSK and Vir are supporting investigator-sponsored studies and fostering scientific collaborations with experienced investigators and networks involved in the continuum of care of immunocompromised patients, to understand the role sotrovimab for prophylaxis could play in this population. Discussions with regulatory authorities regarding the prophylaxis programme will take place in due course.</li> </ul> <b>About global access to sotrovimab</b></p><p><blockquote><ul><li>COMET-ICE：一项III期、多中心、双盲、安慰剂对照试验研究了在进展为严重疾病的高风险、未住院且不需要氧气的轻度至中度新冠肺炎成人中静脉（IV）输注sotrovimab。在1,057名参与者的完整试验人群中，最终COMET-ICE试验结果显示，与安慰剂相比，第29天住院超过24小时或因任何原因死亡的人数减少了79%（调整后的相对风险降低）（p&lt;0.001），达到了试验的主要终点。中期数据发表于<i>新英格兰医学杂志</i>于二零二一年十月二十七日及最终数据于二零二一年十一月八日预先公布<i>medRxiv</i>.</li><li>COMET-TAIL：一项III期、随机、多中心、开放标签、非劣效性试验，在高危非住院成人和儿童患者（12岁及以上）中，肌肉注射（IM）与静脉注射sotrovimab用于早期治疗轻度至中度新冠肺炎。该试验的主要终点达到了，主要数据表明，对于高危人群，肌肉注射sotrovimab并不劣效，并且提供了与静脉注射相似的疗效。两家公司计划将完整的彗尾数据集提交给同行评审期刊，以便于2022年第一季度发表。</li><li>COMET-PEAK：一项II期、随机、多中心、平行组试验，评估轻度至中度新冠肺炎门诊患者静脉注射和肌肉注射sotrovimab。迄今为止，来自试验开放标签B部分的可用数据（500mg IV vs.500mg IM）证明了IM组和IV组之间的病毒学应答等效。两家公司计划将完整的彗星峰值数据集提交给同行评审期刊，以便在适当的时候发表。</li><li>GSK和Vir还合作研究sotrovimab在未感染的免疫功能低下成人中的使用情况，以确定sotrovimab是否可以预防有症状的新冠肺炎感染。GSK和Vir正在支持研究者赞助的研究，并促进与参与免疫功能低下患者连续护理的经验丰富的研究者和网络的科学合作，以了解sotrovimab在该人群中的预防作用。将在适当的时候与监管机构讨论预防计划。</li></ul><b>关于sotrovimab的全球准入</b></blockquote></p><p> <ul>  <li>Sotrovimab is authorised for emergency use in the United States. Xevudy (sotrovimab) received apositive scientific opinionunder Article 5(3) of Regulation 726/2004 from the Committee for Human Medicinal Products (CHMP) in the EU, has been granted a provisional marketing authorisation in Australia, and conditional marketing authorisation in Saudi Arabia. In Japan, it has been approved via the Special Approval for Emergency Pathway. Temporary authorisations for sotrovimab have been granted in a dozen countries.</li>  <li>GSK and Vir also recently submitted the Marketing Authorisation Application (MAA) to the European Medicines Agency for Xevudy (sotrovimab) for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (COVID-19) who do not require oxygen supplementation and who are at risk of progressing to severe</li>  <li>COVID-19.</li>  <li>Sotrovimab is supplied in several countries worldwide, including through national agreements in the United States, United Kingdom, Japan, Australia, Canada, Singapore, Switzerland and United Arab Emirates. We have also signed a Joint Procurement Agreement with the European Commission to supply doses of sotrovimab. Additional agreements are yet to be announced due to confidentiality or regulatory requirements.</li> </ul> <b>Sotrovimab in the United States</b></p><p><blockquote><ul><li>Sotrovimab在美国被授权紧急使用。Xevudy(sotrovimab)根据欧盟人类药品委员会(CHMP)第726/2004号法规第5(3)条获得了积极的科学意见，已在澳大利亚获得临时营销授权，在沙特阿拉伯获得有条件营销授权。在日本，它已通过紧急途径的特别批准获得批准。sotrovimab已在十几个国家获得临时授权。</li><li>GSK和Vir最近还向欧洲药品管理局提交了Xevudy（sotrovimab）的上市许可申请（MAA），用于治疗患有冠状病毒疾病2019（COVID-19）的成人和青少年（12岁及以上，体重至少40公斤），这些人不需要补充氧气，并且有进展为严重的风险</li><li>新冠肺炎。</li><li>Sotrovimab在全球多个国家供应，包括通过美国、英国、日本、澳大利亚、加拿大、新加坡、瑞士和阿拉伯联合酋长国的国家协议。我们还与欧盟委员会签署了一项联合采购协议，以供应sotrovimab的剂量。由于保密或监管要求，其他协议尚未公布。</li></ul><b>Sotrovimab在美国</b></blockquote></p><p> The following is a summary of information for sotrovimab. Healthcare providers in the U.S. should review the Fact Sheets for information about the authorised use of sotrovimab and mandatory requirements of the EUA. Please see theFood and Drug Administration (FDA) Letter of Authorization, fullFact Sheet for Healthcare Providers, and fullFact Sheet for Patients, Parents, and Caregivers.</p><p><blockquote>以下是sotrovimab的信息总结。美国的医疗保健提供者应查看情况说明书，了解有关sotrovimab授权使用和EUA强制性要求的信息。请参见食品药品监督管理局（FDA）的授权书、医疗保健提供者的完整情况说明书和患者、父母和护理人员的完整情况说明书。</blockquote></p><p> Sotrovimab has been authorized by the U.S. FDA for the emergency use described below. Sotrovimab is not FDA-approved for this use.</p><p><blockquote>Sotrovimab已获得美国FDA的紧急使用授权，如下所述。Sotrovimab未被FDA批准用于此用途。</blockquote></p><p> Sotrovimab is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of sotrovimab under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.</p><p><blockquote>Sotrovimab仅在根据法案第564（b）（1）节，21 U.S.C.360BBB-3（b）（1）宣布存在证明授权紧急使用Sotrovimab的情况期间获得授权，除非授权提前终止或撤销。</blockquote></p><p> <b>Authorized Use</b></p><p><blockquote><b>授权使用</b></blockquote></p><p></p><p> The U.S. FDA has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.</p><p><blockquote>美国FDA已发布紧急使用授权（EUA），允许紧急使用未经批准的产品sotrovimab，用于治疗成人和儿科患者（12岁及以上，体重至少40公斤）的轻中度冠状病毒疾病2019（COVID-19），这些患者直接新型冠状病毒病毒检测结果呈阳性，并且有进展为严重COVID-19（包括住院或死亡）的高风险。</blockquote></p><p> <b>Limitations of Authorized Use</b></p><p><blockquote><b>授权使用的限制</b></blockquote></p><p> Sotrovimab is not authorized for use in patients:</p><p><blockquote>Sotrovimab未被授权用于以下患者：</blockquote></p><p> <ul>  <li>who are hospitalized due to COVID-19, OR</li>  <li>who require oxygen therapy due to COVID-19, OR</li>  <li>who require an increase in baseline oxygen flow rate due to COVID-19 (in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity)</li> </ul> Benefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID 19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID 19 requiring high flow oxygen or mechanical ventilation.</p><p><blockquote><ul><li>因COVID-19住院的人，或</li><li>因COVID-19需要氧疗的人，或</li><li>因新冠肺炎而需要增加基线氧流量的人（因潜在的非新冠肺炎相关合并症而接受慢性氧疗的人）</li></ul>在因COVID 19住院的患者中未观察到sotrovimab治疗的益处。当给予需要高流量氧气或机械通气的COVID 19住院患者时，新型冠状病毒单克隆抗体可能与更差的临床结局相关。</blockquote></p><p> <b>Important Safety Information</b></p><p><blockquote><b>重要安全信息</b></blockquote></p><p> <b>CONTRAINDICATIONS</b></p><p><blockquote><b>禁忌证</b></blockquote></p><p> Sotrovimab is contraindicated in patients who have a history of anaphylaxis to sotrovimab or to any of the excipients in the formulation.</p><p><blockquote>对sotrovimab或制剂中的任何赋形剂有过敏反应史的患者禁用sotrovimab。</blockquote></p><p> <b>WARNINGS AND PRECAUTIONS</b></p><p><blockquote><b>警告和注意事项</b></blockquote></p><p> There are limited clinical data available for sotrovimab. Serious and unexpected adverse events may occur that have not been previously reported with sotrovimab use.</p><p><blockquote>sotrovimab的可用临床数据有限。使用sotrovimab可能会发生以前未报告的严重和意外不良事件。</blockquote></p><p> <b>Hypersensitivity Including Anaphylaxis and Infusion-Related Reactions</b></p><p><blockquote><b>超敏反应，包括过敏反应和输液相关反应</b></blockquote></p><p> Serious hypersensitivity reactions, including anaphylaxis, have been observed with administration of sotrovimab. If signs and symptoms of a clinically significant hypersensitivity reaction or anaphylaxis occur, immediately discontinue administration and initiate appropriate medications and/or supportive care.</p><p><blockquote>服用sotrovimab后观察到严重的超敏反应，包括过敏反应。如果出现临床上显著的超敏反应或过敏反应的体征和症状，立即停止给药并开始适当的药物和/或支持性护理。</blockquote></p><p> Infusion-related reactions, occurring during the infusion and up to 24 hours after the infusion, have been observed with administration of sotrovimab. These reactions may be severe or life threatening.</p><p><blockquote>服用sotrovimab时观察到输注期间和输注后24小时内发生的输注相关反应。这些反应可能很严重或危及生命。</blockquote></p><p> Signs and symptoms of infusion-related reactions may include: fever, difficulty breathing, reduced oxygen saturation, chills, fatigue, arrhythmia (eg, atrial fibrillation, sinus tachycardia, bradycardia), chest pain or discomfort, weakness, altered mental status, nausea, headache, bronchospasm, hypotension, hypertension, angioedema, throat irritation, rash including urticaria, pruritus, myalgia, vaso-vagal reactions (eg, pre-syncope, syncope), dizziness and diaphoresis.</p><p><blockquote>输注相关反应的体征和症状可能包括：发热、呼吸困难、氧饱和度降低、寒战、疲劳、心律失常（如房颤、窦性心动过速、心动过缓）、胸痛或不适、虚弱、精神状态改变、恶心、头痛、支气管痉挛、低血压、高血压、血管水肿、咽喉刺激、皮疹（包括荨麻疹）、瘙痒、肌痛、血管迷走神经反应（如晕厥前、晕厥）、头晕和出汗。</blockquote></p><p> Consider slowing or stopping the infusion and administer appropriate medications and/or supportive care if an infusion-related reaction occurs.</p><p><blockquote>如果发生输注相关反应，考虑减慢或停止输注，并给予适当的药物和/或支持性护理。</blockquote></p><p> Hypersensitivity reactions occurring more than 24 hours after the infusion have also been reported with the use of SARS-CoV-2 monoclonal antibodies under Emergency Use Authorization.</p><p><blockquote>在紧急使用授权下使用新型冠状病毒单克隆抗体时，也报告了输注后超过24小时发生的超敏反应。</blockquote></p><p> <b>Clinical Worsening After SARS-CoV-2 Monoclonal Antibody Administration</b></p><p><blockquote><b>新型冠状病毒单克隆抗体给药后临床恶化</b></blockquote></p><p> Clinical worsening of COVID‑19 after administration of SARS-CoV-2 monoclonal antibody treatment has been reported and may include signs or symptoms of fever, hypoxia or increased respiratory difficulty, arrhythmia (eg, atrial fibrillation, tachycardia, bradycardia), fatigue, and altered mental status. Some of these events required hospitalization. It is not known if these events were related to SARS-CoV-2 monoclonal antibody use or were due to progression of COVID‑19.</p><p><blockquote>据报道，接受新型冠状病毒单克隆抗体治疗后，COVID-19的临床恶化可能包括发热、缺氧或呼吸困难增加、心律失常（如房颤、心动过速、心动过缓）、疲劳和精神状态改变的体征或症状。其中一些事件需要住院治疗。尚不清楚这些事件是与新型冠状病毒单克隆抗体的使用有关，还是由于COVID-19的进展。</blockquote></p><p> <b>Limitations of Benefit and Potential for Risk in Patients with Severe COVID‑19</b></p><p><blockquote><b>重症COVID-19患者的获益限制和潜在风险</b></blockquote></p><p> Benefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID‑19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID‑19 requiring high flow oxygen or mechanical ventilation. Therefore, sotrovimab is not authorized for use in patients: who are hospitalized due to COVID‑19, OR who require oxygen therapy due to COVID‑19, OR who require an increase in baseline oxygen flow rate due to COVID‑19 in those on chronic oxygen therapy due to underlying non‑COVID‑19 related comorbidity.</p><p><blockquote>在因COVID-19住院的患者中未观察到sotrovimab治疗的益处。当给予需要高流量氧气或机械通气的COVID-19住院患者时，新型冠状病毒单克隆抗体可能与更差的临床结局相关。因此，sotrovimab未被授权用于以下患者：因新冠肺炎住院的患者，或因新冠肺炎需要氧疗的患者，或因新冠肺炎需要增加基线氧流量的患者，以及因潜在的非新冠肺炎相关合并症而接受慢性氧疗的患者。</blockquote></p><p> <b>ADVERSE EVENTS</b></p><p><blockquote><b>不良事件</b></blockquote></p><p> Hypersensitivity adverse reactions have been observed in 2% of patients treated with sotrovimab and 1% with placebo in COMET-ICE.</p><p><blockquote>在COMET-ICE中，在2%接受sotrovimab治疗的患者和1%接受安慰剂治疗的患者中观察到超敏反应。</blockquote></p><p> The most common treatment-emergent adverse events observed in the sotrovimab treatment group in COMET-ICE were rash (1%) and diarrhea (2%), all of which were Grade 1 (mild) or Grade 2 (moderate). No other treatment-emergent adverse events were reported at a higher rate with sotrovimab compared to placebo.</p><p><blockquote>COMET-ICE中sotrovimab治疗组观察到的最常见的治疗后出现的不良事件为皮疹（1%）和腹泻（2%），均为1级（轻度）或2级（中度）。与安慰剂相比，sotrovimab组未报告其他治疗中出现的不良事件发生率更高。</blockquote></p><p> <b>USE IN SPECIFIC POPULATIONS</b></p><p><blockquote><b>用于特定人群</b></blockquote></p><p> <b>Pregnancy</b></p><p><blockquote><b>妊娠</b></blockquote></p><p></p><p> There are insufficient data to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome. Sotrovimab should be used during pregnancy only if the potential benefit justifies the potential risk for the mother and the fetus.</p><p><blockquote>没有足够的数据来评估药物相关的重大出生缺陷、流产或不良母体或胎儿结局的风险。只有当潜在益处证明对母亲和胎儿的潜在风险合理时，才应在妊娠期间使用Sotrovimab。</blockquote></p><p> <b>Lactation</b></p><p><blockquote><b>哺乳期</b></blockquote></p><p> There are no available data on the presence of sotrovimab in human milk, the effects on the breastfed infant, or the effects on milk production. Individuals with COVID-19 who are breastfeeding should follow practices according to clinical guidelines to avoid exposing the infant to COVID-19.</p><p><blockquote>没有关于母乳中sotrovimab的存在、对母乳喂养婴儿的影响或对产奶量的影响的可用数据。正在母乳喂养的新冠肺炎患者应遵循临床指南的做法，以避免婴儿接触新冠肺炎。</blockquote></p><p> <b>About the GSK and Vir collaboration</b></p><p><blockquote><b>关于GSK与Vir的合作</b></blockquote></p><p> In April 2020, GSK and Vir entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration uses Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventive options to help address the current COVID-19 pandemic and future outbreaks. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to identify anti-coronavirus compounds that target cellular host genes. They will also apply their combined expertise to research SARS-CoV-2 and other coronavirus vaccines.</p><p><blockquote>2020年4月，葛兰素史克和Vir达成合作，研究和开发冠状病毒的解决方案，包括导致COVID-19的新型冠状病毒病毒。此次合作使用Vir专有的单克隆抗体平台技术来加速现有的和识别新的抗病毒抗体，这些抗体可用作治疗或预防选择，以帮助应对当前的新冠肺炎疫情和未来的疫情。两家公司将利用GSK在功能基因组学方面的专业知识，并结合其在CRISPR筛选和人工智能方面的能力，以识别靶向细胞宿主基因的抗冠状病毒化合物。他们还将运用他们的综合专业知识来研究新型冠状病毒和其他冠状病毒疫苗。</blockquote></p><p> <b>GSK commitment to tackling COVID-19</b></p><p><blockquote><b>葛兰素史克致力于应对COVID-19</b></blockquote></p><p> GSK’s response to COVID-19 has been one of the broadest in the industry, with potential treatments in addition to our vaccine candidates in development with partner organisations.</p><p><blockquote>葛兰素史克对新冠肺炎的反应是业内最广泛的反应之一，除了我们与合作伙伴组织正在开发的候选疫苗之外，还有潜在的治疗方法。</blockquote></p><p> GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our adjuvant technology. We are working with Sanofi S.A., Medicago Inc. and SK bioscience Co., Ltd. to develop adjuvanted, protein-based vaccine candidates, and all are now in Phase III clinical trials. The use of an adjuvant can be of particular importance in a pandemic since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and contributing to protecting more people in need.</p><p><blockquote>葛兰素史克正在与几个组织合作开发新冠肺炎疫苗，提供我们的佐剂技术。我们正在与Sanofi S.A.、Medicago Inc.和SK bioscience Co., Ltd.合作开发基于佐剂的蛋白质候选疫苗，目前均处于III期临床试验。佐剂的使用在大流行中可能特别重要，因为它可以减少每剂所需的疫苗蛋白的量，允许生产更多的疫苗剂量并有助于保护更多有需要的人。</blockquote></p><p> GSK is also working with mRNA specialist, CureVac N.V., to jointly develop next-generation, optimised mRNA vaccines for COVID-19 with the potential to address multiple emerging variants in one vaccine.</p><p><blockquote>葛兰素史克还与mRNA专家CureVac N.V.合作，共同开发下一代优化的新冠肺炎mRNA疫苗，有可能在一种疫苗中解决多种新出现的变异。</blockquote></p><p> GSK is also exploring treatments for COVID-19 patients, collaborating with Vir Biotechnology to investigate monoclonal antibodies that could be used as therapeutic or preventive options for COVID-19.</p><p><blockquote>葛兰素史克还在探索新冠肺炎患者的治疗方法，与Vir Biotechnology合作研究可用作新冠肺炎治疗或预防选择的单克隆抗体。</blockquote></p><p> <b>Vir’s commitment to COVID-19</b></p><p><blockquote><b>Vir对COVID-19的承诺</b></blockquote></p><p> Vir was founded with the mission of addressing the world’s most serious infectious diseases. In 2020, Vir responded rapidly to the COVID-19 pandemic by leveraging our unique scientific insights and industry-leading antibody platform to explore multiple monoclonal antibodies as potential therapeutic or preventive options for COVID-19. Sotrovimab is the first SARS-CoV-2-targeting antibody Vir advanced into the clinic. It was carefully selected for its demonstrated promise in preclinical research, including an anticipated high barrier to resistance and potential ability to both block the virus from entering healthy cells and clear infected cells. Vir is continuing to pursue novel therapeutic and prophylactic solutions to combat SARS-CoV-2 and future coronavirus pandemics, both independently and in collaboration with its partners.</p><p><blockquote>Vir成立的使命是解决世界上最严重的传染病。2020年，Vir利用我们独特的科学见解和行业领先的抗体平台，探索多种单克隆抗体作为COVID-19的潜在治疗或预防选择，迅速应对COVID-19大流行。Sotrovimab是第一个挺进临床的新型冠状病毒靶向抗体Vir。它被精心选择是因为它在临床前研究中表现出的前景，包括预期的高耐药性屏障和阻止病毒进入健康细胞和清除受感染细胞的潜在能力。Vir正在继续寻求新的治疗和预防解决方案，以应对新型冠状病毒和未来的冠状病毒大流行，无论是独立还是与其合作伙伴合作。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197973971","content_text":"GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced an update to bioRxiv, a preprint server, with preclinical data demonstrating that sotrovimab, an investigational monoclonal antibody, retains activity against key mutations[1] of the new Omicron SARS-CoV-2 variant (B.1.1.529), including those found in the binding site of sotrovimab. These data were generated through pseudo-virus testing of specific individual mutations found in Omicron. To date, sotrovimab has demonstrated ongoing activity against all tested variants of concern and interest defined by the World Health Organization (WHO). The companies are now completing in vitro pseudo-virus testing to confirm the neutralising activity of sotrovimab against the combination of all the Omicron mutations with the intent to provide an update by the end of 2021.\nGeorge Scangos, PhD, Chief Executive Officer of Vir, said:“Sotrovimab was deliberately designed with a mutating virus in mind. By targeting a highly conserved region of the spike protein that is less likely to mutate, we hoped to address both the current SARS-CoV-2 virus and future variants that we expected would be inevitable. This hypothesis has borne out again and again – with its ongoing ability to maintain activity against all tested variants of concern and interest to date, including key mutations found in Omicron, as demonstrated by preclinical data. We have every expectation that this positive trend will continue and are working rapidly to confirm its activity against the full combination sequence of Omicron.”\nDr Hal Barron, Chief Scientific Officer and President R&D, GSK, said:“Since the beginning of the pandemic, we have been working with Vir to combine our scientific expertise and technologies to deliver an enduring treatment option for patients with COVID-19. Though very early, these pre-clinical data support our long-held view on the potential for sotrovimab to maintain its activity as the virus continues to mutate. We are pleased that this treatment option is available to patients in the US and many other countries, and are working to expand access worldwide.”\nAbout sotrovimab\nSotrovimab is an investigational SARS-CoV-2 neutralising monoclonal antibody. The antibody binds to an epitope on SARS-CoV-2 shared with SARS-CoV-1 (the virus that causes SARS), indicating that the epitope is highly conserved, which may make it more difficult for resistance to develop. Sotrovimab, which incorporates Xencor’s Xtend™ technology, has also been designed to achieve high concentration in the lungs to ensure optimal penetration into airway tissues affected by SARS-CoV-2 and to have an extended half-life.\nUpdated in vitro data, published in bioRxiv, demonstrate that sotrovimab retains activity against all current tested variants of concern and interest of the SARS-CoV-2 virus as defined by WHO, plus others, including but not limited to Delta (B.1.617.2), Delta Plus (AY.1 or AY.2), Mu (B.1.621) and key mutations of Omicron (B.1.1.529).\nAbout the sotrovimab clinical development programme\n\nCOMET-ICE: a Phase III, multi-centre, double-blind, placebo-controlled trial investigated an intravenous (IV) infusion of sotrovimab in adults with mild-to-moderate COVID-19 at high risk of progression to severe disease, who are not hospitalised and not requiring oxygen. The final COMET-ICE trial results in the full trial population of 1,057 participants demonstrated a 79% reduction (adjusted relative risk reduction) (p<0.001) in hospitalisation for more than 24 hours or death due to any cause by Day 29 compared to placebo, meeting the primary endpoint of the trial. Interim data were published inThe New England Journal of Medicineon 27 October 2021 and final data were pre-published on 8 November 2021 onmedRxiv.\nCOMET-TAIL: a Phase III, randomised, multi-centre, open-label, non-inferiority trial of intramuscular (IM) versus IV administration of sotrovimab for the early treatment of mild-to-moderate COVID-19 in high-risk non-hospitalised adult and paediatric patients (12 years of age and older). The trial’s primary endpoint was met, and headline data demonstrated that intramuscularly administered sotrovimab was non-inferior and offered similar efficacy to intravenous administration for high-risk populations. The companies plan to submit the complete COMET-TAIL data set to a peer-reviewed journal for publication in the first quarter of 2022.\nCOMET-PEAK: a Phase II, randomised, multi-centre, parallel-group trial evaluating IV and IM administration of sotrovimab in outpatients with mild-to-moderate COVID-19. Data available to date from open-label Part B of the trial (500mg IV vs. 500mg IM) demonstrated equivalence on the virological response between the IM and IV arms. The companies plan to submit the complete COMET-PEAK data set to a peer-reviewed journal for publication in due course.\nGSK and Vir are also partnering to investigate the use of sotrovimab in uninfected immunocompromised adults to determine whether sotrovimab can prevent symptomatic COVID-19 infection. GSK and Vir are supporting investigator-sponsored studies and fostering scientific collaborations with experienced investigators and networks involved in the continuum of care of immunocompromised patients, to understand the role sotrovimab for prophylaxis could play in this population. Discussions with regulatory authorities regarding the prophylaxis programme will take place in due course.\n\nAbout global access to sotrovimab\n\nSotrovimab is authorised for emergency use in the United States. Xevudy (sotrovimab) received apositive scientific opinionunder Article 5(3) of Regulation 726/2004 from the Committee for Human Medicinal Products (CHMP) in the EU, has been granted a provisional marketing authorisation in Australia, and conditional marketing authorisation in Saudi Arabia. In Japan, it has been approved via the Special Approval for Emergency Pathway. Temporary authorisations for sotrovimab have been granted in a dozen countries.\nGSK and Vir also recently submitted the Marketing Authorisation Application (MAA) to the European Medicines Agency for Xevudy (sotrovimab) for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (COVID-19) who do not require oxygen supplementation and who are at risk of progressing to severe\nCOVID-19.\nSotrovimab is supplied in several countries worldwide, including through national agreements in the United States, United Kingdom, Japan, Australia, Canada, Singapore, Switzerland and United Arab Emirates. We have also signed a Joint Procurement Agreement with the European Commission to supply doses of sotrovimab. Additional agreements are yet to be announced due to confidentiality or regulatory requirements.\n\nSotrovimab in the United States\nThe following is a summary of information for sotrovimab. Healthcare providers in the U.S. should review the Fact Sheets for information about the authorised use of sotrovimab and mandatory requirements of the EUA. Please see theFood and Drug Administration (FDA) Letter of Authorization, fullFact Sheet for Healthcare Providers, and fullFact Sheet for Patients, Parents, and Caregivers.\nSotrovimab has been authorized by the U.S. FDA for the emergency use described below. Sotrovimab is not FDA-approved for this use.\nSotrovimab is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of sotrovimab under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.\nAuthorized Use\nThe U.S. FDA has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.\nLimitations of Authorized Use\nSotrovimab is not authorized for use in patients:\n\nwho are hospitalized due to COVID-19, OR\nwho require oxygen therapy due to COVID-19, OR\nwho require an increase in baseline oxygen flow rate due to COVID-19 (in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity)\n\nBenefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID 19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID 19 requiring high flow oxygen or mechanical ventilation.\nImportant Safety Information\nCONTRAINDICATIONS\nSotrovimab is contraindicated in patients who have a history of anaphylaxis to sotrovimab or to any of the excipients in the formulation.\nWARNINGS AND PRECAUTIONS\nThere are limited clinical data available for sotrovimab. Serious and unexpected adverse events may occur that have not been previously reported with sotrovimab use.\nHypersensitivity Including Anaphylaxis and Infusion-Related Reactions\nSerious hypersensitivity reactions, including anaphylaxis, have been observed with administration of sotrovimab. If signs and symptoms of a clinically significant hypersensitivity reaction or anaphylaxis occur, immediately discontinue administration and initiate appropriate medications and/or supportive care.\nInfusion-related reactions, occurring during the infusion and up to 24 hours after the infusion, have been observed with administration of sotrovimab. These reactions may be severe or life threatening.\nSigns and symptoms of infusion-related reactions may include: fever, difficulty breathing, reduced oxygen saturation, chills, fatigue, arrhythmia (eg, atrial fibrillation, sinus tachycardia, bradycardia), chest pain or discomfort, weakness, altered mental status, nausea, headache, bronchospasm, hypotension, hypertension, angioedema, throat irritation, rash including urticaria, pruritus, myalgia, vaso-vagal reactions (eg, pre-syncope, syncope), dizziness and diaphoresis.\nConsider slowing or stopping the infusion and administer appropriate medications and/or supportive care if an infusion-related reaction occurs.\nHypersensitivity reactions occurring more than 24 hours after the infusion have also been reported with the use of SARS-CoV-2 monoclonal antibodies under Emergency Use Authorization.\nClinical Worsening After SARS-CoV-2 Monoclonal Antibody Administration\nClinical worsening of COVID‑19 after administration of SARS-CoV-2 monoclonal antibody treatment has been reported and may include signs or symptoms of fever, hypoxia or increased respiratory difficulty, arrhythmia (eg, atrial fibrillation, tachycardia, bradycardia), fatigue, and altered mental status. Some of these events required hospitalization. It is not known if these events were related to SARS-CoV-2 monoclonal antibody use or were due to progression of COVID‑19.\nLimitations of Benefit and Potential for Risk in Patients with Severe COVID‑19\nBenefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID‑19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID‑19 requiring high flow oxygen or mechanical ventilation. Therefore, sotrovimab is not authorized for use in patients: who are hospitalized due to COVID‑19, OR who require oxygen therapy due to COVID‑19, OR who require an increase in baseline oxygen flow rate due to COVID‑19 in those on chronic oxygen therapy due to underlying non‑COVID‑19 related comorbidity.\nADVERSE EVENTS\nHypersensitivity adverse reactions have been observed in 2% of patients treated with sotrovimab and 1% with placebo in COMET-ICE.\nThe most common treatment-emergent adverse events observed in the sotrovimab treatment group in COMET-ICE were rash (1%) and diarrhea (2%), all of which were Grade 1 (mild) or Grade 2 (moderate). No other treatment-emergent adverse events were reported at a higher rate with sotrovimab compared to placebo.\nUSE IN SPECIFIC POPULATIONS\nPregnancy\nThere are insufficient data to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome. Sotrovimab should be used during pregnancy only if the potential benefit justifies the potential risk for the mother and the fetus.\nLactation\nThere are no available data on the presence of sotrovimab in human milk, the effects on the breastfed infant, or the effects on milk production. Individuals with COVID-19 who are breastfeeding should follow practices according to clinical guidelines to avoid exposing the infant to COVID-19.\nAbout the GSK and Vir collaboration\nIn April 2020, GSK and Vir entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration uses Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventive options to help address the current COVID-19 pandemic and future outbreaks. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to identify anti-coronavirus compounds that target cellular host genes. They will also apply their combined expertise to research SARS-CoV-2 and other coronavirus vaccines.\nGSK commitment to tackling COVID-19\nGSK’s response to COVID-19 has been one of the broadest in the industry, with potential treatments in addition to our vaccine candidates in development with partner organisations.\nGSK is collaborating with several organisations on COVID-19 vaccines by providing access to our adjuvant technology. We are working with Sanofi S.A., Medicago Inc. and SK bioscience Co., Ltd. to develop adjuvanted, protein-based vaccine candidates, and all are now in Phase III clinical trials. The use of an adjuvant can be of particular importance in a pandemic since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and contributing to protecting more people in need.\nGSK is also working with mRNA specialist, CureVac N.V., to jointly develop next-generation, optimised mRNA vaccines for COVID-19 with the potential to address multiple emerging variants in one vaccine.\nGSK is also exploring treatments for COVID-19 patients, collaborating with Vir Biotechnology to investigate monoclonal antibodies that could be used as therapeutic or preventive options for COVID-19.\nVir’s commitment to COVID-19\nVir was founded with the mission of addressing the world’s most serious infectious diseases. In 2020, Vir responded rapidly to the COVID-19 pandemic by leveraging our unique scientific insights and industry-leading antibody platform to explore multiple monoclonal antibodies as potential therapeutic or preventive options for COVID-19. Sotrovimab is the first SARS-CoV-2-targeting antibody Vir advanced into the clinic. It was carefully selected for its demonstrated promise in preclinical research, including an anticipated high barrier to resistance and potential ability to both block the virus from entering healthy cells and clear infected cells. Vir is continuing to pursue novel therapeutic and prophylactic solutions to combat SARS-CoV-2 and future coronavirus pandemics, both independently and in collaboration with its partners.","news_type":1,"symbols_score_info":{"GSK":0.9}},"isVote":1,"tweetType":1,"viewCount":728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600405958,"gmtCreate":1638182154411,"gmtModify":1638182155906,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600405958","repostId":"1173411638","repostType":4,"isVote":1,"tweetType":1,"viewCount":924,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":144089370,"gmtCreate":1626253290890,"gmtModify":1633928611257,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>How? To hold?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>How? To hold?","text":"$AMC Entertainment(AMC)$How? To hold?","images":[{"img":"https://static.tigerbbs.com/68ec9d50d23be635a4ea0891896b4d18","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/144089370","isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808197255,"gmtCreate":1627563478877,"gmtModify":1633763783330,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/808197255","repostId":"1122445859","repostType":4,"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842704456,"gmtCreate":1636241652933,"gmtModify":1636241654329,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/842704456","repostId":"2181374735","repostType":4,"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876509944,"gmtCreate":1637327756316,"gmtModify":1637327776139,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876509944","repostId":"1138047553","repostType":4,"repost":{"id":"1138047553","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637327403,"share":"https://www.laohu8.com/m/news/1138047553?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:10","market":"us","language":"en","title":"Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older<blockquote>Moderna宣布FDA授权美国18岁及以上成年人接种新冠疫苗加强剂量</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138047553","media":"Tiger Newspress","summary":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of C","content":"<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote>在宣布FDA授权美国18岁及以上成年人接种加强剂量的COVID-19疫苗后，Moderna股价在盘前交易中飙升4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p><p><blockquote>Moderna公司今天宣布，美国。美国食品药品监督管理局(FDA)已将50µg剂量水平的Moderna COVID-19疫苗加强剂量的紧急使用授权扩大到所有18岁及以上的成年人。这种加强剂可用于所有18岁及以上已完成任何其他授权或批准的新冠肺炎疫苗初次接种的个人。</blockquote></p><p> “This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p><p><blockquote>Moderna首席执行官Stéphane Bancel表示：“这项紧急使用授权是在我们进入冬季并面临全国范围内不断增加的COVID-19病例数和住院人数的关键时刻发布的。”“我们感谢FDA的审查，并对强有力的临床证据充满信心，即50µg加强剂量的mRNA-1273可诱导针对COVID-19的强烈免疫反应。”</blockquote></p><p> The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p><p><blockquote>加强剂量将在完成任何初级系列新冠肺炎疫苗接种后至少六个月进行。10月20日，FDA授权65岁及以上人群以及18至64岁严重COVID-19高风险成年人紧急使用50µg剂量水平的Moderna COVID-19疫苗加强剂量；以及经常在机构或职业上接触新型冠状病毒的18至64岁人群。在许多国际市场上，Moderna新冠肺炎加强疫苗被授权用于18岁及以上的成年人，无论职业风险因素如何。此前，100µg mRNA 1273第三剂在免疫功能低下个体中获得批准。</blockquote></p><p> The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p><p><blockquote>FDA根据该公司分享的全部科学证据制定了该EUA，包括mRNA-1273 2期临床研究的数据分析，该研究经过修订，以提供50µg剂量水平的mRNA-1273加强剂量。第二次给药后6-8个月感兴趣的参与者(n=344)。中和抗体滴度在加强之前减弱，特别是针对关注的变体，在大约6个月时。值得注意的是，50µg剂量水平的mRNA-1273加强剂量将中和滴度提高到显著高于3期基准。加强剂量后的安全性概况与先前针对mRNA-1273剂量2观察到的相似。</blockquote></p><p> As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p><p><blockquote>下一步，美国。美国疾病控制和预防中心（CDC）免疫实践咨询委员会（ACIP）将开会讨论向美国人推出新冠肺炎加强剂的潜在建议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older<blockquote>Moderna宣布FDA授权美国18岁及以上成年人接种新冠疫苗加强剂量</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older<blockquote>Moderna宣布FDA授权美国18岁及以上成年人接种新冠疫苗加强剂量</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote>在宣布FDA授权美国18岁及以上成年人接种加强剂量的COVID-19疫苗后，Moderna股价在盘前交易中飙升4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p><p><blockquote>Moderna公司今天宣布，美国。美国食品药品监督管理局(FDA)已将50µg剂量水平的Moderna COVID-19疫苗加强剂量的紧急使用授权扩大到所有18岁及以上的成年人。这种加强剂可用于所有18岁及以上已完成任何其他授权或批准的新冠肺炎疫苗初次接种的个人。</blockquote></p><p> “This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p><p><blockquote>Moderna首席执行官Stéphane Bancel表示：“这项紧急使用授权是在我们进入冬季并面临全国范围内不断增加的COVID-19病例数和住院人数的关键时刻发布的。”“我们感谢FDA的审查，并对强有力的临床证据充满信心，即50µg加强剂量的mRNA-1273可诱导针对COVID-19的强烈免疫反应。”</blockquote></p><p> The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p><p><blockquote>加强剂量将在完成任何初级系列新冠肺炎疫苗接种后至少六个月进行。10月20日，FDA授权65岁及以上人群以及18至64岁严重COVID-19高风险成年人紧急使用50µg剂量水平的Moderna COVID-19疫苗加强剂量；以及经常在机构或职业上接触新型冠状病毒的18至64岁人群。在许多国际市场上，Moderna新冠肺炎加强疫苗被授权用于18岁及以上的成年人，无论职业风险因素如何。此前，100µg mRNA 1273第三剂在免疫功能低下个体中获得批准。</blockquote></p><p> The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p><p><blockquote>FDA根据该公司分享的全部科学证据制定了该EUA，包括mRNA-1273 2期临床研究的数据分析，该研究经过修订，以提供50µg剂量水平的mRNA-1273加强剂量。第二次给药后6-8个月感兴趣的参与者(n=344)。中和抗体滴度在加强之前减弱，特别是针对关注的变体，在大约6个月时。值得注意的是，50µg剂量水平的mRNA-1273加强剂量将中和滴度提高到显著高于3期基准。加强剂量后的安全性概况与先前针对mRNA-1273剂量2观察到的相似。</blockquote></p><p> As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p><p><blockquote>下一步，美国。美国疾病控制和预防中心（CDC）免疫实践咨询委员会（ACIP）将开会讨论向美国人推出新冠肺炎加强剂的潜在建议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138047553","content_text":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.\n\nModerna, Inc. today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.\n“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”\nThe booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.\nThe FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.\nAs a next step, theU.S. Centers for Disease Controland Prevention’s (CDC) Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872874197,"gmtCreate":1637492364994,"gmtModify":1637492365418,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"I dun believe it","listText":"I dun believe it","text":"I dun believe it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872874197","repostId":"2184782893","repostType":4,"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":830240782,"gmtCreate":1629077726146,"gmtModify":1633687590664,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/830240782","repostId":"1129589874","repostType":4,"repost":{"id":"1129589874","kind":"news","pubTimestamp":1629067868,"share":"https://www.laohu8.com/m/news/1129589874?lang=zh_CN&edition=full","pubTime":"2021-08-16 06:51","market":"us","language":"en","title":"Nvidia, Tencent,Walmart, Target and Other Stocks to Watch This Week<blockquote>英伟达、腾讯控股、沃尔玛、塔吉特等本周值得关注的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129589874","media":"Barrons","summary":"It’s the late innings of second-quarter earnings season, with retailers ready to step up to the plate. Walmart and Home Depot report on Tuesday, followed by Lowe’s, Target, and TJX on Wednesday. Kohl’s, Macy’s, BJ’s Wholesale, and L Brands are Thursday’s retail highlights, then Foot Locker closes the week on Friday.The Census Bureau’s July retail sales data for July is also out this week, on Tuesday. Economists on average are forecasting a 0.2% seasonally adjusted increase last month, after a 0.","content":"<p>It’s the late innings of second-quarter earnings season, with retailers ready to step up to the plate. Walmart and Home Depot report on Tuesday, followed by Lowe’s, Target, and TJX on Wednesday.&nbsp;Kohl’s, Macy’s, BJ’s Wholesale, and L Brands are Thursday’s retail highlights, then Foot Locker closes the week on Friday.</p><p><blockquote>现在是第二季度财报季的最后几局，零售商已准备好采取行动。沃尔玛和家得宝周二发布报告，劳氏、塔吉特和TJX周三紧随其后。美国柯尔百货公司、梅西百货、BJ批发和L品牌是周四的零售亮点，然后Foot Locker将于周五结束本周。</blockquote></p><p> The Census Bureau’s July retail sales data for July is also out this week, on Tuesday. Economists on average are forecasting a&nbsp;0.2% seasonally adjusted increase last month, after a 0.6% rise in June.</p><p><blockquote>人口普查局7月份零售销售数据也将于本周周二公布。经济学家平均预测，上个月经季节性调整后的增长率为0。</blockquote></p><p> Major non-retail companies releasing results this week include Pandora and&nbsp;Krispy Kreme&nbsp;on Tuesday, followed by a busy Wednesday:Nvidia,Tencent Holdings,CiscoSystems,Analog Devices,and&nbsp;Lumentum Holdings&nbsp;all report.Applied Materials&nbsp;goes on Thursday and Deere closes the week on Friday.</p><p><blockquote>本周发布业绩的主要非零售公司包括周二发布业绩的Pandora和Krispy Kreme，随后是繁忙的周三：Nvidia、腾讯控股控股公司、思科系统公司、Analog Devices和Lumentum Holdings均发布业绩。应用材料公司周四公布业绩，Deere公司本周收盘周五。</blockquote></p><p> Economic data out this week include several housing-market metrics:&nbsp;The National Association of Home Builders’ NAHB/Wells Fargo Housing Market Index for August on Tuesday and the Census Bureau’s new residential construction report for July on Wednesday.</p><p><blockquote>本周公布的经济数据包括几项房地产市场指标：周二公布的全国住宅建筑商协会8月份NAHB/富国银行住房市场指数，以及周三公布的人口普查局7月份新住宅建设报告。</blockquote></p><p> Also on Wednesday, the&nbsp;Federal Reserve’s monetary policy committee releases the minutes from its last meeting in late July. Then, the&nbsp;Conference Board publishes its Leading Economic Index for July on Thursday.</p><p><blockquote>同样在周三，美联储货币政策委员会公布了7月底上次会议的纪要。然后，世界大型企业联合会将于周四公布7月份领先经济指数。</blockquote></p><p> <b>Monday 8/16</b></p><p><blockquote><b>星期一8/16</b></blockquote></p><p> Tencent Music Entertainment Group,Tokyo Electron,and&nbsp;Clear Secure&nbsp;are among the companies holding earnings conference calls.</p><p><blockquote>腾讯控股音乐娱乐集团、Tokyo Electron和Clear Secure等公司在评级举行财报会议。</blockquote></p><p> <b>The Federal Reserve</b>&nbsp;Bank of New York releases its Empire State Manufacturing Survey for August. The consensus estimate is for a 26.5 reading. That compares with a record high of 43.0 in July, when the general business conditions index rose 26 points.</p><p><blockquote><b>美联储</b>纽约银行发布八月份帝国州制造业调查。普遍估计读数为26.5。相比之下，7月份的历史新高为43.0，当时总体商业状况指数上涨了26点。</blockquote></p><p> <b>Tuesday 8/17</b></p><p><blockquote><b>星期二8/17</b></blockquote></p><p> BHP, Walmart, Home Depot,Agilent Technologies,Pandora, and Krispy Kreme are among the companies hosting earnings conference calls.</p><p><blockquote>必和必拓、沃尔玛、家得宝、安捷伦科技、Pandora和Krispy Kreme等公司在评级举办财报会议。</blockquote></p><p> America’s Car-Mart,Jack Henry &amp; Associates,and&nbsp;La-Z-Boy&nbsp;report financial results after the market closes and will hold earnings calls the following morning, Aug. 18.</p><p><blockquote>America's Car-Mart、Jack Henry&amp;Associates和La-Z-Boy在收盘后报告财务业绩，并将于第二天（8月18日）上午举行收益评级。</blockquote></p><p> <b>The Federal Reserve</b>&nbsp;releases capacity utilization in the industrial sector for July. Consensus calls for a 75.7% reading, little changed from June’s 75.4% reading. Industrial production is seen rising 0.5% from June’s 0.4% seasonally adjusted increase.</p><p><blockquote><b>美联储</b>发布7月工业部门产能利用率。评级共识为75.7%，与6月份的75.4%几乎没有变化。工业生产预计将比6月份经季节调整后的0.4%增长0.5%。</blockquote></p><p> <b>The National Association</b>&nbsp;of Home Builders releases its NAHB/Wells Fargo Housing Market Index for August. Economists forecast an 80 reading, the same as in July. The index is down from its all-time high of 90 set in November.</p><p><blockquote><b>全国协会</b>房屋建筑商协会发布了8月份NAHB/富国银行住房市场指数。经济学家预测读数为80，与7月份相同。该指数较11月份创下的历史高点90有所回落。</blockquote></p><p> <b>Federal Reserve Board</b>&nbsp;Chairman Jay Powell will host a virtual town hall with educators and students.</p><p><blockquote><b>联邦储备委员会</b>主席杰伊·鲍威尔将与教育工作者和学生一起主持一个虚拟市政厅。</blockquote></p><p> <b>The Census Bureau reports</b>&nbsp;retail sales data for July. Expectations are for a 0.3% seasonally adjusted month-over-month decrease, following a 0.6% rise in June. Excluding autos, spending is seen rising 0.2%, compared with a 1.3% rise in the previous month.</p><p><blockquote><b>人口普查局报告</b>7月零售销售数据。继6月份上涨0.6%后，预计经季节调整后环比下降0.3%。不包括汽车在内，支出预计将增长0.2%，而上个月为增长1.3%。</blockquote></p><p> <b>Wednesday 8/18</b></p><p><blockquote><b>星期三8/18</b></blockquote></p><p> <b>The Federal Open Market</b>&nbsp;Committee releases the minutes from its late-July monetary-policy meeting.</p><p><blockquote><b>联邦公开市场</b>委员会公布了7月底货币政策会议的纪要。</blockquote></p><p> Cisco Systems, Lowe’s, Target, TJX, Tencent Holdings,Brinker International,Analog Devices,Synopsys,Lumentum Holdings, and Nvidia host earnings conference calls.</p><p><blockquote>思科系统、劳氏、塔吉特、TJX、腾讯控股控股、Brinker International、Analog Devices、Synopsys、Lumentum Holdings和Nvidia在评级举办财报会议。</blockquote></p><p> <b>The Census Bureau’s</b>new residential construction report for July is expected to show the seasonally adjusted annual rate of housing starts at 1.610 million, down from June’s 1.643 million. Housing starts hit a postpandemic peak of 1.73 million in March.</p><p><blockquote><b>人口普查局的</b>7月份新住宅建设报告预计显示，经季节调整后的新屋开工年率为161.0万套，低于6月份的164.3万套。3月份新屋开工量达到173万套的疫情后峰值。</blockquote></p><p> <b>Thursday 8/19</b></p><p><blockquote><b>星期四8/19</b></blockquote></p><p> BJ’s Wholesale,<b>L Brands</b>, Applied Materials,Ross Stores,Estée Lauder,Kohl’s, Macy’s,Performance Food Group,Petco Health and Wellness,and Farfetch host earnings conference calls.</p><p><blockquote>BJ的批发，<b>L品牌</b>、Applied Materials、Ross Stores、雅诗兰黛、Kohl's、Macy's、Performance Food Group、Petco Health and Wellness和Farfetch将在评级举办财报会议。</blockquote></p><p> <b>The Conference Board</b>releases its Leading Economic Index for July. The LEI is expected to increase 0.7% month over month, after gaining 0.7% in June.</p><p><blockquote><b>世界大型企业联合会</b>发布7月份领先经济指数。继6月份上涨0.7%后，LEI预计将环比上涨0.7%。</blockquote></p><p> <b>Friday 8/20</b></p><p><blockquote><b>星期五8/20</b></blockquote></p><p> Deere and Foot Locker host conference calls to discuss financial results.</p><p><blockquote>Deere和Foot Locker在评级主办会议讨论财务业绩。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia, Tencent,Walmart, Target and Other Stocks to Watch This Week<blockquote>英伟达、腾讯控股、沃尔玛、塔吉特等本周值得关注的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia, Tencent,Walmart, Target and Other Stocks to Watch This Week<blockquote>英伟达、腾讯控股、沃尔玛、塔吉特等本周值得关注的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-08-16 06:51</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It’s the late innings of second-quarter earnings season, with retailers ready to step up to the plate. Walmart and Home Depot report on Tuesday, followed by Lowe’s, Target, and TJX on Wednesday.&nbsp;Kohl’s, Macy’s, BJ’s Wholesale, and L Brands are Thursday’s retail highlights, then Foot Locker closes the week on Friday.</p><p><blockquote>现在是第二季度财报季的最后几局，零售商已准备好采取行动。沃尔玛和家得宝周二发布报告，劳氏、塔吉特和TJX周三紧随其后。美国柯尔百货公司、梅西百货、BJ批发和L品牌是周四的零售亮点，然后Foot Locker将于周五结束本周。</blockquote></p><p> The Census Bureau’s July retail sales data for July is also out this week, on Tuesday. Economists on average are forecasting a&nbsp;0.2% seasonally adjusted increase last month, after a 0.6% rise in June.</p><p><blockquote>人口普查局7月份零售销售数据也将于本周周二公布。经济学家平均预测，上个月经季节性调整后的增长率为0。</blockquote></p><p> Major non-retail companies releasing results this week include Pandora and&nbsp;Krispy Kreme&nbsp;on Tuesday, followed by a busy Wednesday:Nvidia,Tencent Holdings,CiscoSystems,Analog Devices,and&nbsp;Lumentum Holdings&nbsp;all report.Applied Materials&nbsp;goes on Thursday and Deere closes the week on Friday.</p><p><blockquote>本周发布业绩的主要非零售公司包括周二发布业绩的Pandora和Krispy Kreme，随后是繁忙的周三：Nvidia、腾讯控股控股公司、思科系统公司、Analog Devices和Lumentum Holdings均发布业绩。应用材料公司周四公布业绩，Deere公司本周收盘周五。</blockquote></p><p> Economic data out this week include several housing-market metrics:&nbsp;The National Association of Home Builders’ NAHB/Wells Fargo Housing Market Index for August on Tuesday and the Census Bureau’s new residential construction report for July on Wednesday.</p><p><blockquote>本周公布的经济数据包括几项房地产市场指标：周二公布的全国住宅建筑商协会8月份NAHB/富国银行住房市场指数，以及周三公布的人口普查局7月份新住宅建设报告。</blockquote></p><p> Also on Wednesday, the&nbsp;Federal Reserve’s monetary policy committee releases the minutes from its last meeting in late July. Then, the&nbsp;Conference Board publishes its Leading Economic Index for July on Thursday.</p><p><blockquote>同样在周三，美联储货币政策委员会公布了7月底上次会议的纪要。然后，世界大型企业联合会将于周四公布7月份领先经济指数。</blockquote></p><p> <b>Monday 8/16</b></p><p><blockquote><b>星期一8/16</b></blockquote></p><p> Tencent Music Entertainment Group,Tokyo Electron,and&nbsp;Clear Secure&nbsp;are among the companies holding earnings conference calls.</p><p><blockquote>腾讯控股音乐娱乐集团、Tokyo Electron和Clear Secure等公司在评级举行财报会议。</blockquote></p><p> <b>The Federal Reserve</b>&nbsp;Bank of New York releases its Empire State Manufacturing Survey for August. The consensus estimate is for a 26.5 reading. That compares with a record high of 43.0 in July, when the general business conditions index rose 26 points.</p><p><blockquote><b>美联储</b>纽约银行发布八月份帝国州制造业调查。普遍估计读数为26.5。相比之下，7月份的历史新高为43.0，当时总体商业状况指数上涨了26点。</blockquote></p><p> <b>Tuesday 8/17</b></p><p><blockquote><b>星期二8/17</b></blockquote></p><p> BHP, Walmart, Home Depot,Agilent Technologies,Pandora, and Krispy Kreme are among the companies hosting earnings conference calls.</p><p><blockquote>必和必拓、沃尔玛、家得宝、安捷伦科技、Pandora和Krispy Kreme等公司在评级举办财报会议。</blockquote></p><p> America’s Car-Mart,Jack Henry &amp; Associates,and&nbsp;La-Z-Boy&nbsp;report financial results after the market closes and will hold earnings calls the following morning, Aug. 18.</p><p><blockquote>America's Car-Mart、Jack Henry&amp;Associates和La-Z-Boy在收盘后报告财务业绩，并将于第二天（8月18日）上午举行收益评级。</blockquote></p><p> <b>The Federal Reserve</b>&nbsp;releases capacity utilization in the industrial sector for July. Consensus calls for a 75.7% reading, little changed from June’s 75.4% reading. Industrial production is seen rising 0.5% from June’s 0.4% seasonally adjusted increase.</p><p><blockquote><b>美联储</b>发布7月工业部门产能利用率。评级共识为75.7%，与6月份的75.4%几乎没有变化。工业生产预计将比6月份经季节调整后的0.4%增长0.5%。</blockquote></p><p> <b>The National Association</b>&nbsp;of Home Builders releases its NAHB/Wells Fargo Housing Market Index for August. Economists forecast an 80 reading, the same as in July. The index is down from its all-time high of 90 set in November.</p><p><blockquote><b>全国协会</b>房屋建筑商协会发布了8月份NAHB/富国银行住房市场指数。经济学家预测读数为80，与7月份相同。该指数较11月份创下的历史高点90有所回落。</blockquote></p><p> <b>Federal Reserve Board</b>&nbsp;Chairman Jay Powell will host a virtual town hall with educators and students.</p><p><blockquote><b>联邦储备委员会</b>主席杰伊·鲍威尔将与教育工作者和学生一起主持一个虚拟市政厅。</blockquote></p><p> <b>The Census Bureau reports</b>&nbsp;retail sales data for July. Expectations are for a 0.3% seasonally adjusted month-over-month decrease, following a 0.6% rise in June. Excluding autos, spending is seen rising 0.2%, compared with a 1.3% rise in the previous month.</p><p><blockquote><b>人口普查局报告</b>7月零售销售数据。继6月份上涨0.6%后，预计经季节调整后环比下降0.3%。不包括汽车在内，支出预计将增长0.2%，而上个月为增长1.3%。</blockquote></p><p> <b>Wednesday 8/18</b></p><p><blockquote><b>星期三8/18</b></blockquote></p><p> <b>The Federal Open Market</b>&nbsp;Committee releases the minutes from its late-July monetary-policy meeting.</p><p><blockquote><b>联邦公开市场</b>委员会公布了7月底货币政策会议的纪要。</blockquote></p><p> Cisco Systems, Lowe’s, Target, TJX, Tencent Holdings,Brinker International,Analog Devices,Synopsys,Lumentum Holdings, and Nvidia host earnings conference calls.</p><p><blockquote>思科系统、劳氏、塔吉特、TJX、腾讯控股控股、Brinker International、Analog Devices、Synopsys、Lumentum Holdings和Nvidia在评级举办财报会议。</blockquote></p><p> <b>The Census Bureau’s</b>new residential construction report for July is expected to show the seasonally adjusted annual rate of housing starts at 1.610 million, down from June’s 1.643 million. Housing starts hit a postpandemic peak of 1.73 million in March.</p><p><blockquote><b>人口普查局的</b>7月份新住宅建设报告预计显示，经季节调整后的新屋开工年率为161.0万套，低于6月份的164.3万套。3月份新屋开工量达到173万套的疫情后峰值。</blockquote></p><p> <b>Thursday 8/19</b></p><p><blockquote><b>星期四8/19</b></blockquote></p><p> BJ’s Wholesale,<b>L Brands</b>, Applied Materials,Ross Stores,Estée Lauder,Kohl’s, Macy’s,Performance Food Group,Petco Health and Wellness,and Farfetch host earnings conference calls.</p><p><blockquote>BJ的批发，<b>L品牌</b>、Applied Materials、Ross Stores、雅诗兰黛、Kohl's、Macy's、Performance Food Group、Petco Health and Wellness和Farfetch将在评级举办财报会议。</blockquote></p><p> <b>The Conference Board</b>releases its Leading Economic Index for July. The LEI is expected to increase 0.7% month over month, after gaining 0.7% in June.</p><p><blockquote><b>世界大型企业联合会</b>发布7月份领先经济指数。继6月份上涨0.7%后，LEI预计将环比上涨0.7%。</blockquote></p><p> <b>Friday 8/20</b></p><p><blockquote><b>星期五8/20</b></blockquote></p><p> Deere and Foot Locker host conference calls to discuss financial results.</p><p><blockquote>Deere和Foot Locker在评级主办会议讨论财务业绩。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/stocks-to-watch-this-week-51629054047?mod=hp_LEAD_2\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛",".DJI":"道琼斯","TGT":"塔吉特","NVDA":"英伟达",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","TME":"腾讯音乐"},"source_url":"https://www.barrons.com/articles/stocks-to-watch-this-week-51629054047?mod=hp_LEAD_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129589874","content_text":"It’s the late innings of second-quarter earnings season, with retailers ready to step up to the plate. Walmart and Home Depot report on Tuesday, followed by Lowe’s, Target, and TJX on Wednesday. Kohl’s, Macy’s, BJ’s Wholesale, and L Brands are Thursday’s retail highlights, then Foot Locker closes the week on Friday.\nThe Census Bureau’s July retail sales data for July is also out this week, on Tuesday. Economists on average are forecasting a 0.2% seasonally adjusted increase last month, after a 0.6% rise in June.\nMajor non-retail companies releasing results this week include Pandora and Krispy Kreme on Tuesday, followed by a busy Wednesday:Nvidia,Tencent Holdings,CiscoSystems,Analog Devices,and Lumentum Holdings all report.Applied Materials goes on Thursday and Deere closes the week on Friday.\nEconomic data out this week include several housing-market metrics: The National Association of Home Builders’ NAHB/Wells Fargo Housing Market Index for August on Tuesday and the Census Bureau’s new residential construction report for July on Wednesday.\nAlso on Wednesday, the Federal Reserve’s monetary policy committee releases the minutes from its last meeting in late July. Then, the Conference Board publishes its Leading Economic Index for July on Thursday.\nMonday 8/16\nTencent Music Entertainment Group,Tokyo Electron,and Clear Secure are among the companies holding earnings conference calls.\nThe Federal Reserve Bank of New York releases its Empire State Manufacturing Survey for August. The consensus estimate is for a 26.5 reading. That compares with a record high of 43.0 in July, when the general business conditions index rose 26 points.\nTuesday 8/17\nBHP, Walmart, Home Depot,Agilent Technologies,Pandora, and Krispy Kreme are among the companies hosting earnings conference calls.\nAmerica’s Car-Mart,Jack Henry & Associates,and La-Z-Boy report financial results after the market closes and will hold earnings calls the following morning, Aug. 18.\nThe Federal Reserve releases capacity utilization in the industrial sector for July. Consensus calls for a 75.7% reading, little changed from June’s 75.4% reading. Industrial production is seen rising 0.5% from June’s 0.4% seasonally adjusted increase.\nThe National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for August. Economists forecast an 80 reading, the same as in July. The index is down from its all-time high of 90 set in November.\nFederal Reserve Board Chairman Jay Powell will host a virtual town hall with educators and students.\nThe Census Bureau reports retail sales data for July. Expectations are for a 0.3% seasonally adjusted month-over-month decrease, following a 0.6% rise in June. Excluding autos, spending is seen rising 0.2%, compared with a 1.3% rise in the previous month.\nWednesday 8/18\nThe Federal Open Market Committee releases the minutes from its late-July monetary-policy meeting.\nCisco Systems, Lowe’s, Target, TJX, Tencent Holdings,Brinker International,Analog Devices,Synopsys,Lumentum Holdings, and Nvidia host earnings conference calls.\nThe Census Bureau’snew residential construction report for July is expected to show the seasonally adjusted annual rate of housing starts at 1.610 million, down from June’s 1.643 million. Housing starts hit a postpandemic peak of 1.73 million in March.\nThursday 8/19\nBJ’s Wholesale,L Brands, Applied Materials,Ross Stores,Estée Lauder,Kohl’s, Macy’s,Performance Food Group,Petco Health and Wellness,and Farfetch host earnings conference calls.\nThe Conference Boardreleases its Leading Economic Index for July. The LEI is expected to increase 0.7% month over month, after gaining 0.7% in June.\nFriday 8/20\nDeere and Foot Locker host conference calls to discuss financial results.","news_type":1,"symbols_score_info":{"TGT":0.9,".IXIC":0.9,"WMT":0.9,"NVDA":0.9,".SPX":0.9,"TME":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800175234,"gmtCreate":1627288624128,"gmtModify":1633766492980,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/800175234","repostId":"2154934710","repostType":4,"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116584895,"gmtCreate":1622812318017,"gmtModify":1634097787014,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Should buy?","listText":"Should buy?","text":"Should buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/116584895","repostId":"1169305457","repostType":4,"repost":{"id":"1169305457","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622793856,"share":"https://www.laohu8.com/m/news/1169305457?lang=zh_CN&edition=full","pubTime":"2021-06-04 16:04","market":"us","language":"en","title":"AMC shares tanked another 5% in premarket trading<blockquote>AMC股价在盘前交易中又下跌5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169305457","media":"Tiger Newspress","summary":"AMC shares tanked another 5% in premarket trading.AMC Entertainment shares plunged 18% on Thursday f","content":"<p>AMC shares tanked another&nbsp;5% in premarket trading.</p><p><blockquote>AMC股价在盘前交易中又下跌5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/651c70ab98e89bf8e6705480ef126728\" tg-width=\"909\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>AMC Entertainment&nbsp;shares plunged&nbsp;18% on Thursday&nbsp;following a stock sale announcement.</p><p><blockquote>在宣布出售股票后，AMC院线股价周四暴跌18%。</blockquote></p><p>AMC Entertainment Holdings Inc.&nbsp;is asking investors to authorize an additional 25 million new shares,aiming tocapitalize on a rally that has sent the stock of the ailing movie-theater chain up about 2,300% this year.</p><p><blockquote>AMC院线控股公司(Taylor Swift Holdings Inc.)要求投资者授权额外发行2500万股新股，旨在利用今年以来这家陷入困境的连锁电影院股价上涨约2,300%的涨势。</blockquote></p><p>The proposal announced Thursday in a filing will be put to a vote at the company’s July 29 annual meeting. The equity today would be valued at $1.3 billion, though the company promised not to issue the new shares in 2021.</p><p><blockquote>周四在一份文件中宣布的提案将在该公司7月29日的年会上进行投票。尽管该公司承诺在2021年不会发行新股，但目前的股权价值为13亿美元。</blockquote></p><p>“To successfully navigate the road ahead, we seek to assemble all of the financial tools that might help us,” Chief Executive Officer Adam Aron said in a statement. “An important tool for any company is having shares available to issue.”</p><p><blockquote>首席执行官亚当·阿伦(Adam Aron)在一份声明中表示：“为了成功驾驭未来的道路，我们寻求汇集所有可能对我们有帮助的金融工具。”“对于任何公司来说，一个重要的工具就是拥有可供发行的股票。”</blockquote></p><p>The request is perhaps unsurprising for a company that’s become the king of meme stocks, at the heart of a frenzy of online traders determine to pump up its valuation.</p><p><blockquote>对于一家已成为模因股票之王的公司来说，这一要求或许并不令人意外，该公司正处于在线交易者疯狂抬高其估值的核心。</blockquote></p><p>Still, it’s a major retreat from a request earlier this year to authorize 500 million new shares. That proposal was originally up for a vote in May, but the annual meeting was postponed and the request withdrawn after it became clear investors would shoot it down.</p><p><blockquote>尽管如此，与今年早些时候授权5亿股新股的请求相比，这是一个重大倒退。该提案原定于5月份进行投票，但年会被推迟，在投资者显然会否决该提案后，该请求被撤回。</blockquote></p><p>Aron said in April the struggling company could issue about 43 million new shares. With sales of new stock totaling more than $800 million just this week, AMC has now completed nearly all of that authorization, according to the filing.</p><p><blockquote>阿伦4月份表示，这家陷入困境的公司可能会发行约4300万股新股。文件显示，仅本周新股销售总额就超过8亿美元，AMC现已完成几乎所有授权。</blockquote></p><p>In a YouTube interview Thursday, Aron said proceeds from another equity sale, if approved, would be used to reduce debt, help the company negotiate with landlords who are owed $400 million, and to chase acquisitions “hard.”</p><p><blockquote>阿伦周四在接受YouTube采访时表示，如果获得批准，另一次股权出售的收益将用于减少债务、帮助公司与欠债4亿美元的房东进行谈判，并“努力”追逐收购。</blockquote></p><p>”It’s our view that we’re strengthening the company,” he said. “We’re not hurting the company.”</p><p><blockquote>“我们认为我们正在加强公司，”他说。“我们不会伤害公司。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC shares tanked another 5% in premarket trading<blockquote>AMC股价在盘前交易中又下跌5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC shares tanked another 5% in premarket trading<blockquote>AMC股价在盘前交易中又下跌5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-04 16:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>AMC shares tanked another&nbsp;5% in premarket trading.</p><p><blockquote>AMC股价在盘前交易中又下跌5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/651c70ab98e89bf8e6705480ef126728\" tg-width=\"909\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>AMC Entertainment&nbsp;shares plunged&nbsp;18% on Thursday&nbsp;following a stock sale announcement.</p><p><blockquote>在宣布出售股票后，AMC院线股价周四暴跌18%。</blockquote></p><p>AMC Entertainment Holdings Inc.&nbsp;is asking investors to authorize an additional 25 million new shares,aiming tocapitalize on a rally that has sent the stock of the ailing movie-theater chain up about 2,300% this year.</p><p><blockquote>AMC院线控股公司(Taylor Swift Holdings Inc.)要求投资者授权额外发行2500万股新股，旨在利用今年以来这家陷入困境的连锁电影院股价上涨约2,300%的涨势。</blockquote></p><p>The proposal announced Thursday in a filing will be put to a vote at the company’s July 29 annual meeting. The equity today would be valued at $1.3 billion, though the company promised not to issue the new shares in 2021.</p><p><blockquote>周四在一份文件中宣布的提案将在该公司7月29日的年会上进行投票。尽管该公司承诺在2021年不会发行新股，但目前的股权价值为13亿美元。</blockquote></p><p>“To successfully navigate the road ahead, we seek to assemble all of the financial tools that might help us,” Chief Executive Officer Adam Aron said in a statement. “An important tool for any company is having shares available to issue.”</p><p><blockquote>首席执行官亚当·阿伦(Adam Aron)在一份声明中表示：“为了成功驾驭未来的道路，我们寻求汇集所有可能对我们有帮助的金融工具。”“对于任何公司来说，一个重要的工具就是拥有可供发行的股票。”</blockquote></p><p>The request is perhaps unsurprising for a company that’s become the king of meme stocks, at the heart of a frenzy of online traders determine to pump up its valuation.</p><p><blockquote>对于一家已成为模因股票之王的公司来说，这一要求或许并不令人意外，该公司正处于在线交易者疯狂抬高其估值的核心。</blockquote></p><p>Still, it’s a major retreat from a request earlier this year to authorize 500 million new shares. That proposal was originally up for a vote in May, but the annual meeting was postponed and the request withdrawn after it became clear investors would shoot it down.</p><p><blockquote>尽管如此，与今年早些时候授权5亿股新股的请求相比，这是一个重大倒退。该提案原定于5月份进行投票，但年会被推迟，在投资者显然会否决该提案后，该请求被撤回。</blockquote></p><p>Aron said in April the struggling company could issue about 43 million new shares. With sales of new stock totaling more than $800 million just this week, AMC has now completed nearly all of that authorization, according to the filing.</p><p><blockquote>阿伦4月份表示，这家陷入困境的公司可能会发行约4300万股新股。文件显示，仅本周新股销售总额就超过8亿美元，AMC现已完成几乎所有授权。</blockquote></p><p>In a YouTube interview Thursday, Aron said proceeds from another equity sale, if approved, would be used to reduce debt, help the company negotiate with landlords who are owed $400 million, and to chase acquisitions “hard.”</p><p><blockquote>阿伦周四在接受YouTube采访时表示，如果获得批准，另一次股权出售的收益将用于减少债务、帮助公司与欠债4亿美元的房东进行谈判，并“努力”追逐收购。</blockquote></p><p>”It’s our view that we’re strengthening the company,” he said. “We’re not hurting the company.”</p><p><blockquote>“我们认为我们正在加强公司，”他说。“我们不会伤害公司。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169305457","content_text":"AMC shares tanked another 5% in premarket trading.AMC Entertainment shares plunged 18% on Thursday following a stock sale announcement.AMC Entertainment Holdings Inc. is asking investors to authorize an additional 25 million new shares,aiming tocapitalize on a rally that has sent the stock of the ailing movie-theater chain up about 2,300% this year.The proposal announced Thursday in a filing will be put to a vote at the company’s July 29 annual meeting. The equity today would be valued at $1.3 billion, though the company promised not to issue the new shares in 2021.“To successfully navigate the road ahead, we seek to assemble all of the financial tools that might help us,” Chief Executive Officer Adam Aron said in a statement. “An important tool for any company is having shares available to issue.”The request is perhaps unsurprising for a company that’s become the king of meme stocks, at the heart of a frenzy of online traders determine to pump up its valuation.Still, it’s a major retreat from a request earlier this year to authorize 500 million new shares. That proposal was originally up for a vote in May, but the annual meeting was postponed and the request withdrawn after it became clear investors would shoot it down.Aron said in April the struggling company could issue about 43 million new shares. With sales of new stock totaling more than $800 million just this week, AMC has now completed nearly all of that authorization, according to the filing.In a YouTube interview Thursday, Aron said proceeds from another equity sale, if approved, would be used to reduce debt, help the company negotiate with landlords who are owed $400 million, and to chase acquisitions “hard.””It’s our view that we’re strengthening the company,” he said. “We’re not hurting the company.”","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":848,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":864125293,"gmtCreate":1633076360568,"gmtModify":1633076361565,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864125293","repostId":"2172951249","repostType":4,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690605469,"gmtCreate":1639660809729,"gmtModify":1639660810880,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690605469","repostId":"1191683541","repostType":4,"repost":{"id":"1191683541","kind":"news","pubTimestamp":1639658241,"share":"https://www.laohu8.com/m/news/1191683541?lang=zh_CN&edition=full","pubTime":"2021-12-16 20:37","market":"us","language":"en","title":"10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191683541","media":"Benzinga","summary":"Stifel cut the price target on Under Armour, Inc.. from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading.RBC Capital lowered the price target on Airbnb, Inc. from $195 to $175. Airbnb shares rose 0.3% to $168.62 in pre-market trading.Morgan Stanley lowered DocuSign, Inc. price target from $350 to $165. DocuSign shares dropped 2.4% to $147.51 in pre-market trading.Barclays cut the price target on Aptiv PLC from $212 to $200. Aptiv shares rose 2.7% to $168.91 in pre-market","content":"<p><div> Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading. RBC Capital lowered the price target on Airbnb, Inc.(NASDAQ...</p><p><blockquote><div>Stifel将Under Armour，Inc.（纽约证券交易所代码：UAA）的目标价从30美元下调至24美元。Under Armour股价在盘前交易中下跌0.7%，至22.22美元。加拿大皇家银行资本下调了Airbnb，Inc.（纳斯达克...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Thursday<blockquote>周四10个最大价格目标变化</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-12-16 20:37</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading. RBC Capital lowered the price target on Airbnb, Inc.(NASDAQ...</p><p><blockquote><div>Stifel将Under Armour，Inc.（纽约证券交易所代码：UAA）的目标价从30美元下调至24美元。Under Armour股价在盘前交易中下跌0.7%，至22.22美元。加拿大皇家银行资本下调了Airbnb，Inc.（纳斯达克...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"At&T","DOCU":"Docusign","ABNB":"爱彼迎"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/21/12/24641061/10-biggest-price-target-changes-for-thursday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191683541","content_text":"Stifel cut the price target on Under Armour, Inc..(NYSE:UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading.\nRBC Capital lowered the price target on Airbnb, Inc.(NASDAQ:ABNB) from $195 to $175. Airbnb shares rose 0.3% to $168.62 in pre-market trading.\nMorgan Stanley cut AT&T Inc.(NYSE:T) price target from $32 to $28. AT&T shares rose 1.7% to $22.55 in pre-market trading.\nMorgan Stanley lowered DocuSign, Inc.(NASDAQ:DOCU) price target from $350 to $165. DocuSign shares dropped 2.4% to $147.51 in pre-market trading.\nBarclays cut the price target on Aptiv PLC(NYSE:APTV) from $212 to $200. Aptiv shares rose 2.7% to $168.91 in pre-market trading.\nRaymond James raised The Progressive Corporation(NYSE:PGR) price target from $105 to $110. Progressive shares rose 4.8% to close at $101.81 on Wednesday.\nWells Fargo boosted the price target for Magna International Inc.(NYSE:MGA) from $84 to $93. Magna International shares rose 1.7% to $79.04 in pre-market trading.\nB of A Securities reduced the price target for Wayfair Inc.(NYSE:W) from $265 to $175. Wayfair shares dropped 2.4% to $202.28 in pre-market trading.\nHC Wainwright & Co. cut IGM Biosciences, Inc.(NASDAQ:IGMS) price target from $114 to $76. IGM Biosciences shares fell 0.1% to close at $28.35 on Wednesday.\nNeedham cut Medtronic plc(NYSE:MDT) price target from $145 to $131. Medtronic shares rose 0.1% to $105.01 in pre-market trading.","news_type":1,"symbols_score_info":{"T":0.9,"DOCU":0.9,"ABNB":0.9}},"isVote":1,"tweetType":1,"viewCount":2727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604284528,"gmtCreate":1639403527473,"gmtModify":1639403980729,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604284528","repostId":"1101330061","repostType":4,"repost":{"id":"1101330061","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639402663,"share":"https://www.laohu8.com/m/news/1101330061?lang=zh_CN&edition=full","pubTime":"2021-12-13 21:37","market":"us","language":"en","title":"Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101330061","media":"Tiger Newspress","summary":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today ann","content":"<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 21:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERU":"Veru Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101330061","content_text":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).\nENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.","news_type":1,"symbols_score_info":{"VERU":0.9}},"isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605640297,"gmtCreate":1639160477225,"gmtModify":1639160478352,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605640297","repostId":"1133027099","repostType":4,"repost":{"id":"1133027099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639152670,"share":"https://www.laohu8.com/m/news/1133027099?lang=zh_CN&edition=full","pubTime":"2021-12-11 00:11","market":"us","language":"en","title":"Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133027099","media":"Tiger Newspress","summary":"Sea Ltd stock dropped more than 5% in morning trading.","content":"<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-11 00:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133027099","content_text":"Sea Ltd stock dropped more than 5% in morning trading.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":985,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840566249,"gmtCreate":1635661104951,"gmtModify":1635661105328,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840566249","repostId":"2179226336","repostType":4,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853243645,"gmtCreate":1634819063566,"gmtModify":1634819074078,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/853243645","repostId":"1192205953","repostType":4,"repost":{"id":"1192205953","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634818772,"share":"https://www.laohu8.com/m/news/1192205953?lang=zh_CN&edition=full","pubTime":"2021-10-21 20:19","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192205953","media":"Tiger Newspress","summary":"Stock futures edged lower Thursday morning, with the major indexes hovering slightly below all-time ","content":"<p>Stock futures edged lower Thursday morning, with the major indexes hovering slightly below all-time highs as a parade of strong earnings results helped buoy equity prices earlier this week.</p><p><blockquote>周四上午，股指期货小幅走低，主要股指略低于历史高点，本周早些时候一系列强劲的盈利结果帮助提振了股价。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4be1cf44a88f742bce145b6a6868682f\" tg-width=\"286\" tg-height=\"117\" width=\"100%\" height=\"auto\">At 8:00 a.m. ET, Dow e-minis were&nbsp;down&nbsp;108&nbsp;points, or 0.3%, S&amp;P 500 e-minis were&nbsp;down&nbsp;13.75 points, or 0.3%, and Nasdaq 100 e-minis were down&nbsp;61&nbsp;points, or 0.4%.</p><p><blockquote>截至美国东部时间上午8点，道琼斯指数下跌108点，跌幅0.3%，标普500指数下跌13.75点，跌幅0.3%，纳斯达克100指数下跌61点，跌幅0.4%。</blockquote></p><p> IBM&nbsp;slipped 4.7% after it missed market estimates for quarterly revenue as its managed infrastructure business suffered from a decline in orders.</p><p><blockquote>IBM股价下跌4.7%，因其托管基础设施业务订单下降，季度收入低于市场预期。</blockquote></p><p> Tesla fell 1% in premarket trading as it said on Wednesday its upcoming factories and supply-chain headwinds would put pressure on its margins after it beat Wall Street expectations for third-quarter revenue.</p><p><blockquote>特斯拉在盘前交易中下跌1%，该公司周三表示，在第三季度营收超出华尔街预期后，即将到来的工厂和供应链阻力将给其利润率带来压力。</blockquote></p><p> AT&amp;T rose 1% after the telecom operator's quarterly revenue and monthly phone bill paying subscriber additions beat market expectations.</p><p><blockquote>AT&amp;T上涨1%，此前该电信运营商的季度收入和每月电话费支付用户增加超出市场预期。</blockquote></p><p> Dow gained 1.1% after it posted a more than a five-fold jump in third-quarter profit as economic recovery boosted prices for chemicals.</p><p><blockquote>由于经济复苏推高了化学品价格，道琼斯指数第三季度利润增长了五倍多，上涨1.1%。</blockquote></p><p> In currencies,the euro was little changed at $1.1640,the British pound fell 0.1% to $1.3810,the Japanese yen rose 0.3% to 114.02 per dollar.</p><p><blockquote>货币方面，欧元变化不大，报1.1640美元，英镑下跌0.1%，至1.3810美元，日元上涨0.3%，至114.02美元。</blockquote></p><p> In bonds,the yield on 10-year Treasuries was little changed at 1.66%,Germany’s 10-year yield advanced two basis points to -0.11%,Britain’s 10-year yield advanced four basis points to 1.18%.</p><p><blockquote>债券方面，10年期国债收益率变化不大，为1.66%，德国10年期国债收益率上涨2个基点至-0.11%，英国10年期国债收益率上涨4个基点至1.18%。</blockquote></p><p> In commodities,West Texas Intermediate crude fell 0.8% to $82.75 a barrel,Gold futures were little changed.</p><p><blockquote>大宗商品方面，西德克萨斯中质原油下跌0.8%，至每桶82.75美元，黄金期货变化不大。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-21 20:19</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stock futures edged lower Thursday morning, with the major indexes hovering slightly below all-time highs as a parade of strong earnings results helped buoy equity prices earlier this week.</p><p><blockquote>周四上午，股指期货小幅走低，主要股指略低于历史高点，本周早些时候一系列强劲的盈利结果帮助提振了股价。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4be1cf44a88f742bce145b6a6868682f\" tg-width=\"286\" tg-height=\"117\" width=\"100%\" height=\"auto\">At 8:00 a.m. ET, Dow e-minis were&nbsp;down&nbsp;108&nbsp;points, or 0.3%, S&amp;P 500 e-minis were&nbsp;down&nbsp;13.75 points, or 0.3%, and Nasdaq 100 e-minis were down&nbsp;61&nbsp;points, or 0.4%.</p><p><blockquote>截至美国东部时间上午8点，道琼斯指数下跌108点，跌幅0.3%，标普500指数下跌13.75点，跌幅0.3%，纳斯达克100指数下跌61点，跌幅0.4%。</blockquote></p><p> IBM&nbsp;slipped 4.7% after it missed market estimates for quarterly revenue as its managed infrastructure business suffered from a decline in orders.</p><p><blockquote>IBM股价下跌4.7%，因其托管基础设施业务订单下降，季度收入低于市场预期。</blockquote></p><p> Tesla fell 1% in premarket trading as it said on Wednesday its upcoming factories and supply-chain headwinds would put pressure on its margins after it beat Wall Street expectations for third-quarter revenue.</p><p><blockquote>特斯拉在盘前交易中下跌1%，该公司周三表示，在第三季度营收超出华尔街预期后，即将到来的工厂和供应链阻力将给其利润率带来压力。</blockquote></p><p> AT&amp;T rose 1% after the telecom operator's quarterly revenue and monthly phone bill paying subscriber additions beat market expectations.</p><p><blockquote>AT&amp;T上涨1%，此前该电信运营商的季度收入和每月电话费支付用户增加超出市场预期。</blockquote></p><p> Dow gained 1.1% after it posted a more than a five-fold jump in third-quarter profit as economic recovery boosted prices for chemicals.</p><p><blockquote>由于经济复苏推高了化学品价格，道琼斯指数第三季度利润增长了五倍多，上涨1.1%。</blockquote></p><p> In currencies,the euro was little changed at $1.1640,the British pound fell 0.1% to $1.3810,the Japanese yen rose 0.3% to 114.02 per dollar.</p><p><blockquote>货币方面，欧元变化不大，报1.1640美元，英镑下跌0.1%，至1.3810美元，日元上涨0.3%，至114.02美元。</blockquote></p><p> In bonds,the yield on 10-year Treasuries was little changed at 1.66%,Germany’s 10-year yield advanced two basis points to -0.11%,Britain’s 10-year yield advanced four basis points to 1.18%.</p><p><blockquote>债券方面，10年期国债收益率变化不大，为1.66%，德国10年期国债收益率上涨2个基点至-0.11%，英国10年期国债收益率上涨4个基点至1.18%。</blockquote></p><p> In commodities,West Texas Intermediate crude fell 0.8% to $82.75 a barrel,Gold futures were little changed.</p><p><blockquote>大宗商品方面，西德克萨斯中质原油下跌0.8%，至每桶82.75美元，黄金期货变化不大。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","TSLA":"特斯拉","IBM":"IBM"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192205953","content_text":"Stock futures edged lower Thursday morning, with the major indexes hovering slightly below all-time highs as a parade of strong earnings results helped buoy equity prices earlier this week.\nAt 8:00 a.m. ET, Dow e-minis were down 108 points, or 0.3%, S&P 500 e-minis were down 13.75 points, or 0.3%, and Nasdaq 100 e-minis were down 61 points, or 0.4%.\nIBM slipped 4.7% after it missed market estimates for quarterly revenue as its managed infrastructure business suffered from a decline in orders.\nTesla fell 1% in premarket trading as it said on Wednesday its upcoming factories and supply-chain headwinds would put pressure on its margins after it beat Wall Street expectations for third-quarter revenue.\nAT&T rose 1% after the telecom operator's quarterly revenue and monthly phone bill paying subscriber additions beat market expectations.\nDow gained 1.1% after it posted a more than a five-fold jump in third-quarter profit as economic recovery boosted prices for chemicals.\nIn currencies,the euro was little changed at $1.1640,the British pound fell 0.1% to $1.3810,the Japanese yen rose 0.3% to 114.02 per dollar.\nIn bonds,the yield on 10-year Treasuries was little changed at 1.66%,Germany’s 10-year yield advanced two basis points to -0.11%,Britain’s 10-year yield advanced four basis points to 1.18%.\nIn commodities,West Texas Intermediate crude fell 0.8% to $82.75 a barrel,Gold futures were little changed.","news_type":1,"symbols_score_info":{"IBM":0.9,".DJI":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":817388967,"gmtCreate":1630907542459,"gmtModify":1631889057217,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/817388967","repostId":"1110543090","repostType":4,"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814314281,"gmtCreate":1630762960443,"gmtModify":1631891242354,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814314281","repostId":"1169514310","repostType":4,"repost":{"id":"1169514310","kind":"news","pubTimestamp":1630656896,"share":"https://www.laohu8.com/m/news/1169514310?lang=zh_CN&edition=full","pubTime":"2021-09-03 16:14","market":"us","language":"en","title":"2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet<blockquote>股市尚未准备好爆炸的2个充分理由</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169514310","media":"Barron's","summary":"tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So w","content":"<p>tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just keep on going.</p><p><blockquote>到目前为止，股票经历了令人印象深刻的一年，但距离2021年结束还有四个月的时间。那么接下来会发生什么？更正？更多收获？现在，更容易证明涨势继续下去。</blockquote></p><p> First, though, it’s understandable why investors might be nervous.</p><p><blockquote>不过，首先，投资者感到紧张是可以理解的。</blockquote></p><p> TheS&amp;P 500has gained about 21% year to date, far above the historical average annual return of about 10%. And in the first eight months, the index hasn’t had a pullback of more than 5%— a correction is defined as a 10% drawdown.</p><p><blockquote>标准普尔500指数今年迄今已上涨约21%，远高于约10%的历史平均年回报率。在前八个月，该指数的回调幅度没有超过5%——回调被定义为下跌10%。</blockquote></p><p> Still, a good run needs something to stop it—likehigher corporate taxes,which the Biden administration supports. They could shave 5% or more off projected earnings estimates for S&amp;P 500 companies. Or persistent inflation, which could cause the Federal Reserve to rapidly reduce economic support. And there are a host of other catalysts, enough to push some analyststo forecast a retreat.</p><p><blockquote>尽管如此，良好的运行需要一些东西来阻止它——比如拜登政府支持的更高的公司税。他们可能会将标普500公司的盈利预期下调5%或更多。或者持续的通胀，这可能导致美联储迅速减少经济支持。还有许多其他催化剂，足以促使一些分析师预测经济会出现回落。</blockquote></p><p> But who knows how long Washington might take to put a new tax structure in place, or if lawmakers even will. Or what the deal is with inflation. There has been tapering talk for a few months now, and the Fed holds firm to its wait-and-see approach.</p><p><blockquote>但谁知道华盛顿可能需要多长时间才能建立新的税收结构，或者立法者是否会这样做。或者通货膨胀是怎么回事。缩减购债规模的讨论已经持续了几个月，美联储仍坚持观望态度。</blockquote></p><p> So the nature of the market’s climb in the past couple of weeks seems to be the surest, strongest sign of what’s ahead. The S&amp;P 500 is up 3% since Aug. 18, the bottom of a brief and shallow drop.</p><p><blockquote>因此，过去几周市场上涨的性质似乎是未来最确定、最强烈的迹象。自8月18日以来，标普500已上涨3%，这是短暂而浅跌的底部。</blockquote></p><p> “[Market] internals improved last week,” writes&nbsp;Michael Gibbs, director of equity portfolio and technical strategy at Raymond James.</p><p><blockquote>雷蒙德·詹姆斯(Raymond James)股票投资组合和技术策略总监迈克尔·吉布斯(Michael Gibbs)写道：“上周[市场]内部结构有所改善。”</blockquote></p><p> First off, transaction volumes are improving.</p><p><blockquote>首先，交易量正在改善。</blockquote></p><p> In late August, the daily number of shares traded on the&nbsp;SPDR S&amp;P 500 Exchange-Traded Fund Trust(SPY) has been about 54 million, according to FactSet. That’s above just under 50 million seen in the middle of the month.</p><p><blockquote>FactSet的数据显示，8月底，SPDR标普500交易所交易基金信托（SPDR标普500指数ETF）的每日交易股票数量约为5400万股。这高于本月中旬的略低于5000万。</blockquote></p><p> The upshot: When more market participants are transacting and they are bidding prices higher, it’s a vote of confidence in the market.</p><p><blockquote>结果是：当更多的市场参与者进行交易并且他们出价更高时，这是对市场的信任票。</blockquote></p><p> Secondly, the rally has been broad-based—many stocks have participated. For example, almost 80% of stocks listed on the New York Stock Exchange have been gaining, according to Raymond James.</p><p><blockquote>其次，涨势基础广泛——许多股票都参与其中。例如，雷蒙德·詹姆斯(Raymond James)表示，纽约证券交易所上市的近80%的股票都在上涨。</blockquote></p><p> The last time that metric hit such a high was November 2020. More stocks participating in the rally means the major indexes are less dependent on one group of stocks to move higher. Plus, witheconomically sensitive stocks on a run as well,it means investors are confident in sustained economic growth ahead.</p><p><blockquote>该指标上一次达到如此高的水平是在2020年11月。更多股票参与涨势意味着主要股指较少依赖一组股票走高。此外，经济敏感型股票也在上涨，这意味着投资者对未来经济持续增长充满信心。</blockquote></p><p> So more gains or a correction? We’ve made our case, but time will tell.</p><p><blockquote>那么更多的收益还是修正？我们已经证明了我们的观点，但时间会证明一切。</blockquote></p><p></p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet<blockquote>股市尚未准备好爆炸的2个充分理由</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet<blockquote>股市尚未准备好爆炸的2个充分理由</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barron's</strong><span class=\"h-time small\">2021-09-03 16:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p>tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just keep on going.</p><p><blockquote>到目前为止，股票经历了令人印象深刻的一年，但距离2021年结束还有四个月的时间。那么接下来会发生什么？更正？更多收获？现在，更容易证明涨势继续下去。</blockquote></p><p> First, though, it’s understandable why investors might be nervous.</p><p><blockquote>不过，首先，投资者感到紧张是可以理解的。</blockquote></p><p> TheS&amp;P 500has gained about 21% year to date, far above the historical average annual return of about 10%. And in the first eight months, the index hasn’t had a pullback of more than 5%— a correction is defined as a 10% drawdown.</p><p><blockquote>标准普尔500指数今年迄今已上涨约21%，远高于约10%的历史平均年回报率。在前八个月，该指数的回调幅度没有超过5%——回调被定义为下跌10%。</blockquote></p><p> Still, a good run needs something to stop it—likehigher corporate taxes,which the Biden administration supports. They could shave 5% or more off projected earnings estimates for S&amp;P 500 companies. Or persistent inflation, which could cause the Federal Reserve to rapidly reduce economic support. And there are a host of other catalysts, enough to push some analyststo forecast a retreat.</p><p><blockquote>尽管如此，良好的运行需要一些东西来阻止它——比如拜登政府支持的更高的公司税。他们可能会将标普500公司的盈利预期下调5%或更多。或者持续的通胀，这可能导致美联储迅速减少经济支持。还有许多其他催化剂，足以促使一些分析师预测经济会出现回落。</blockquote></p><p> But who knows how long Washington might take to put a new tax structure in place, or if lawmakers even will. Or what the deal is with inflation. There has been tapering talk for a few months now, and the Fed holds firm to its wait-and-see approach.</p><p><blockquote>但谁知道华盛顿可能需要多长时间才能建立新的税收结构，或者立法者是否会这样做。或者通货膨胀是怎么回事。缩减购债规模的讨论已经持续了几个月，美联储仍坚持观望态度。</blockquote></p><p> So the nature of the market’s climb in the past couple of weeks seems to be the surest, strongest sign of what’s ahead. The S&amp;P 500 is up 3% since Aug. 18, the bottom of a brief and shallow drop.</p><p><blockquote>因此，过去几周市场上涨的性质似乎是未来最确定、最强烈的迹象。自8月18日以来，标普500已上涨3%，这是短暂而浅跌的底部。</blockquote></p><p> “[Market] internals improved last week,” writes&nbsp;Michael Gibbs, director of equity portfolio and technical strategy at Raymond James.</p><p><blockquote>雷蒙德·詹姆斯(Raymond James)股票投资组合和技术策略总监迈克尔·吉布斯(Michael Gibbs)写道：“上周[市场]内部结构有所改善。”</blockquote></p><p> First off, transaction volumes are improving.</p><p><blockquote>首先，交易量正在改善。</blockquote></p><p> In late August, the daily number of shares traded on the&nbsp;SPDR S&amp;P 500 Exchange-Traded Fund Trust(SPY) has been about 54 million, according to FactSet. That’s above just under 50 million seen in the middle of the month.</p><p><blockquote>FactSet的数据显示，8月底，SPDR标普500交易所交易基金信托（SPDR标普500指数ETF）的每日交易股票数量约为5400万股。这高于本月中旬的略低于5000万。</blockquote></p><p> The upshot: When more market participants are transacting and they are bidding prices higher, it’s a vote of confidence in the market.</p><p><blockquote>结果是：当更多的市场参与者进行交易并且他们出价更高时，这是对市场的信任票。</blockquote></p><p> Secondly, the rally has been broad-based—many stocks have participated. For example, almost 80% of stocks listed on the New York Stock Exchange have been gaining, according to Raymond James.</p><p><blockquote>其次，涨势基础广泛——许多股票都参与其中。例如，雷蒙德·詹姆斯(Raymond James)表示，纽约证券交易所上市的近80%的股票都在上涨。</blockquote></p><p> The last time that metric hit such a high was November 2020. More stocks participating in the rally means the major indexes are less dependent on one group of stocks to move higher. Plus, witheconomically sensitive stocks on a run as well,it means investors are confident in sustained economic growth ahead.</p><p><blockquote>该指标上一次达到如此高的水平是在2020年11月。更多股票参与涨势意味着主要股指较少依赖一组股票走高。此外，经济敏感型股票也在上涨，这意味着投资者对未来经济持续增长充满信心。</blockquote></p><p> So more gains or a correction? We’ve made our case, but time will tell.</p><p><blockquote>那么更多的收益还是修正？我们已经证明了我们的观点，但时间会证明一切。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/stock-market-outlook-crash-or-rally-51630526109?siteid=yhoof2\">Barron's</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.barrons.com/articles/stock-market-outlook-crash-or-rally-51630526109?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169514310","content_text":"tocks have had an impressive year so far, but there are still four months before 2021 wraps up. So what’s ahead? A correction? More gains? Right now, it’s easier to make the case for the rally to just keep on going.\nFirst, though, it’s understandable why investors might be nervous.\nTheS&P 500has gained about 21% year to date, far above the historical average annual return of about 10%. And in the first eight months, the index hasn’t had a pullback of more than 5%— a correction is defined as a 10% drawdown.\nStill, a good run needs something to stop it—likehigher corporate taxes,which the Biden administration supports. They could shave 5% or more off projected earnings estimates for S&P 500 companies. Or persistent inflation, which could cause the Federal Reserve to rapidly reduce economic support. And there are a host of other catalysts, enough to push some analyststo forecast a retreat.\nBut who knows how long Washington might take to put a new tax structure in place, or if lawmakers even will. Or what the deal is with inflation. There has been tapering talk for a few months now, and the Fed holds firm to its wait-and-see approach.\nSo the nature of the market’s climb in the past couple of weeks seems to be the surest, strongest sign of what’s ahead. The S&P 500 is up 3% since Aug. 18, the bottom of a brief and shallow drop.\n“[Market] internals improved last week,” writes Michael Gibbs, director of equity portfolio and technical strategy at Raymond James.\nFirst off, transaction volumes are improving.\nIn late August, the daily number of shares traded on the SPDR S&P 500 Exchange-Traded Fund Trust(SPY) has been about 54 million, according to FactSet. That’s above just under 50 million seen in the middle of the month.\nThe upshot: When more market participants are transacting and they are bidding prices higher, it’s a vote of confidence in the market.\nSecondly, the rally has been broad-based—many stocks have participated. For example, almost 80% of stocks listed on the New York Stock Exchange have been gaining, according to Raymond James.\nThe last time that metric hit such a high was November 2020. More stocks participating in the rally means the major indexes are less dependent on one group of stocks to move higher. Plus, witheconomically sensitive stocks on a run as well,it means investors are confident in sustained economic growth ahead.\nSo more gains or a correction? We’ve made our case, but time will tell.","news_type":1,"symbols_score_info":{"SPY":0.9,".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812287285,"gmtCreate":1630590673047,"gmtModify":1631891242365,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812287285","repostId":"1108690074","repostType":4,"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890109525,"gmtCreate":1628085539167,"gmtModify":1633753745172,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/890109525","repostId":"1108635314","repostType":4,"repost":{"id":"1108635314","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628084737,"share":"https://www.laohu8.com/m/news/1108635314?lang=zh_CN&edition=full","pubTime":"2021-08-04 21:45","market":"us","language":"en","title":"AMD gained over 5% and reached record high<blockquote>AMD涨超5%创历史新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1108635314","media":"Tiger Newspress","summary":"(August 4) AMD gained over 5% and reached record high.","content":"<p>(August 4)&nbsp;<a href=\"https://laohu8.com/S/AMD\">AMD</a> gained over 5% and reached record high.</p><p><blockquote>（8月4日）<a href=\"https://laohu8.com/S/AMD\">AMD</a>涨幅超过5%，创历史新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8b23aa43d6e0816bc9aeaa95fc08fcd6\" tg-width=\"837\" tg-height=\"558\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD gained over 5% and reached record high<blockquote>AMD涨超5%创历史新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD gained over 5% and reached record high<blockquote>AMD涨超5%创历史新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-04 21:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(August 4)&nbsp;<a href=\"https://laohu8.com/S/AMD\">AMD</a> gained over 5% and reached record high.</p><p><blockquote>（8月4日）<a href=\"https://laohu8.com/S/AMD\">AMD</a>涨幅超过5%，创历史新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8b23aa43d6e0816bc9aeaa95fc08fcd6\" tg-width=\"837\" tg-height=\"558\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108635314","content_text":"(August 4) AMD gained over 5% and reached record high.","news_type":1,"symbols_score_info":{"AMD":0.9}},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141228897,"gmtCreate":1625876245119,"gmtModify":1633936553728,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Keep on hold? Any advice?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Keep on hold? Any advice?","text":"$AMC Entertainment(AMC)$Keep on hold? Any advice?","images":[{"img":"https://static.tigerbbs.com/7f5a964972d7799ab932c087f5eac71f","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/141228897","isVote":1,"tweetType":1,"viewCount":787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":112340149,"gmtCreate":1622853032981,"gmtModify":1634097423462,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"themes":[],"htmlText":"Should buy","listText":"Should buy","text":"Should buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/112340149","repostId":"1154529120","repostType":4,"repost":{"id":"1154529120","kind":"news","pubTimestamp":1622810459,"share":"https://www.laohu8.com/m/news/1154529120?lang=zh_CN&edition=full","pubTime":"2021-06-04 20:40","market":"hk","language":"en","title":"Can Alibaba Stock Hit $500? If You Got Time, Yes<blockquote>阿里巴巴-SW股价能否触及500美元？如果你有时间，是的</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1154529120","media":"seekingalpha","summary":"Alibaba is a battleground stock where some see a lot of opportunities, while others see many risks.I believe that there are both opportunities and risks, but would see the prior outweighing the latter.In the long run, BABA has a chance of delivering strong gains for those that buy at the current, quite low, valuation.Since its IPO, Alibaba has seen strong share price gains, but it should also be mentioned that shares did peek in H2 2020, and have declined considerably since then:. Alibaba Group'","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is a battleground stock where some see a lot of opportunities, while others see many risks.</li>  <li>I believe that there are both opportunities and risks, but would see the prior outweighing the latter.</li>  <li>In the long run, BABA has a chance of delivering strong gains for those that buy at the current, quite low, valuation.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/567d19950e6c8789ce2192b4503f0fa5\" tg-width=\"1536\" tg-height=\"653\" referrerpolicy=\"no-referrer\"><span>Photo by efetova/iStock via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW是一只战场股票，有些人看到了很多机会，而另一些人则看到了很多风险。</li><li>我相信机遇和风险都存在，但我认为前者大于后者。</li><li>从长远来看，阿里巴巴有机会为那些以目前相当低的估值买入的人带来强劲收益。</li></ul><p class=\"t-img-caption\"><span>摄影：efetova/iStock，来自Getty Images</span></p></blockquote></p><p> <b>Article Thesis</b></p><p><blockquote><b>文章论文</b></blockquote></p><p> Alibaba Group (BABA) is a leading global high-tech name that continues to generate attractive growth and that offers investors exposure to the high-growth Chinese consumer market. At the same time, through a range of ventures, Alibaba is also active in additional industries, such as cloud computing. Shares have declined considerably over the last couple of months, but I believe that the long-term potential is significant. I would not be surprised to see shares rise towards $500, although that will not happen in the near term.</p><p><blockquote>阿里巴巴-SW集团（BABA）是一家全球领先的高科技公司，持续产生有吸引力的增长，并为投资者提供了接触高增长的中国消费市场的机会。与此同时，通过一系列合资企业，阿里巴巴-SW还活跃在云计算等其他行业。过去几个月股价大幅下跌，但我相信长期潜力巨大。如果股价上涨至500美元，我不会感到惊讶，尽管这不会在短期内发生。</blockquote></p><p> <b>BABA Stock Price</b></p><p><blockquote><b>阿里巴巴股价</b></blockquote></p><p> Since its IPO, Alibaba has seen strong share price gains, but it should also be mentioned that shares did peek in H2 2020, and have declined considerably since then:</p><p><blockquote>自IPO以来，阿里巴巴-SW股价强劲上涨，但也应该提到的是，股价在2020年下半年确实出现了小幅上涨，此后大幅下跌：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8079eeb5384ea003fb3725d3cd1e877f\" tg-width=\"635\" tg-height=\"403\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> Shares are now basically where they were one year ago, as the gains during summer 2020 have been erased when Ant Financial's IPO plans were stopped. The flat share price performance over the last year is somewhat surprising, though, as Alibaba continued to generate strong results in that time frame. During the last quarter, for example, Alibaba showcased a&nbsp;revenue growth rate of 64%, while revenue growth during the previous quarter was also very strong, at around 50%. This is not the only positive in Alibaba's earnings releases, however. The company also managed to grow its user count by 32 million during the most recent quarter alone, which equates to an annualized user growth rate of around 20%. This bodes well for future quarters, as more users on Alibaba's platform should translate into higher revenues. On top of that, the strong user growth shows that there is still growing demand for the shopping services that Alibaba's platforms offer -- the market is not saturated at all. Alibaba also managed to grow its EBITDA by 25% year over year, which is an attractive growth pace as well, and which was achieved despite growing investments in what management calls key growth areas. Income from operations, meanwhile, grew at an even faster pace, thanks to some operating leverage, rising by 48% year over year when adjusted for the fine that Alibaba had to pay during Q1. It makes, I believe, sense to back out this one-time item to get a clearer picture about Alibaba's underlying, \"core\" profitability during an average quarter.</p><p><blockquote>由于蚂蚁金服IPO计划被叫停后，2020年夏季的涨幅已被抹去，股价目前基本处于一年前的水平。不过，去年持平的股价表现有些令人惊讶，因为阿里巴巴-SW在此期间继续取得强劲业绩。例如，上一季度，阿里巴巴-SW的收入增长率为64%，而上一季度的收入增长也非常强劲，在50%左右。然而，这并不是阿里巴巴-SW财报中唯一的积极因素。仅在最近一个季度，该公司的用户数量就增加了3200万，相当于用户年化增长率约为20%。这对未来几个季度来说是个好兆头，因为阿里巴巴-SW平台上的更多用户应该会转化为更高的收入。最重要的是，强劲的用户增长表明，对阿里巴巴-SW平台提供的购物服务的需求仍在增长——市场根本没有饱和。阿里巴巴-SW的EBITDA也同比增长了25%，这也是一个有吸引力的增长速度，尽管管理层在评级关键增长领域的投资不断增加，但这一增长还是实现了。与此同时，由于一些运营杠杆，运营收入增长速度更快，经调整阿里巴巴-SW第一季度必须支付的罚款后，同比增长48%。我认为，为了更清楚地了解阿里巴巴-SW平均季度的基本“核心”盈利能力，放弃这一一次性项目是有意义的。</blockquote></p><p> Alibaba Group's weak share price performance, relative to the broad market and other tech names, is thus not the result of weak operating performance, but rather a result of multiple compression, driven by weak investor sentiment due to China exposure and&nbsp;fears about regulation.</p><p><blockquote>因此，相对于大盘和其他科技股，阿里巴巴-SW集团的股价表现疲软，并不是经营业绩疲软的结果，而是多重压缩的结果，原因是投资者情绪疲软以及对监管的担忧。</blockquote></p><p> At its current price of $220, BABA trades at a quite large discount compared to the current consensus analyst price target of $298. If Alibaba were to hit that, shares would gain 35%. Analyst price targets are usually issued with a 1-year time frame, thus, if the analyst community is correct, Alibaba could be a great investment. From a valuation standpoint, this price target doesn't seem outrageous at all, as $298 would equate to around 29x this year's expected net profits, or 23x next year's net earnings. The latter is likely the more telling one when we talk about a price target for summer 2022, i.e. 1 year from now.</p><p><blockquote>以目前220美元的价格计算，与目前分析师298美元的一致目标价相比，阿里巴巴的交易价格有相当大的折扣。如果阿里巴巴-SW达到这一目标，股价将上涨35%。分析师的价格目标通常以1年的时间框架发布，因此，如果分析师界是正确的，阿里巴巴-SW可能是一项伟大的投资。从估值的角度来看，这个目标价似乎一点也不离谱，因为298美元相当于今年预期净利润的29倍左右，或明年净利润的23倍。当我们谈论2022年夏季（即一年后）的价格目标时，后者可能更能说明问题。</blockquote></p><p> <b>Can Alibaba Stock Hit $500?</b></p><p><blockquote><b>阿里巴巴-SW股价能否触及500美元？</b></blockquote></p><p> The answer to that question, I think, depends on your time frame. If you are looking at a 12-month window, then Alibaba will most likely not be able to hit $500. The ~$300 price target seems achievable, although that is, of course, also not guaranteed. If, however, we take a longer-term view, then $500 seems like a share price that BABA could hit eventually. Let's look at a couple of examples.</p><p><blockquote>我认为，这个问题的答案取决于你的时间框架。如果你着眼于12个月的窗口期，那么阿里巴巴-SW很可能无法达到500美元。300美元左右的价格目标似乎是可以实现的，尽管这当然也不能保证。然而，如果我们从更长远的角度来看，那么500美元似乎是阿里巴巴最终可能触及的股价。让我们看几个例子。</blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $20 at some point and traded at an earnings multiple of 25, then shares would trade at $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW在某个时候每股收益为20美元，市盈率为25倍，那么股价将为500美元。</i></blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $25 and traded at a 20x earnings multiple, then shares would trade at $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW的每股收益为25美元，市盈率为20倍，那么股价将为500美元。</i></blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $17 and traded at 29x its net profits, then shares would trade at (marginally below) $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW的每股收益为17美元，交易价格为净利润的29倍，那么股价将为（略低于）500美元。</i></blockquote></p><p></p><p> We see that there are many scenarios that could get us to a $500 share price for BABA, some of them more likely than others. Of course, the higher your target multiple, the lower the earnings that would be required. This, in turn, means that the price target can be hit sooner, as less cumulative earnings growth would be required. When we take a look at how Alibaba was valued in the past, we see that the longer-term median earnings multiples for BABA look like this:</p><p><blockquote>我们看到，有很多情况可能会让阿里巴巴的股价达到500美元，其中一些情况比其他情况更有可能。当然，你的目标倍数越高，所需的收益就越低。这反过来意味着可以更快达到价格目标，因为所需的累计盈利增长较少。当我们看一下阿里巴巴-SW过去的估值时，我们会发现阿里巴巴的长期市盈率中位数如下所示：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2d42b7094deb394266d6410287c2e4\" tg-width=\"635\" tg-height=\"436\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> At 30-40x net earnings, Alibaba was clearly trading at a massive premium relative to how shares are valued today (around 20x this year's earnings). I think that the current valuation is too low, but on the other hand, I do not expect Alibaba to trade at 30, 35, or even 40x net profits in coming years. Due to the growing scale of Alibaba, which makes it a little harder to maintain its excellent growth in coming years, shares will likely trade at a lower valuation in coming years, compared to how they were valued in the past.</p><p><blockquote>阿里巴巴-SW的净利润为30-40倍，相对于目前的股价估值（约为今年盈利的20倍），显然存在巨大溢价。我认为目前的估值太低，但另一方面，我预计阿里巴巴-SW未来几年的净利润不会达到30倍、35倍甚至40倍。由于阿里巴巴-SW的规模不断扩大，这使得其在未来几年保持出色的增长变得更加困难，与过去的估值相比，未来几年的股价可能会较低。</blockquote></p><p> I still think that shares do have some valuation expansion potential from the current earnings multiple of around 21, thus let's assume that shares trade at 23x net profits in the future. This would still represent a massive discount versus the historic valuation, and also a substantial discount compared to how US-based high-tech mega-caps are valued -- Amazon (AMZN), for example, trades at 59x this year's earnings.</p><p><blockquote>我仍然认为，从目前21倍左右的市盈率来看，该股确实有一定的估值扩张潜力，因此让我们假设该股未来的净利润为23倍。与历史估值相比，这仍然是一个巨大的折扣，与美国高科技大型股的估值相比也是一个巨大的折扣——例如，亚马逊(AMZN)的交易价格是今年市盈率的59倍。</blockquote></p><p> If we want to get to a $500 share price for BABA using a 23x earnings multiple, then we get to earnings per share of $21.70 that Alibaba must generate. When could this be the case? In the following chart, we see EPS estimates for the current year, next year (CY 2022), and CY 2023:</p><p><blockquote>如果我们想使用23倍的市盈率将阿里巴巴的股价达到500美元，那么阿里巴巴-SW必须产生的每股收益为21.70美元。什么时候会是这种情况？在下图中，我们看到了本年度、明年（2022财年）和2023财年的每股收益预测：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6fcf78e0b071eff9753afbdcd96f751c\" tg-width=\"635\" tg-height=\"436\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> If analysts are right, Alibaba will not get to earn $22 a share through 2023, and I think that is realistic. I do not see earnings per share rising by 100%+ between this year and 2023, either. From 2023, it would take another 43% increase in Alibaba's earnings per share to get to $21.70, which is our \"target EPS\" for a $500 share price.</p><p><blockquote>如果分析师是对的，阿里巴巴-SW到2023年每股收益将无法达到22美元，我认为这是现实的。我也不认为今年到2023年间每股收益会增长100%以上。从2023年开始，阿里巴巴-SW的每股收益需要再增长43%才能达到21.70美元，这是我们500美元股价的“目标每股收益”。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7b4c351b4b5eb3328191ccaa9a3b776c\" tg-width=\"635\" tg-height=\"403\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> Analysts are currently forecasting long-term EPS growth of around 27%, which would mean it would take Alibaba about 1.5 years to grow its EPS from $15.20 (2023 estimate) to our target of $21.70. Even if we assume that this is too optimistic and that growth will be just 20% in 2024 and 2025, EPS of $21.70 could be hit by the end of 2025. So, in other words, if Alibaba grows a little less than what analysts are forecasting right now, Alibaba could trade at $500 by the end of 2025 -- or 4.5 years from now. Note that this scenario does not require a high earnings multiple at all -- at 23x net profits, Alibaba wouldn't be expensive, I believe.</p><p><blockquote>分析师目前预测长期每股收益增长约为27%，这意味着阿里巴巴-SW需要大约1.5年的时间才能将每股收益从15.20美元（2023年估计）增长到我们21.70美元的目标。即使我们假设这过于乐观，2024年和2025年的增长率仅为20%，到2025年底每股收益也可能达到21.70美元。因此，换句话说，如果阿里巴巴-SW的增长略低于分析师目前的预测，那么到2025年底（即4.5年后），阿里巴巴-SW的交易价格可能会达到500美元。请注意，这种情况根本不需要很高的市盈率——我相信，阿里巴巴-SW的净利润为23倍，价格并不昂贵。</blockquote></p><p> We can get even more conservative and assume that the 2023 EPS estimate is 10% too high and that EPS will grow by just 17% a year in the years beyond 2023 (versus a long-term forecast of 27% a year by the analyst community). In that case, Alibaba would hit $21.70 in earnings per share in 2026, and shares would rise to $500 over the next 5.5 years. Even in this scenario, BABA wouldn't be a bad investment at all -- a 130% share price increase from the current level over the next 5.5 years would equate to annualized returns of 16%.</p><p><blockquote>我们可以更加保守地假设2023年每股收益预期过高10%，并且2023年之后的几年每股收益每年仅增长17%（而分析师社区的长期预测为每年27%）。在这种情况下，阿里巴巴-SW的每股收益将在2026年达到21.70美元，股价将在未来5.5年内升至500美元。即使在这种情况下，阿里巴巴也根本不是一项糟糕的投资——未来5.5年内股价较当前水平上涨130%，相当于年化回报率为16%。</blockquote></p><p> So, to sum this section up, I'd say<i>yes, BABA can hit $500</i>-- but it will realistically take a couple of years. By the mid-2020s, this seems like a very achievable goal to me, although there are, of course, no guarantees.</p><p><blockquote>所以，总结一下这一部分，我想说<i>是的，阿里巴巴可以达到500美元</i>——但实际上需要几年时间。到2020年代中期，对我来说，这似乎是一个非常可以实现的目标，尽管当然没有任何保证。</blockquote></p><p> <b>Is Alibaba Stock A Buy Or Sell Now?</b></p><p><blockquote><b>阿里巴巴-SW股票现在是买入还是卖出？</b></blockquote></p><p> Alibaba Group is, I believe, a strong investment. The company generates strong growth, profits from multiple long-term macro trends, such as growing consumer spending in China, growing e-commerce market share, and cloud computing. There are, however, risks to consider: Alibaba is highly China-dependent, and in case the economic growth story in China ends, Alibaba would be hurt a lot. On top of that, Alibaba could be targeted again by regulators, although I personally think that it is not in China's best interest to hurt one of its highest-growth tech companies.</p><p><blockquote>我认为，阿里巴巴-SW集团是一项强有力的投资。该公司增长强劲，利润来自多个长期宏观趋势，例如中国消费者支出的增长、电子商务市场份额的增长和云计算。然而，也有一些风险需要考虑：阿里巴巴-SW高度依赖中国，如果中国的经济增长故事结束，阿里巴巴-SW将受到很大伤害。最重要的是，阿里巴巴-SW可能会再次成为监管机构的目标，尽管我个人认为伤害中国增长最快的科技公司之一不符合中国的最佳利益。</blockquote></p><p></p><p> For those that worry about these risks, Alibaba may not be the right choice, but for those that see Alibaba as a potentially very rewarding play on Chinese consumers, BABA could be a strong pick in a diversified portfolio. I belong to the latter group and thus rate the stock a buy at current valuations, expecting significant upside over the coming years. Depending on your risk tolerance and how you weigh the opportunities and threats of investing in Chinese companies, you may decide differently, however.</p><p><blockquote>对于那些担心这些风险的人来说，阿里巴巴-SW可能不是正确的选择，但对于那些认为阿里巴巴-SW对中国消费者来说可能非常有益的投资的人来说，阿里巴巴可能是多元化投资组合中的一个强有力的选择。我属于后一类，因此按当前估值将该股评级为买入，预计未来几年将大幅上涨。然而，根据您的风险承受能力以及您如何权衡投资中国公司的机会和威胁，您可能会做出不同的决定。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Alibaba Stock Hit $500? If You Got Time, Yes<blockquote>阿里巴巴-SW股价能否触及500美元？如果你有时间，是的</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Alibaba Stock Hit $500? If You Got Time, Yes<blockquote>阿里巴巴-SW股价能否触及500美元？如果你有时间，是的</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-06-04 20:40</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is a battleground stock where some see a lot of opportunities, while others see many risks.</li>  <li>I believe that there are both opportunities and risks, but would see the prior outweighing the latter.</li>  <li>In the long run, BABA has a chance of delivering strong gains for those that buy at the current, quite low, valuation.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/567d19950e6c8789ce2192b4503f0fa5\" tg-width=\"1536\" tg-height=\"653\" referrerpolicy=\"no-referrer\"><span>Photo by efetova/iStock via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW是一只战场股票，有些人看到了很多机会，而另一些人则看到了很多风险。</li><li>我相信机遇和风险都存在，但我认为前者大于后者。</li><li>从长远来看，阿里巴巴有机会为那些以目前相当低的估值买入的人带来强劲收益。</li></ul><p class=\"t-img-caption\"><span>摄影：efetova/iStock，来自Getty Images</span></p></blockquote></p><p> <b>Article Thesis</b></p><p><blockquote><b>文章论文</b></blockquote></p><p> Alibaba Group (BABA) is a leading global high-tech name that continues to generate attractive growth and that offers investors exposure to the high-growth Chinese consumer market. At the same time, through a range of ventures, Alibaba is also active in additional industries, such as cloud computing. Shares have declined considerably over the last couple of months, but I believe that the long-term potential is significant. I would not be surprised to see shares rise towards $500, although that will not happen in the near term.</p><p><blockquote>阿里巴巴-SW集团（BABA）是一家全球领先的高科技公司，持续产生有吸引力的增长，并为投资者提供了接触高增长的中国消费市场的机会。与此同时，通过一系列合资企业，阿里巴巴-SW还活跃在云计算等其他行业。过去几个月股价大幅下跌，但我相信长期潜力巨大。如果股价上涨至500美元，我不会感到惊讶，尽管这不会在短期内发生。</blockquote></p><p> <b>BABA Stock Price</b></p><p><blockquote><b>阿里巴巴股价</b></blockquote></p><p> Since its IPO, Alibaba has seen strong share price gains, but it should also be mentioned that shares did peek in H2 2020, and have declined considerably since then:</p><p><blockquote>自IPO以来，阿里巴巴-SW股价强劲上涨，但也应该提到的是，股价在2020年下半年确实出现了小幅上涨，此后大幅下跌：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8079eeb5384ea003fb3725d3cd1e877f\" tg-width=\"635\" tg-height=\"403\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> Shares are now basically where they were one year ago, as the gains during summer 2020 have been erased when Ant Financial's IPO plans were stopped. The flat share price performance over the last year is somewhat surprising, though, as Alibaba continued to generate strong results in that time frame. During the last quarter, for example, Alibaba showcased a&nbsp;revenue growth rate of 64%, while revenue growth during the previous quarter was also very strong, at around 50%. This is not the only positive in Alibaba's earnings releases, however. The company also managed to grow its user count by 32 million during the most recent quarter alone, which equates to an annualized user growth rate of around 20%. This bodes well for future quarters, as more users on Alibaba's platform should translate into higher revenues. On top of that, the strong user growth shows that there is still growing demand for the shopping services that Alibaba's platforms offer -- the market is not saturated at all. Alibaba also managed to grow its EBITDA by 25% year over year, which is an attractive growth pace as well, and which was achieved despite growing investments in what management calls key growth areas. Income from operations, meanwhile, grew at an even faster pace, thanks to some operating leverage, rising by 48% year over year when adjusted for the fine that Alibaba had to pay during Q1. It makes, I believe, sense to back out this one-time item to get a clearer picture about Alibaba's underlying, \"core\" profitability during an average quarter.</p><p><blockquote>由于蚂蚁金服IPO计划被叫停后，2020年夏季的涨幅已被抹去，股价目前基本处于一年前的水平。不过，去年持平的股价表现有些令人惊讶，因为阿里巴巴-SW在此期间继续取得强劲业绩。例如，上一季度，阿里巴巴-SW的收入增长率为64%，而上一季度的收入增长也非常强劲，在50%左右。然而，这并不是阿里巴巴-SW财报中唯一的积极因素。仅在最近一个季度，该公司的用户数量就增加了3200万，相当于用户年化增长率约为20%。这对未来几个季度来说是个好兆头，因为阿里巴巴-SW平台上的更多用户应该会转化为更高的收入。最重要的是，强劲的用户增长表明，对阿里巴巴-SW平台提供的购物服务的需求仍在增长——市场根本没有饱和。阿里巴巴-SW的EBITDA也同比增长了25%，这也是一个有吸引力的增长速度，尽管管理层在评级关键增长领域的投资不断增加，但这一增长还是实现了。与此同时，由于一些运营杠杆，运营收入增长速度更快，经调整阿里巴巴-SW第一季度必须支付的罚款后，同比增长48%。我认为，为了更清楚地了解阿里巴巴-SW平均季度的基本“核心”盈利能力，放弃这一一次性项目是有意义的。</blockquote></p><p> Alibaba Group's weak share price performance, relative to the broad market and other tech names, is thus not the result of weak operating performance, but rather a result of multiple compression, driven by weak investor sentiment due to China exposure and&nbsp;fears about regulation.</p><p><blockquote>因此，相对于大盘和其他科技股，阿里巴巴-SW集团的股价表现疲软，并不是经营业绩疲软的结果，而是多重压缩的结果，原因是投资者情绪疲软以及对监管的担忧。</blockquote></p><p> At its current price of $220, BABA trades at a quite large discount compared to the current consensus analyst price target of $298. If Alibaba were to hit that, shares would gain 35%. Analyst price targets are usually issued with a 1-year time frame, thus, if the analyst community is correct, Alibaba could be a great investment. From a valuation standpoint, this price target doesn't seem outrageous at all, as $298 would equate to around 29x this year's expected net profits, or 23x next year's net earnings. The latter is likely the more telling one when we talk about a price target for summer 2022, i.e. 1 year from now.</p><p><blockquote>以目前220美元的价格计算，与目前分析师298美元的一致目标价相比，阿里巴巴的交易价格有相当大的折扣。如果阿里巴巴-SW达到这一目标，股价将上涨35%。分析师的价格目标通常以1年的时间框架发布，因此，如果分析师界是正确的，阿里巴巴-SW可能是一项伟大的投资。从估值的角度来看，这个目标价似乎一点也不离谱，因为298美元相当于今年预期净利润的29倍左右，或明年净利润的23倍。当我们谈论2022年夏季（即一年后）的价格目标时，后者可能更能说明问题。</blockquote></p><p> <b>Can Alibaba Stock Hit $500?</b></p><p><blockquote><b>阿里巴巴-SW股价能否触及500美元？</b></blockquote></p><p> The answer to that question, I think, depends on your time frame. If you are looking at a 12-month window, then Alibaba will most likely not be able to hit $500. The ~$300 price target seems achievable, although that is, of course, also not guaranteed. If, however, we take a longer-term view, then $500 seems like a share price that BABA could hit eventually. Let's look at a couple of examples.</p><p><blockquote>我认为，这个问题的答案取决于你的时间框架。如果你着眼于12个月的窗口期，那么阿里巴巴-SW很可能无法达到500美元。300美元左右的价格目标似乎是可以实现的，尽管这当然也不能保证。然而，如果我们从更长远的角度来看，那么500美元似乎是阿里巴巴最终可能触及的股价。让我们看几个例子。</blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $20 at some point and traded at an earnings multiple of 25, then shares would trade at $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW在某个时候每股收益为20美元，市盈率为25倍，那么股价将为500美元。</i></blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $25 and traded at a 20x earnings multiple, then shares would trade at $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW的每股收益为25美元，市盈率为20倍，那么股价将为500美元。</i></blockquote></p><p> <i>- If Alibaba were to generate earnings per share of $17 and traded at 29x its net profits, then shares would trade at (marginally below) $500.</i></p><p><blockquote><i>-如果阿里巴巴-SW的每股收益为17美元，交易价格为净利润的29倍，那么股价将为（略低于）500美元。</i></blockquote></p><p></p><p> We see that there are many scenarios that could get us to a $500 share price for BABA, some of them more likely than others. Of course, the higher your target multiple, the lower the earnings that would be required. This, in turn, means that the price target can be hit sooner, as less cumulative earnings growth would be required. When we take a look at how Alibaba was valued in the past, we see that the longer-term median earnings multiples for BABA look like this:</p><p><blockquote>我们看到，有很多情况可能会让阿里巴巴的股价达到500美元，其中一些情况比其他情况更有可能。当然，你的目标倍数越高，所需的收益就越低。这反过来意味着可以更快达到价格目标，因为所需的累计盈利增长较少。当我们看一下阿里巴巴-SW过去的估值时，我们会发现阿里巴巴的长期市盈率中位数如下所示：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd2d42b7094deb394266d6410287c2e4\" tg-width=\"635\" tg-height=\"436\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> At 30-40x net earnings, Alibaba was clearly trading at a massive premium relative to how shares are valued today (around 20x this year's earnings). I think that the current valuation is too low, but on the other hand, I do not expect Alibaba to trade at 30, 35, or even 40x net profits in coming years. Due to the growing scale of Alibaba, which makes it a little harder to maintain its excellent growth in coming years, shares will likely trade at a lower valuation in coming years, compared to how they were valued in the past.</p><p><blockquote>阿里巴巴-SW的净利润为30-40倍，相对于目前的股价估值（约为今年盈利的20倍），显然存在巨大溢价。我认为目前的估值太低，但另一方面，我预计阿里巴巴-SW未来几年的净利润不会达到30倍、35倍甚至40倍。由于阿里巴巴-SW的规模不断扩大，这使得其在未来几年保持出色的增长变得更加困难，与过去的估值相比，未来几年的股价可能会较低。</blockquote></p><p> I still think that shares do have some valuation expansion potential from the current earnings multiple of around 21, thus let's assume that shares trade at 23x net profits in the future. This would still represent a massive discount versus the historic valuation, and also a substantial discount compared to how US-based high-tech mega-caps are valued -- Amazon (AMZN), for example, trades at 59x this year's earnings.</p><p><blockquote>我仍然认为，从目前21倍左右的市盈率来看，该股确实有一定的估值扩张潜力，因此让我们假设该股未来的净利润为23倍。与历史估值相比，这仍然是一个巨大的折扣，与美国高科技大型股的估值相比也是一个巨大的折扣——例如，亚马逊(AMZN)的交易价格是今年市盈率的59倍。</blockquote></p><p> If we want to get to a $500 share price for BABA using a 23x earnings multiple, then we get to earnings per share of $21.70 that Alibaba must generate. When could this be the case? In the following chart, we see EPS estimates for the current year, next year (CY 2022), and CY 2023:</p><p><blockquote>如果我们想使用23倍的市盈率将阿里巴巴的股价达到500美元，那么阿里巴巴-SW必须产生的每股收益为21.70美元。什么时候会是这种情况？在下图中，我们看到了本年度、明年（2022财年）和2023财年的每股收益预测：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6fcf78e0b071eff9753afbdcd96f751c\" tg-width=\"635\" tg-height=\"436\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> If analysts are right, Alibaba will not get to earn $22 a share through 2023, and I think that is realistic. I do not see earnings per share rising by 100%+ between this year and 2023, either. From 2023, it would take another 43% increase in Alibaba's earnings per share to get to $21.70, which is our \"target EPS\" for a $500 share price.</p><p><blockquote>如果分析师是对的，阿里巴巴-SW到2023年每股收益将无法达到22美元，我认为这是现实的。我也不认为今年到2023年间每股收益会增长100%以上。从2023年开始，阿里巴巴-SW的每股收益需要再增长43%才能达到21.70美元，这是我们500美元股价的“目标每股收益”。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7b4c351b4b5eb3328191ccaa9a3b776c\" tg-width=\"635\" tg-height=\"403\"><span>Data byYCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> Analysts are currently forecasting long-term EPS growth of around 27%, which would mean it would take Alibaba about 1.5 years to grow its EPS from $15.20 (2023 estimate) to our target of $21.70. Even if we assume that this is too optimistic and that growth will be just 20% in 2024 and 2025, EPS of $21.70 could be hit by the end of 2025. So, in other words, if Alibaba grows a little less than what analysts are forecasting right now, Alibaba could trade at $500 by the end of 2025 -- or 4.5 years from now. Note that this scenario does not require a high earnings multiple at all -- at 23x net profits, Alibaba wouldn't be expensive, I believe.</p><p><blockquote>分析师目前预测长期每股收益增长约为27%，这意味着阿里巴巴-SW需要大约1.5年的时间才能将每股收益从15.20美元（2023年估计）增长到我们21.70美元的目标。即使我们假设这过于乐观，2024年和2025年的增长率仅为20%，到2025年底每股收益也可能达到21.70美元。因此，换句话说，如果阿里巴巴-SW的增长略低于分析师目前的预测，那么到2025年底（即4.5年后），阿里巴巴-SW的交易价格可能会达到500美元。请注意，这种情况根本不需要很高的市盈率——我相信，阿里巴巴-SW的净利润为23倍，价格并不昂贵。</blockquote></p><p> We can get even more conservative and assume that the 2023 EPS estimate is 10% too high and that EPS will grow by just 17% a year in the years beyond 2023 (versus a long-term forecast of 27% a year by the analyst community). In that case, Alibaba would hit $21.70 in earnings per share in 2026, and shares would rise to $500 over the next 5.5 years. Even in this scenario, BABA wouldn't be a bad investment at all -- a 130% share price increase from the current level over the next 5.5 years would equate to annualized returns of 16%.</p><p><blockquote>我们可以更加保守地假设2023年每股收益预期过高10%，并且2023年之后的几年每股收益每年仅增长17%（而分析师社区的长期预测为每年27%）。在这种情况下，阿里巴巴-SW的每股收益将在2026年达到21.70美元，股价将在未来5.5年内升至500美元。即使在这种情况下，阿里巴巴也根本不是一项糟糕的投资——未来5.5年内股价较当前水平上涨130%，相当于年化回报率为16%。</blockquote></p><p> So, to sum this section up, I'd say<i>yes, BABA can hit $500</i>-- but it will realistically take a couple of years. By the mid-2020s, this seems like a very achievable goal to me, although there are, of course, no guarantees.</p><p><blockquote>所以，总结一下这一部分，我想说<i>是的，阿里巴巴可以达到500美元</i>——但实际上需要几年时间。到2020年代中期，对我来说，这似乎是一个非常可以实现的目标，尽管当然没有任何保证。</blockquote></p><p> <b>Is Alibaba Stock A Buy Or Sell Now?</b></p><p><blockquote><b>阿里巴巴-SW股票现在是买入还是卖出？</b></blockquote></p><p> Alibaba Group is, I believe, a strong investment. The company generates strong growth, profits from multiple long-term macro trends, such as growing consumer spending in China, growing e-commerce market share, and cloud computing. There are, however, risks to consider: Alibaba is highly China-dependent, and in case the economic growth story in China ends, Alibaba would be hurt a lot. On top of that, Alibaba could be targeted again by regulators, although I personally think that it is not in China's best interest to hurt one of its highest-growth tech companies.</p><p><blockquote>我认为，阿里巴巴-SW集团是一项强有力的投资。该公司增长强劲，利润来自多个长期宏观趋势，例如中国消费者支出的增长、电子商务市场份额的增长和云计算。然而，也有一些风险需要考虑：阿里巴巴-SW高度依赖中国，如果中国的经济增长故事结束，阿里巴巴-SW将受到很大伤害。最重要的是，阿里巴巴-SW可能会再次成为监管机构的目标，尽管我个人认为伤害中国增长最快的科技公司之一不符合中国的最佳利益。</blockquote></p><p></p><p> For those that worry about these risks, Alibaba may not be the right choice, but for those that see Alibaba as a potentially very rewarding play on Chinese consumers, BABA could be a strong pick in a diversified portfolio. I belong to the latter group and thus rate the stock a buy at current valuations, expecting significant upside over the coming years. Depending on your risk tolerance and how you weigh the opportunities and threats of investing in Chinese companies, you may decide differently, however.</p><p><blockquote>对于那些担心这些风险的人来说，阿里巴巴-SW可能不是正确的选择，但对于那些认为阿里巴巴-SW对中国消费者来说可能非常有益的投资的人来说，阿里巴巴可能是多元化投资组合中的一个强有力的选择。我属于后一类，因此按当前估值将该股评级为买入，预计未来几年将大幅上涨。然而，根据您的风险承受能力以及您如何权衡投资中国公司的机会和威胁，您可能会做出不同的决定。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4432992-alibaba-stock-hit-500\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"source_url":"https://seekingalpha.com/article/4432992-alibaba-stock-hit-500","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154529120","content_text":"Summary\n\nAlibaba is a battleground stock where some see a lot of opportunities, while others see many risks.\nI believe that there are both opportunities and risks, but would see the prior outweighing the latter.\nIn the long run, BABA has a chance of delivering strong gains for those that buy at the current, quite low, valuation.\n\nPhoto by efetova/iStock via Getty Images\nArticle Thesis\nAlibaba Group (BABA) is a leading global high-tech name that continues to generate attractive growth and that offers investors exposure to the high-growth Chinese consumer market. At the same time, through a range of ventures, Alibaba is also active in additional industries, such as cloud computing. Shares have declined considerably over the last couple of months, but I believe that the long-term potential is significant. I would not be surprised to see shares rise towards $500, although that will not happen in the near term.\nBABA Stock Price\nSince its IPO, Alibaba has seen strong share price gains, but it should also be mentioned that shares did peek in H2 2020, and have declined considerably since then:\nData byYCharts\nShares are now basically where they were one year ago, as the gains during summer 2020 have been erased when Ant Financial's IPO plans were stopped. The flat share price performance over the last year is somewhat surprising, though, as Alibaba continued to generate strong results in that time frame. During the last quarter, for example, Alibaba showcased a revenue growth rate of 64%, while revenue growth during the previous quarter was also very strong, at around 50%. This is not the only positive in Alibaba's earnings releases, however. The company also managed to grow its user count by 32 million during the most recent quarter alone, which equates to an annualized user growth rate of around 20%. This bodes well for future quarters, as more users on Alibaba's platform should translate into higher revenues. On top of that, the strong user growth shows that there is still growing demand for the shopping services that Alibaba's platforms offer -- the market is not saturated at all. Alibaba also managed to grow its EBITDA by 25% year over year, which is an attractive growth pace as well, and which was achieved despite growing investments in what management calls key growth areas. Income from operations, meanwhile, grew at an even faster pace, thanks to some operating leverage, rising by 48% year over year when adjusted for the fine that Alibaba had to pay during Q1. It makes, I believe, sense to back out this one-time item to get a clearer picture about Alibaba's underlying, \"core\" profitability during an average quarter.\nAlibaba Group's weak share price performance, relative to the broad market and other tech names, is thus not the result of weak operating performance, but rather a result of multiple compression, driven by weak investor sentiment due to China exposure and fears about regulation.\nAt its current price of $220, BABA trades at a quite large discount compared to the current consensus analyst price target of $298. If Alibaba were to hit that, shares would gain 35%. Analyst price targets are usually issued with a 1-year time frame, thus, if the analyst community is correct, Alibaba could be a great investment. From a valuation standpoint, this price target doesn't seem outrageous at all, as $298 would equate to around 29x this year's expected net profits, or 23x next year's net earnings. The latter is likely the more telling one when we talk about a price target for summer 2022, i.e. 1 year from now.\nCan Alibaba Stock Hit $500?\nThe answer to that question, I think, depends on your time frame. If you are looking at a 12-month window, then Alibaba will most likely not be able to hit $500. The ~$300 price target seems achievable, although that is, of course, also not guaranteed. If, however, we take a longer-term view, then $500 seems like a share price that BABA could hit eventually. Let's look at a couple of examples.\n- If Alibaba were to generate earnings per share of $20 at some point and traded at an earnings multiple of 25, then shares would trade at $500.\n- If Alibaba were to generate earnings per share of $25 and traded at a 20x earnings multiple, then shares would trade at $500.\n- If Alibaba were to generate earnings per share of $17 and traded at 29x its net profits, then shares would trade at (marginally below) $500.\nWe see that there are many scenarios that could get us to a $500 share price for BABA, some of them more likely than others. Of course, the higher your target multiple, the lower the earnings that would be required. This, in turn, means that the price target can be hit sooner, as less cumulative earnings growth would be required. When we take a look at how Alibaba was valued in the past, we see that the longer-term median earnings multiples for BABA look like this:\nData byYCharts\nAt 30-40x net earnings, Alibaba was clearly trading at a massive premium relative to how shares are valued today (around 20x this year's earnings). I think that the current valuation is too low, but on the other hand, I do not expect Alibaba to trade at 30, 35, or even 40x net profits in coming years. Due to the growing scale of Alibaba, which makes it a little harder to maintain its excellent growth in coming years, shares will likely trade at a lower valuation in coming years, compared to how they were valued in the past.\nI still think that shares do have some valuation expansion potential from the current earnings multiple of around 21, thus let's assume that shares trade at 23x net profits in the future. This would still represent a massive discount versus the historic valuation, and also a substantial discount compared to how US-based high-tech mega-caps are valued -- Amazon (AMZN), for example, trades at 59x this year's earnings.\nIf we want to get to a $500 share price for BABA using a 23x earnings multiple, then we get to earnings per share of $21.70 that Alibaba must generate. When could this be the case? In the following chart, we see EPS estimates for the current year, next year (CY 2022), and CY 2023:\nData byYCharts\nIf analysts are right, Alibaba will not get to earn $22 a share through 2023, and I think that is realistic. I do not see earnings per share rising by 100%+ between this year and 2023, either. From 2023, it would take another 43% increase in Alibaba's earnings per share to get to $21.70, which is our \"target EPS\" for a $500 share price.\nData byYCharts\nAnalysts are currently forecasting long-term EPS growth of around 27%, which would mean it would take Alibaba about 1.5 years to grow its EPS from $15.20 (2023 estimate) to our target of $21.70. Even if we assume that this is too optimistic and that growth will be just 20% in 2024 and 2025, EPS of $21.70 could be hit by the end of 2025. So, in other words, if Alibaba grows a little less than what analysts are forecasting right now, Alibaba could trade at $500 by the end of 2025 -- or 4.5 years from now. Note that this scenario does not require a high earnings multiple at all -- at 23x net profits, Alibaba wouldn't be expensive, I believe.\nWe can get even more conservative and assume that the 2023 EPS estimate is 10% too high and that EPS will grow by just 17% a year in the years beyond 2023 (versus a long-term forecast of 27% a year by the analyst community). In that case, Alibaba would hit $21.70 in earnings per share in 2026, and shares would rise to $500 over the next 5.5 years. Even in this scenario, BABA wouldn't be a bad investment at all -- a 130% share price increase from the current level over the next 5.5 years would equate to annualized returns of 16%.\nSo, to sum this section up, I'd sayyes, BABA can hit $500-- but it will realistically take a couple of years. By the mid-2020s, this seems like a very achievable goal to me, although there are, of course, no guarantees.\nIs Alibaba Stock A Buy Or Sell Now?\nAlibaba Group is, I believe, a strong investment. The company generates strong growth, profits from multiple long-term macro trends, such as growing consumer spending in China, growing e-commerce market share, and cloud computing. There are, however, risks to consider: Alibaba is highly China-dependent, and in case the economic growth story in China ends, Alibaba would be hurt a lot. On top of that, Alibaba could be targeted again by regulators, although I personally think that it is not in China's best interest to hurt one of its highest-growth tech companies.\nFor those that worry about these risks, Alibaba may not be the right choice, but for those that see Alibaba as a potentially very rewarding play on Chinese consumers, BABA could be a strong pick in a diversified portfolio. I belong to the latter group and thus rate the stock a buy at current valuations, expecting significant upside over the coming years. Depending on your risk tolerance and how you weigh the opportunities and threats of investing in Chinese companies, you may decide differently, however.","news_type":1,"symbols_score_info":{"BABA":0.9,"09988":0.9}},"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}